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Restenosis remains a common problem affecting the patency of endovascular 
intervention such as balloon angioplasty and stent placement as treatments for 
atherosclerosis.  Denudation of the endothelial layer and the increased injury from 
balloon deployment can cause phenotypic changes in surrounding vascular smooth 
muscle cells (SMCs) in vivo.  The presented work modeled this mechanical environment 
in vitro to investigate the role of the altered mechanical environment on the phenotypic 
response of SMCs.  Through the system design and CFD channel characterization, a six-
independent-channel system providing low oscillating wall shear stress (WSS) was 
manufactured to apply concurrent shear and tensile forces with uniform strain and WSS 
profiles over the cell location.  The project hypothesis that balloon angioplasty 
endovascular intervention exposing vascular smooth muscle cells to an altered 
mechanical environment would evoke a cell phenotype change.  The exposure of SMCs 
to concurrent shear and tensile forces following balloon angioplasty resulted in a more 
synthetic phenotype behavior marked by such characteristics as increased synth tic 
morphology, increased proliferation, increased apoptosis and decreased expression of 
contractile markers.   
 Clinical implications for this work suggest that physiological dynamic regimens 
should be incorporated into in vitro studies.  We simulated balloon angioplasty through 
increased strains and a clinical heparin bolus administration, both of which evoked 
different SMC responses compared to controls.  SMC response triggered by exposure to 





dynamic concurrent shear and tensile forces should be incorporated in vascular in vitro 
testing to possibly lead to better treatment and prevention of restenosis following 
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1.1 Clinical Significance 
Cardiovascular disease is an ongoing problem facing healthcare systems.  
Atherosclerosis is the leading cardiovascular disease which causes problems of 
thickening in arteries and a decrease in lumen size.  When a severe atherosclerotic lesion 
forms, clinical intervention is required such as arterial bypass or a less invasive 
endovascular procedure percutaneous transluminal angioplasty (PTA).  Unfortunately, 
following PTA, endothelial cells that comprise the lumen of the artery are denuded an  
arterial smooth muscle cells are exposed to normally unseen blood flow.   Under normal 
conditions, arterial smooth muscle cells are in direct contact with tensile forces from the 
expansion of the blood vessel, but following PTA, they are exposed to concurrent shear 
and tensile forces.  In vivo response of smooth muscle cells following angioplasty include 
increased migration and proliferation, which can initiate restenosis, or the reclosing of the 
artery. 
Following balloon angioplasty, the denudation of the endothelial cell layer allows 
the exposure of the smooth muscle cells (SMCs) to normally unseen shear forces from 
blood flow.  The response of the SMCs to these mechanical forces includes apoptosis, 
differentiation, migration, hypertrophy and proliferation.  The balloon angioplasty 
induced injury can be the etiology for the SMC change from a contractile to a synthetic 
phenotype [1].  Synthetic smooth muscle cells are characterized by: increased number of 





decreased α-actin, increased protein secretion, loss of contraction ability, and an 
increased cell volume [2-5].  In contrast, contractile smooth muscle cells are generally 
spindle shaped, non-proliferative, able to contract, and contain relatively more α-actin, 
calponin, and smooth muscle myosin heavy chain isoforms than synthetic smooth muscle 
cells [2, 3, 5-7].   
Smooth muscle proliferation is believed to be an acute response to injury and can 
occur up to seven days following balloon angioplasty with most of the cells entering the 
growth cycle within the first 1-3 days following injury [8].  Following the acute response, 
the number of smooth muscle cells within the intima stays relatively constant up to a year 
following the endovascular procedure.  Due to the stability of the smooth muscle cell 
population with time, further increases in intimal hyperplasia are believed to be due to the 
production of extracellular matrix and connective tissue and from cellular hypetro hy 
[9].  Maximum intimal thickening in humans usually occurs within 2-3 months of injury 
[10].  The degree of activation of smooth muscle cells following angioplasty effects the 
migration and proliferation characteristics of smooth muscle cells and directly contributes 
to the degree of intimal thickening and hyperplasia.  To date there have been many 
studies designed to investigate the in vivo response of SMC to injury following balloon 
angioplasty.  Due to difficulty in maintaining concurrent shear and tensile forcs to 
evaluate their effect on SMC in vitro, limited studies have been performed using an  
vitro model.   
In the development of an in vitro model, it is important to incorporate the vascular 





has been developed for use in this project.  In addition, this model can also be used to 
investigate the effect of increased forces during PTA.  The custom designed syst m was 
implemented to evaluate the effects of applied stress levels on vascular smooth muscle 
cell response through the following aims of this project with the ultimate goal of this 
project to provide a clinically relevant platform for the reaction of smooth muscle cells 
that could be implemented for use in testing of pharmaceutical agents for the prevention 
of restenosis.   
 
1.2 Project Hypothesis: 
 
It was hypothesized that balloon angioplasty endovascular intervention exposing vascular 
smooth muscle cells to an altered mechanical environment will evoke a cell phenotype 
change.  The exposure of smooth muscle cells to concurrent shear and tensile forces 
following balloon angioplasty will result in a more synthetic phenotype of the smooth 
muscle cells when compared to normalized dynamic strain which was thought to 
maintain the contractile behavior of the cells.   The hypothesized synthetic behavior w s 
hypothesized to result in increased proliferation, altered cell morphology, increased 
hypertrophy, increased apoptosis, and decreased expression of contractile phenotype 
markers.  Incorporation of a clinical administration of heparin within the dynamic injury 
model was hypothesized to result in decreased SMC proliferation potentially conserve 
contractile phenotype markers.  Changes in protein expression due to mechanical stimuli 
were hypothesized to be controlled in part by extracelluar signal-regulat d kinase (ERK) 






1.3 Summarized Project Aims 
 
Aim 1- Design a six-station concurrent shear and tensile mechanical force in vitro 
simulator to model clinically significant levels of physiological strain and shear stress. 
 
The designed system consists of two Lexan vascular mechanics simulators.  Six 
independent channels receive fluid from multichannel peristaltic pump system which 
provides fully developed laminar fluid flow to cells grown on a collagen coated flexible 
silicone membrane.  Cyclic tensile force to cells is applied by vacuum application which 
stretches the silicone membrane containing the cells over a rigid platform.  The vacuum 
regimen is regulated through the FlexCell computer system and the system was 
successfully calibrated to relate the programmed elongation versus the actual 
experimentally determined percentages of elongation within reasonable error.  
 
Aim 2- Computational Characterization of system using Computational Fluid Dynamics  
 
 
In order to validate the shear component of the design and to investigate 
alterations of the theoretical wall shear stress (WSS), Computational Fluid Dynamics 
(CFD) simulations were performed using GAMBIT for the geometry construction and 
FLUENT for the CFD simulations. The particular parameters of interest were th  wall 
shear stresses and the fluid velocity profiles at the location of the cells following suction 
of the silicone membrane simulating balloon angioplasty.  Steady-state deformation 
simulations did not result in significant WSS changes.  Simplified moving wall 
deformation in unsteady demonstrated that the changes in WSS in dynamic simulations 





geometry changes.  Parabolic unsteady dynamic simulations confirmed this princ pal, 
demonstrating oscillating WSS at the site of the cells with positive velocitis maintained 
over deformation.  This analysis demonstrated that dynamic simulation is needed to 
accurately model shear mechanical forces on cells in vascular mechanics simulator and 
will provide insight to the actual mechanical stresses that are present at the cells.   
 
 
Aim 3- Establish a vascular smooth muscle cell proliferation model using a short time 
point with in vitro mechanical application and clinical intervention. 
 
In this acute study (8 hours), rat aortic SMC demonstrated significant cell 
proliferation following applied angioplasty injury and shear exposure when compared to 
“normal function” tensile exposure.  Low wall shear stress was applied to the cells to 
simulate areas where early intimal thickening commonly occurs, such as immediately 
following a stent strut where fluid profiles are dramatically altered an  fluid shear 
stresses are dramatically decreased.   
The increased expression of the phenotypic marker SM α-actin indicated a 
significant increase in synthetic behavior of the smooth muscle cells exposed to balloon
angioplasty injury and concurrent shear and tensile mechanical forces.  These findings 
demonstrate the efficacy of the developed model for in-vitro angioplasty and the 











Aim 4-  Evaluation of the Increased Synthetic Phenotype Behavior of Smooth Muscle 
Cells in Response to in vitro Balloon Angioplasty 24h Injury Model  
 
Expansion of the previous 8 hour study to 24 hour resulted in alterations in cell 
responses of apoptosis, proliferation, cell hypertrophy, and phenotype behavior.  The 
injury model resulted in increased proliferation and apoptosis and decreased SM α-actin,
SM22α, and calponin expression of the dynamic groups (IM, BA, CT) compared to the 
static group (U).  Expression of the synthetic marker, vimentin, was increased in th  
injury model with combined concurrent forces in comparison to the decreased expression 
in those exposed to strain alone (CT).  Overall, increased cell hypertrophy, decreased 
contractile markers, and an increased number of cells demonstrate the highest synthetic 
behavior of the SMCs within the developed injury model.   
 
Aim 5- The Effects of Heparin Administration in Concurrent Force Injury Model 
 
The effect of the administration of heparin on smooth muscle cells (SMCs) after 24 hours 
was investigated using the developed injury model.  A local administration of 100 µg/ml 
was compared to a clinically relevant bolus of 10,000 units for 5 minutes prior to balloon 
angioplasty followed by 100 µg/ml administration over the course of 24 hours.  It was 
found that the heparin bolus dynamic group resulted in a decreased number of cells while 
the 100 µg/ml administration had no effect within the injury model.  Additionally, 
heparin was shown to significantly decrease calponin expression within the bolus injury 





responses demonstrate the necessity of using dynamic clinically relevant in itro models 
for pharmaceutical agent testing. 
 
Aim 6- Evaluating the Role of ERK ½ in Injury Model Protein Expression Response 
Decreased in ERK ½ activity were confirmed in the concurrent force injury model to 
similar levels as with the ERK ½ inhibitor U0126.  The inhibited and uninhibited injury 
models resulted in similar expressions of SM22α and SM α-actin.  However, comparison 
to the inhibited and uninhibited static control (U) demonstrated that the large differnces 
in ERK ½ activity were not attributed to inhibition.  ERK ½ may be partially involved, 
but other mechanotransduction pathways must be involved to evoke these SMC 
responses.   
 
 




Atherosclerosis is the continually leading type of heart disease and cause of 
mortality each year in the United States.  Atherosclerosis is usually characterized by a 
fatty streak, fibrous plaque, and resultant lesions.  Fatty streaks are present in many 
stages of life; however different arteries normally contain fatty streak lesions in different 
stages.  For example, fatty streaks are present in the aorta, in coronary arteries, and in the 







Mechanisms of Atherosclerosis 
 Role of Endothelium 
Endothelial dysfunction is believed to be one of the initiating factors of 
atherosclerosis.  Early stages of atherosclerosis consist of intimal accumulation of fat-
filled cells due to endothelium dysfunction.  In a normal vessel, the endothelium acts as a 
non-thrombogenic surface and a selectively permeable barrier to protect the lumen and 
control passage between the blood and tissues [11, 12].  Anatomically, it makes up the 
intima of the blood vessel and provides a non-thrombogenic interface for contact with 
blood.  
At early stages of atherosclerosis, the endothelial cells are believed to express 
adhesion molecules where monocytes can attach. The process begins with the rolling of 
leukocytes on the endothelium mediated by adhesion molecules such as ICAM or 
selectins such as P-selectin [13].   The actual adhesion of these molecules may be 
mediated by molecules such as VCAM-1 on the endothelium and VLA-4 on the 
monocytes and T cells [11].   The process of leukocyte transmigration across the 
endothelium is demonstrated in Figure 1.     
 
 
Figure 1.1 Endothelium Interaction with Leukocyte Adhesion
 
Role of Monocytes and Macrophages
The monocytes can then turn into macrophages and trsudate further into the 
vessel wall [12, 14].   In atherosclerosis, increased monocyte recruitmen  and 
macrophage proliferation also occurs.  Monocy
receptor CCR2 have been shown to affect the number of r cruited monocytes 
The cytokine such as M-CSF has been shown to be involved in the proliferation and 
differentiation of macrophages 
cholesterol from transudated plasma lipoproteins, becoming foam cells and secreting 
growth factors and chemotactic factors which recruit more macrophages and leukocytes 






te chemotactic protein (MCP-
[17].   The transudated macrophages can then engulf 
 
1) and its 





Role of Lipoproteins 
When increased levels of circulating low density lipoprotein (LDL) are present, 
transport and retention in sites for atherosclerotic lesion formation are increased [11].  
LDL passively diffuses through endothelial cell junctions and is retained in the vess l 
wall by apolipoprotein B (apoB) and matrix proteoglycans [18].  Modification of the 
trapped LDL in the forms of oxidation, lipolysis, proteolysis, and aggregation, allws for 
increased uptake by macrophages in order to form foam cells and contribute to 
inflammation [11].  Accumulation of minimally oxidized LDL can also stimulate 
endothelial cells to produce adhesion molecules and growth factors, ultimately le ding to 
the recruitment of monocytes and lymphocytes as previously discussed [11].  Nitric oxide 
production can be inhibited by oxidized LDL which can also contribute to atherosclerosis 
due to decreased vasorelaxation function and resultant higher blood pressures [11, 14].     
 Atherosclerotic Lesion Classification  
 Atherosclerotic lesions can form from the fibrosis and cell death that occurs 
within the artery wall.  These are usually stable and consist of collagen and calcium.  
These lesions are commonly classified using Stary’s Classification which characterized 
lesions into five phases shown in Figure 2 [12].   
 
 
Figure 1.2 Stary’s Classification of Lesion Classification 
 
The first phase is usually characterized by lesion types I
under 30 years old.  Lesion type I consists of foam cells and lipid droplets, type II 
contains macrophages and smooth muscle cells with lip d deposits, and type II consist
mostly of smooth muscle cells surrounded by extracellular lipid.  The plaque that is 
present in Phase II is high in lipid content, which can lead to rupture.  The types of lesion 
in Phase II are types IV and Va.  Both of these contain large amounts of ex
lipid, but the lipid in Va is usually covered by a fibrous cap.  These can evolve into more 
severe lesions of Vb or Vc into Phase 3 or 4.  Vb lesions contain more smooth muscle 
cells, lipid, and connective tissue while Vc lesions contain larger
Phase 4, the lesion may rupture or fissure, or a thombus may form.  Phase 5 can result in 
fibrotic behavior and partial or total occlusion of the artery.     
11 
       
        
[12] 
-III and can occur in individuals 
tracellular 
 amounts of collagen.  In 
 







In higher stages, the stability of the lesion tends to decrease.  Plaque consisting of 
extracellular lipids and macrophages may be more vulnerable to rupture, and may be 
more influential than the size of the lesion.  The plaque in atherosclerosis consists f both 
intracellular and extracellular lipids in addition to macrophages, T-cells, smooth muscle 
cells, proteoglycans, collagen, calcium, and necrotic debris [11]. 
Contributing Factors to Atherosclerosis 
There are several factors, both environmental and genetic, which can lead to 
higher risks of atherosclerosis.  Environmental factors include: high-fat diet, smoking, 
low antioxidant levels, lack of exercise, and infectious agents [11].  Genetic factors 
include: elevated levels of LDL/VLDL, reduced levels of HDL, elevated levels of 
lipoprotein(a), elevated blood pressure, elevated levels of homocysteine, family histor , 
diabetes and obesity, elevated haemostatic factors, male gender, systemic infla mation, 
metabolic syndrome, and depression and other behavioral traits [11].  Elevated levels of 
LDL can lead to accumulation and increased passage through the endothelial junctions, 
ultimately resulting in the formation of foam cells as previously discussed.  Low levels of 
high density lipoprotein (HDL) are promoters of atherosclerosis because HDL protects 
against atherosclerosis.  HDL removes excess cholesterol from the surrounding tissue and 
inhibits lipoprotein oxidation [11].           
Clinical Assessment and Intervention for atherosclerosis 
Imaging and Assessment 
A growing occlusion of the blood vessel can lead to decreased blood flow to peripheral 





artery is decreased.  These lumen decreases are generally detected with methods such as 
ultrasound or angiography.   
Intravascular ultrasound (IVUS) is an invasive ultrasound technique that can 
provide higher resolution images and information about the blood vessel.  In this method, 
cross-sectional arterial images are obtained by inserting an ultrasonic transducer mounted 
on a catheter.  It uses an ultrasound beam at varying frequencies to form images of 
surrounding objects.  High frequencies are used for higher resolution while low 
frequencies are used when depth of penetration are more of interest [19].  Three 
dimensional images can be formed by catheter controlled advancement or contraction.  
IVUS is used in both pre-operative and post-operative assessments following 
endovascular intervention.  IVUS can be used to examine vascular compliance and 
characterize plaque through detection of differences in acoustic impedances [19, 20].  
Angiography is a lower resolution imaging technique but is still important in 
endovascular imaging.  In angiography, a liquid iodinated contrast agent gas is injected 
into the blood stream in order to image the vascular tree [19].  Angiography uses a 
system of fluoroscopy and x-ray to create images of the blood flow.  It is often used 
during surgery for proper balloon placement and stent positioning.  Following surgery, it 
shows the restored patency of the artery while IVUS is better at demonstrating he 
microenvironment of the artery [19].   Angiography can also be used with magnetic 
resonance imaging (MRI) in the process of magnetic resonance angiography (MRA) 
which is used to evaluate the vasculature or with computed topography (CT) in computed 





angiography is still more prevalently used in part due to the increased acquisition t me 
and image manipulation of these other techniques.  In addition, MRA may still 
overestimate the amount of stenosis present within an artery.  Summarized information 
concerning diagnostics is provided below in Table 1.1.       
Table 1.1 Comparison of Diagnostic Techniques 
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 Surgical Procedures 
If the degree of occlusion is significant, surgical intervention is required.  Arterial 
bypass using artificial grafts or vein grafts is one possible surgical treatment. Artificial 





polytetrafluoroethylene (PTFE).  However, arterial bypass has drawbacks that include the 
need for open surgery, material biocompatibility, and differences in hemodynamic 
velocity profiles.  Endovascular procedures are considered minimally invasive nd 
require less time in the hospital and less time for patient recuperation than open bypass 
surgeries.      
Balloon Angioplasty 
 Percutaneous transluminal angioplasty (PTA), or balloon angioplasty, is an 
example of an endovascular procedure that prevents the need for open surgery.  During 
PTA, as the balloon is expanded, plaque within the walls of the vessel is compressed.  
Balloon deployment may also tear the plaque in order to enlarge the lumen area [12].  In
balloon angioplasty, a catheter is inserted usually through the artery with a deflated 
polyethylene (PE) or polyethylene terephthalate (PET) balloon on the tip of the catheter 
[19].  The length and diameter of the balloon is determined prior to surgery according to 
ultrasound and angiography results yielding information on the length, location, and 
severity of the lesion area.  For large arteries such as the iliac, a balloon diameter in the 
range of 5 to 10 mm in diameter is generally needed [19].  In general, balloon sizes 
increased 20 to 30 percent larger than the vessel are used in PTA depending on the 
compliance of the balloon [19]. 
The mechanics of the balloon deployment can vary between procedures.  The 
balloon is deployed with saline.  The balloon can be deployed with an inflation device or 
according to the surgeon’s discretion.  During deployment, the balloon expands until the 





stress that is placed on the vessel wall due to deployment is referred to as the hoop stress 
which is a product of the outward fluid pressure and the balloon diameter [19].  The 
pressures on the arterial wall range between 5-15 atmospheres [19].  Local differences in 
pressures caused from variations in the geometry of the stenosis can result in increased 
longitudinal and outward vector forces [19].     
The duration of balloon deployment is generally 10-20 seconds with an average 
number of two deployments [19].  Two deployments is suggested to allow for 
reconfiguration of the vessel and different frictional forces which upon the second 
deployment, may demonstrate increased efficacy of the balloon angioplasty [19].   
Intravascular Stents 
Balloon angioplasty can be performed as an individual procedure or paired with a 
stent placement.  A stent is a slotted metal tube designed to mechanically assist in 
maintaining the lumen of the artery to maintain proper blood flow in the artery.  Stents 
are generally categorized as thermal, self, or balloon-expandable.  Thermally expandable 
stents are made of out nitinol, which is an alloy of nickel and tantalum and referred to as 
a memory shape alloy [21].  During a nitinol stent deployment, the stent expands in its 
austenite phase at the temperature of 37 degrees Celsius [22].  A study performed by 
Carter and collaborators found that the thermal expanded nitinol stent compared to the 
balloon deployed Wallstent resulted in decreased thrombus formation, infiltration of 
inflammatory cells, and neointimal formation [22].  Overall, thermal expansion stents are 





[22].  However, the methods of this study used direct stenting without balloon 
“predilation” prior to stent placement which could affect the results.   
Balloon expandable wire stents are crimped over the balloon to allow passage 
through the arterial access.  One of the first used stents implemented was the P lmaz 
stent.  This stent is made of stainless steel with silver soldered cross points to help resist 
radial collapse [19].  The Palmaz stent is still commercially used today.  During a stent 
placement, balloon angioplasty is sometimes first performed to expand the lumen of th  
artery, referred to as “predilation” [19].  After retraction of the catheter, another catheter 
is inserted with a balloon with a crimped stent over the balloon.  As the balloon is inflated 
again to approximately 10 atmospheres pressure for about 10 seconds, the stent is 
deployed and secured into the vessel wall [19].   
Although stents can reduce the effect of negative remodeling, they can also resu t 
in higher cases of intimal hyperplasia than angioplasty alone [23-25].  There are several 
variables which could potentially affect this such as the balloon compliance, pressure of 
inflation, and the distance between stent struts.  Using both in vivo and finite element 
analysis (FEA), Rogers and collaborators demonstrated that there are  higher contact 
stresses between the stent struts and a greater surface-contact area betwe n the stent and 
the artery with higher balloon inflation pressures, increased balloon compliance, and 
wider stent-strut openings [26].  Understanding this relationship is important is stent 







 Drug eluting stents 
Drug eluting stents (DES) are a recent advancement in stent technology although 
long term studies are still under evaluation.  In a drug eluting stent, drugs can be directly 
attached to the metal stent or embedded within a polymer coating within the stent which 
serves as a reservoir for drug release [27].  Local dosage tissue delivery of drug eluting 
stents eliminates the risk of systemic toxicity [28].  New drugs are constantly under 
evaluation for use in drug eluting stents.  Anticoagulants, steroids, and antiproliferative 
agents have three general categories of possible coatings applied to stents [29].  The two 
most well documented and FDA approved drugs commercially are rapamycin 
(Sirolomus) and taxane (Paclitaxel).  Both of these drugs are commonly used but have 
differing attributes.  For example, arterial transmural distribution of sir lomus tends to be 
evenly distributed while paclitaxel remains within the subintimal space [30]. The 
mechanisms of action also differ between these two pharmacokinetic agents.  
Sirolomus inhibits the mammalian target of rapamycin (mTOR) [27, 31].  mTOR 
regulates protein translation and the inhibition of mTOR results in G1 arrest of the cell 
cycle [27, 32].  Arresting the cell cycle in the late G1 phase does not allow DNA 
replication of the cell [31].  In result, vascular smooth muscle cell migration, 
proliferation, and growth are inhibited [32].  This mechanism is shown in Figure 3.  In 
animal studies, sirolomus has been shown to have decreased inflammatory response and 
neointimal hyperplasia formation in addition to inhibited SMC migration and promotion 





have increased platelet aggregation which paired with delayed re-endothelialization 
results in a higher risk of subacute thrombosis [36]. 
Paclitaxel is an anti-proliferative agent belonging to the group of taxanes which 
are commonly used in cancer treatment [27].  Paclitaxel works by disrupting the 
cytoskeletal components during cell division.  Specifically, paclitaxel polymerizes the α 
and β units of tubulin incorporated with the microtubule structure [27].  Paclitaxel arrests 
the cell in the G2/M phase of mitosis by accumulation of microtubule structures [31].  
This mechanism can be seen in Figure 3.  The disruption of the microtubules in mitosis is 
important because the microtubules form the mitotic spindle during cell division.  Similar 
to sirolomus, paclitaxel has been shown to inhibit smooth muscle cell migration and 
proliferation [37].  Some of the adverse effects of paclitaxel in studies have been 
incomplete healing, increased number of macrophages, and fibrin deposition [38].  Direct 
application of paclitaxol has demonstrated differing results than polymer coatd stents 
with paclitaxol within the polymer.  Stents coated with poly(lactide-co-Σ-caprolactone) 
have shown a more effective drug kinetic profile with high initial release but lower 
controlled release within the following 10 days [39].  Stents with directly attached 






Figure 1.3 Drug-eluting stents: mitosis inhibition by sirolomus and paclitaxe  [40] 
 
Other drugs including derivatives of sirolomus and paclitaxel continue to be 
investigated for use in drug eluting stents, but results are still preliminary.  Some of the 
points of interest for potential drugs include: time to re-endothelialization, endothelial 
cell function, smooth muscle cell migration, smooth muscle cell proliferation, smooth 
muscle cell phenotype, vascular healing, and inflammatory response.  A combinatory 
drug approach to address multiple points is also a subject of interest for drug elutin  
stents.  
Variations of the stent and polymer coatings can also affect the response of drug
eluting stents.  The ideal drug eluting stent should have appropriate radial strength, 





have struts close together to allow for complete drug coverage distributed to the lesion 
and surrounding areas [27].  If the struts are too far apart, areas of the blood vessel will be 
unable to gain access to the drug.  One particular stent, the Conor drug delivery stent, 
uses laser cut pockets to allow for a combination of different polymers and drugs within 
different pockets and an optimal drug release profile with time over the affected area 
[41].   
The purpose of the polymer coating is to promote adequate drug adherence to the 
stent.  Different layers of polymers or different polymer concentrations ca  also be used 
to vary the drug release over time [27].  Early polymeric coatings were associated with 
problems of biocompatibility, inflammatory response, and neointimal proliferation [42].  
Inorganic coatings are currently used to enhance the electromechanical properties and 
reduce inflammatory response and platelet activation [27].  The polymer coating f he 
commercially available sirolomus eluting stent Cypher contains a co-polymer system 
consisting of polyethylene-co-vinyl acetate and poly n-butl methancrylate 
(PEVA/PBMA).  The polymer of the paclitaxel eluting stent Taxus manufactred by 
Boston Scientific consists of the Translute polymer [Poly(styrene-b-isobutylene-b-
styrene)].  Since long-term studies are still limited with drug eluting stents, there is some 
question concerning the stability and inertness of the polymer coatings with time.  For 
example, Poly-methacrylate, the major component of the sirolomus-eluting stent, has 
been shown to induce smooth muscle cell apoptosis in vitro [43].   
The future of drug eluting stents would ideally incorporate biodegradable stents.  





implanted at the site of injury and slowly degrade over time, releasing the drug as it 
degrades.  Unfortunately, currently there has not been a biodegradable stent with the
required mechanical strength and surface properties like metal stents [31].  The idea of 
biodegradable stents would eliminate the trauma associated with a permanent rigid 
foreign body [31].    
The potential of drug eluting stents decreasing the rates of restenosis is a h ghly 
significant factor in health care systems.  Although drug eluting stents currently cost 
about five times more than non-coated stents, the cost and effectiveness profiles are 
promising [44].  Current costs of drug eluting stents are high due to developmental and 
research costs, exclusive licenses for pharmaceutical agents, and low production yield 
[44].  Longer term studies and resultant reinterventions will be used for future evaluations 
of cost effectiveness.   
1.4.2 Restenosis 
Following the endovascular procedure, restenosis, or the reclosing of the artery 
can occur.    Restenosis in balloon angioplasty alone can occur in 30-60% of the 
procedures [45].  Stenting reduces the rate of restenosis to 13-36%, but is still cl nically 
significant [12].  There are several factors that can contribute to restenosis which include 
both chemical and mechanical factors.  Intimal hyperplasia, injury response, elastic
recoil, and vascular remodeling are key components of restenosis.   
Characteristics of Restenosis 
Restenosis following stenting can differ from restenosis following balloon 





with only 11% cells and consists mostly of ECM, proteoglycans, and collagen [40].  
Neointimal hyperplasia is mostly due smooth muscle cell hyperplasia [29].  The primary 
difference between in-stent restenosis and balloon angioplasty alone is the increased 
presence of cells and their proliferation in addition to inflammatory markers in thecase of 
in-stent restenosis [46, 47].  Neointimal proliferation surrounding a stent results from the 
vascular trauma from stent wires at the time of implantation, the interaction of the blood 
components and the stent material interface, and the altered fluid velocity and pressure 
profiles [48-50]. 
Contributing Factors to Restenosis 
Many factors contribute to intimal hyperplasia and potentially resteno is.  As 
noted, following endovascular procedures like balloon angioplasty and stent placement, 
the endothelial monolayer is severely damage or completely denuded from the arterial 
lumen.  This removal of the protective endothelial cells can result in platelet adh sion and 
aggregation due to the release of platelet-derived growth factor (PDGF) [51].   
Role of Endothelial Cells 
Endothelial cells are also important in their release of heparin.  Studies have 
shown that heparin helps to maintain the quiescent, low proliferating state of smooth 
muscle cells [52].  Without the anti-proliferative effect of the heparin fromthe 
endothelial cells, there is less control on smooth muscle cell proliferation. 
However, there are limitations to the involvement of endothelial cells in intimal 
hyperplasia.   When a small arterial area is denuded but endothelial cells recoverthe area, 





denuded and endothelial coverage is incomplete, intimal hyperplasia may reach a 
maximum thickness at 2 months without endothelial cells [51].  This suggests that the 
acute response and following few months are important for the role of endothelial cells in 
restenosis.   
Role of Platelet-derived growth factor (PDGF) 
Studies have shown the importance of endothelial cells but there are other factors 
that could potentially play key roles in restenosis.  Adherent platelets deliver PDGF  to 
the injured vessel wall which may be an important factor [51].  However, aggregated 
platelets may play a significantly lesser role due to the rapid clearance of their released 
PDGF [51].  PDGF stimulates DNA synthesis and cell proliferation by allowing the cell 
to leave the arrest state (G0) and move into the cell cycle state of (G1).  The release of 
PDGF stimulates mitogenic and chemotactic movement of medial smooth muscle cell , 
causing migration and proliferation of the smooth muscle cells toward the intima [51].   
Smooth Muscle Cell Migration 
Smooth muscle cell migration plays a contributing role in intimal proliferation.  
Cell migration is influenced by both biochemical and mechanical influences.  Endothelial 
cells are important in the regulation of smooth muscle cell migration.  Endothelial cel s 
are responsible for the secretion of autocrine and paracrine factors.  There are several 
factors that may inhibit smooth muscle cell migration that are associated with endothelial 
cells.  Some of these include: nitric oxide [54, 55], endothelial plasminogen activator 
inhibitor-1 (PAI-1) [56], platelet derived growth factor isoforms (PDGF-AA and PDGF-





factor-β1 secretion, and inhibition of SMC hyaluronanic secretion [59].  Denudation of 
the endothelial layer and these factors allows for SMC migration.   
Matrix metalloproteinases (MMPs) are a group of mechanosensitive proteases 
that may be important to smooth muscle cell migration.  They degrade extracellular 
matrix components such as collagen, laminin, and fibronectin [60].  In addition, they 
break down non-matrix substrates such as growth factors and cell surface receptors [60].  
These functions make them very important in the process of vascular remodeling.  In 
combination with chronic strain (5%), endothelial derived MMP-2 has been shown to 
mediate the down-regulation of BASMC migration [61].  The same response was not 
seen in the static controls, suggesting the importance of cyclic strain.  In response to 
vascular remodeling stimuli, the up-regulation of MMP-2 and MMP-9 derived from 
smooth muscle cells degrades the basement membrane and the surrounding extracellular 
matrix, therefore facilitating smooth muscle cell migration [61].    
 Smooth Muscle Cell Proliferation      
Smooth muscle proliferation is believed to be an acute response to injury and can 
occur up to seven days following balloon angioplasty with most of the cells entering the 
growth cycle within the first 2-3 days following injury [8].  Following the acute response, 
the number of smooth muscle cells within the intima stays relatively constant up to a year 
following the endovascular procedure.  Due to the stability of the smooth muscle cell 
population with time, further increases in intimal hyperplasia are believed to be due to the 





[9].   Maximum intimal thickening in humans usually occurs within 2-3 months of injury 
[10].  
 
Phenotype of Vascular Smooth Muscle Cells 
Normal non-diseased smooth muscle cells reside primarily in the media layer of 
the blood vessel and are of a contractile phenotype.  Following balloon angioplasty, 
medial smooth muscle cells can change from a contractile to a synthetic phenotype [1].  
These synthetic cells migrate to the intima and proliferate and excrete extracellular matrix 
components such as elastin, collagen, and proteoglycans [12].  The extracellular matrix 
production of synthetic smooth muscle cells is 4-5 times the amount of ECM produced by 
contractile smooth muscle cells.  It is estimated that 50% of the smooth muscle cells that 
migrate from the media due to balloon angioplasty divide 3 times [8].  These cells make 
up eight ninths of the resultant intimal smooth muscle cell population [8].   The 
remaining one ninth of the resultant smooth intimal smooth muscle cell population 
consist of the remaining 50% of smooth muscle cells activated from balloon angioplasty 
which simply migrated to the intima without further replication [8].  Synthetic smooth 
muscle cells are characterized by: increased number of synthetic organelles, such as 
rough endoplasmic reticulum, increased proliferation, decreased α-actin, loss of 
contraction ability, and an increased cell volume [2].  In contrast, contractile smooth 
muscle cells are generally spindle shaped, non-proliferative, able to contract, and contain 
relatively more α-actin than synthetic smooth muscle cells [2].  Mechanically, the 





smooth muscle cells [62],  and suggested to be from an increased amount of actin within 
the SMCs [62].   
In summary, it is hypothesized that the degree of activation of smooth muscle 
cells following angioplasty affects the migration and proliferation characte istics of 
smooth muscle cells and directly contribute to the degree of intimal thickening and 
hyperplasia.   
Impact of Endovascular Intervention 
The actual surgical procedure can impact restenosis.  Balloon angioplasty 
specifications depend on the disease state of the vasculature, surgical preference, balloon 
diameter, injury length, and other contributing factors.  The extent of the injury in terms
of the transmural pressure exerted on the vessel wall and on the cells within the vessel 
wall can affect the cellular response to injury.  Experiments in literature have shown that 
a large injury without media damage initiated medial smooth muscle cell replication, but 
no intimal proliferation [63].  In contrast, when a small but deeper injury was performed, 
intimal proliferation occurred.   In the first case, there was also platelet dh sion and late 
endothelial recovery while in the second case, platelets were absent and the endothelial 
monolayer was quickly recovered.      
This can also be associated with the rupture of the internal elastic lamina.  This 
supports the theory that mechanical or possibly inflammatory activation of smooth 
muscle cells is needed to initiate smooth muscle cell proliferation and that platelet 
adhesion and endothelial denudation, although can contribute to proliferation, are not 





angioplasty can cause several disturbances within the blood vessel including platelet 
aggregation, endothelial denudation, growth factor production from injured and dead 
smooth muscle cells, attraction of leukocytes and macrophages from the inflammatory 
response, and mechanical sustained stretch of smooth muscle cells, which can all 
contribute to cellular proliferation [51]. 
Composition of Atherosclerotic Lesion 
The composition of the atherosclerotic lesion can indirectly contribute to intimal 
hyperplasia and restenosis.  With varying amounts of fibrous tissue, lipid, calcium, and 
organized thrombus, the mechanical rigidity of the plaque can differ. The resultant 
distensibility of the lesion area of the vessel is significantly lower than te ormal vessel 
wall and is not easily compressed by the tensile forces of the balloon.  The plaque within 
the wall is not compliant so unfortunately, the surrounding smooth muscle cells and 
tissue are subject to most of the applied balloon tensile force [51].  The stiffer the plaqu  
composition, the more force that is necessary to expand the vessel, resulting in higher 
pressures exerted on surrounding cells.  The severe increase in diameter from increased 
radial expansion also exposes a greater surface area of smooth muscle cells that are 
exposed to shear force and subject to platelet adhesion.   However, the higher the plaque 
content within the blood vessel, the more likely the vessel will retain the open lumen 
following angioplasty due to less elastic recoil because of the lower elastic properties of 








  The body reacts to foreign objects not normally seen, even if they are considered 
to be biocompatible materials.  With a stent placement, there is a reaction to the 
mechanical force of the stent in addition to the material reaction.  After stent deploym nt, 
the stent is in contact with both surrounding cells and with blood flow.  With any implant, 
both the acute and long-term responses are important for function.  In the case of a stent, 
the reaction will be driven by the surface characteristics of the material such as 
roughness, electrical charge, free surface energy, and wettability [64].  The roughness of 
a stent can be altered by the machining process.  The thrombogenicity of a materi l 
increases with rougher materials [64].  In the case of a bare metal stent, a thi  metal oxide 
layer resides between the stent and surrounding tissue [64].   
 Immediately following stent implantation, reaction occurs.  Bare metal metallic 
stents have an initial positive surface charge [64].  When implanted, this surface potential 
attracts plasma proteins and results in a 5-20 nm thick layer of fibrinogen surrounding the 
implant within seconds of implantation [64].  After 24 hours, a layer of fibrin strands 
oriented in the direction of flow is present [65].  After a few days, a fibromuscular tissue 
replaces the thrombotic layer [64].  This tissue reaches a maximum thickness around
eight weeks and then replaced by collagen [66].   
 According to Palmaz, the embedment of the stent struts within the vessel wall can 
impact the thrombogenic response.  If the stent is not embedded, thrombus can be 





therefore increased time for possible thrombus deposition and fibromyocyte proliferati n 
[64].    
 In general, the surface interaction of the stent with surrounding tissue is an 
important consideration in the issue of thrombosis.  Surrounding tissues can be affected 
significantly by smaller scale factors such as metal ions and polymer particles at the 
individual cell level due to geometries, surface energy, and electrical charge.   
 
Drug Therapies and Restenosis 
New pharmacologic approaches are continually being investigated for restenosi , 
targeting different mechanisms.  Three of the common categories of interest ar : 
• Antiplatelet agents 
• Antiproliferative agents  
• Antimigratory agents    
Although there has been limited success with antiplatelet agents reducing 
restenosis in clinical studies, there is a potential for development.  Animal studies have 
shown that by decreasing the number of circulating platelets, smooth muscle cell 
proliferation can be reduced [67].  However, this can cause complications of hemorrhage.  
In addition, Cyclooxygenase inhibitors like aspirin are antiplatelet and anti-inflammatory 
agents that can actually increase smooth muscle cell proliferation in vitro [68, 69].  
Antiproliferative agents such as heparin can help reduce smooth muscle cell 
proliferation and migration [52, 70].  It should be noted that heparin subfragments are of 





complications are minimized.  PDGF antagonists, such as triazolopyrimidine, lovastatin, 
prostaglandin E1 or I2, are other antiproliferative agents that can inhibit smooth muscle 
cell proliferation [69, 71-74]. 
Antimigratory agents could help reduce smooth muscle cell migration, and 
therefore intimal proliferation.  These include caffeic acid derivatives and calcium 
antagonists [75-77].  Other agents that have been investigated reduce the production of 
extracellular matrix and therefore reduce intimal thickening [78].    
Other pharmacologic approaches investigated for restenosis include anti-
inflammatory agents and anti-thrombotic agents.  Tissue factor pathway inhibitor (TFPI) 
is an anti-thrombotic agent that has been shown to prevent thrombotic occlusion and 
prevent formation of neointima in a balloon angioplasty experiments [79, 80].  It has also 
been shown to inhibit smooth muscle cell proliferation in vitro [81].  TFPI is thought to 
inhibit synthetic smooth muscle cell proliferation and block medial smooth muscle cell 
proliferation [12].       
Overall, pharmocologic agents should act before or immediately following 
balloon angioplasty.  As previously mentioned, intimal proliferation begins immediately 
following injury and can continue for up to two weeks.  Success in clinical trials with 
current agents has been limited probably due to the complexity of the balloon angioplsty 
injury in vivo.  Injuries in stenotic arteries induce a larger injury with a gre ter surface 
area for platelet exposure.  The increased injury in clinical angioplasty induces an 
increased smooth muscle response [51].   Synergistic combinations of pharmacologic 





In addition to pharmacologic agents, there are other approaches that are being 
investigated to minimize restenosis.  These include: 1) minimizing smooth muscle cell 
injury, 2) destruction of smooth muscle cells, and 3) improvement of blood flow.  
Minimizing smooth muscle cell injury may be achieved through direct laser or ultrasonic 
ablation of atheroma or linear extrusion balloon techniques [51].  The destruction of 
smooth muscle cells in the lesion could reduce smooth muscle cell proliferation [51].  
Blood flow can be improved with stent devices to maintain the area of the lumen; 
however, these have problems associated with them as well due to alteration of fluid 
mechanic forces. 
 
1.4.3 Blood Vessel Mechanical Forces 
Mechanical forces play a key role in normal vessel function, diseased vessels, and 
injury response.  There are several forces that can affect the blood vessel such as the 
shear force from blood flow, tensile force exertion due to dilation, and hydrostatic fluid 
pressure.  These applied forces result in stresses in the longitudinal, radial, an  
circumferential directions [82].   
Fluid Forces 
 Flow mechanics of the arterial system are important regulators of thearterial 
system.  The flow rate, velocity profile, and resultant wall shear stresses directly affect 
surrounding vascular components.  Differences in arterial location, direction, 
bifurcations, and unhealthy conditions can complicate the fluid profile characteriz tion of 





to Hagen-Poiseuille flow, or laminar flow through circular tubes [83].  Smaller vessels 
which may be more prone to occlusion, such as the carotid artery have flow rates in the 
range of 300-400 mL/min.  In the case of atherosclerosis, several almost contradi ti g 
fluid alterations have been considered in the past as initiating or contributing factors such 
as both high and low shear stresses and both high and low pressures [84].  In actuality, 
both low and high extremes for conditions could have negative results.  For example, 
although recently low shear stress is seen more as atherogenic and high shear stress s 
atheroprotective, early studies have shown that intimal thickness results in areas of high 
shear at early time points while low wall shear was associated with advanced intimal 
thickening, demonstrating negative effects in both cases deviated from an optimum range 
[85, 86]      
Flow can be steady or unsteady in nature.  In steady flow, the velocity of the fluid 
at a fixed point does not change with time, while the velocity field varies over tim for 
unsteady flow.  Three types of unsteady flow include: nonperiodic flow, periodic flow, 
and truly random flow [83].  Blood flow would be considered periodic flow regulated by 
the cardiac cycle.  However, the pattern of blood flow depends on the location of the 
artery.  Large arteries such as the aorta are generally unsteady while blood flow through 
small arteries and capillaries is considered almost steady in nature. 
 The velocity profile of a fluid can be either laminar or turbulent.  If a flow is 
laminar, it has a uni-directional stream-lined velocity profile.  In contrast, turbulent flow 
is characterized by random three dimensional vorticity [83].  The unitless characteristic 





nature.  The formula for the Reynold’s number (Re) of a straight circular tube of constant 




=   
Equation 1. Reynold’s number to determine laminar or turbulent fluid behavior 
Where ρ, U, d, and µ represent the fluid density (kg/cm3),  velocity (cm/s), diameter (cm) 
and dynamic viscosity (dyne*sec/cm2),  respectively.  In the general case for pipe flow, 
flow is considered to be laminar if the Reynold’s number is less than 2100, and turbulent 
if it is greater than 2100 [83].  However, if the Reynold’s number is close to 2100, the 
fluid may be considered semi-turbulent.  
 In the case of arterial mechanics, variations in arterial geometry can cause areas of 
localized turbulence.  These could be naturally occurring due to a bifurcation or a result 
of a protruding atherosclerotic lesion or stent strut effects.  These areas of turbulence 
result in local changes of wall shear stress behavior on the surrounding cells.   
 The turbulence due to atherosclerotic lesions has been used in the past to 
characterize atherosclerotic arteries.  The auditory frequency of the blood is different in 
areas of turbulence [84].  The variation in sound could be used to estimate the lumen area 
reduction due to the presence of relatively large plaque formations [87].  Within the past 
twenty years or so, many improvements upon this principle have been instated in the 
form of Doppler velocimetry ultrasound as a non-invasive diagnostic technique.           
Shear stress is another important fluid characteristic formula when examining 





shear stress is dependent upon the radial location.  For a parabolic profile, the formula  
shear stress is given in Equation 2 where µ is the fluid dynamic viscosity 
(dynes*sec/cm2), U is the velocity (cm/s), and r is the diameter of the blood vessel (cm).  
dU
dr
τ µ=  [88] 
Equation 2.  Shear Stress Formula 
With the cell location lining the arterial walls, the wall shear stress is of greater 
interest.  Wall shear stress of a cylinder is directly related to the volumetric flow rate 









=  [88] 
Equation 3. Wall shear stress formula  
Where τw is the wall shear stress (dynes/cm
2), µ is the dynamic viscosity of the fluid 
(dynes*sec/cm2), Q is the volumetric flow rate (cm3/sec), and R is the radius of the blood 
vessel (cm).  Interestingly, despite significant differences in arteri l diameter, most blood 
vessels will adjust to maintain wall shear stresses of 10-20 dynes/cm2 [84].   This 
compensatory adjustment brought way to an early theory of atherosclerosis presented by 
Giddens and collaborators which proposed that early atherosclerotic plaque location is 
initiated by an unstable arterial remodeling response to decrease the radius of the artery if 
the wall shear stress is below the optimum range [84, 89].            
Besides the adjustment of the parameters of the Equation 2, alterations in 
geometry can cause localized area of turbulence.  The normal blood flow of an artery is 





been shown to be more susceptible to atherosclerosis.  Arterial bifurcations are often 
susceptible to disease due to altered velocity profiles.  For example, where the common 
carotid branches into the internal and external carotid, an area of flow separation occurs 
at the outer sinus wall, resulting in a fluctuation in the direction of the fluid velocity and a 
decreased wall shear stress [90, 91] 
 The viscosity of blood is an important parameter to consider.  Blood is a Casson 
fluid, meaning the viscosity of the fluid decreases with increasing shear rat.  This is in 
contrast to Newtonian flow which has a constant viscosity at all shear rates. Th  reason 
for the varying behavior of blood is due to the cellular components and proteins within 
the blood that make blood a heterogeneous fluid [88].  As the shear rate increases, the 
fluid starts to act as a Newtonian fluid as the aggregates of particles are broken up and the 
result is a decrease in apparent viscosity of the fluid [88].  The shear rat t which blood 
starts to act as a Newtonian fluid is approximately 100/sec at 37 degrees Celsiu  [88].  
Near the walls of the blood vessel, the flow can be considered Newtonian because the 
wall shear rate is greater than 100/sec [88].     
 
Effect of Atherosclerosis on Fluid Mechanics Properties of a Blood Vessel 
Although these fluid properties can be easily identified in normal healthy linear 
blood vessels, alterations in these components that are of greater interest in 
atherosclerotic lesion and restenosis research.  Clinical autopsies have shown that early 
atherosclerotic lesions were more likely to develop in areas of flow separation, low wall 





outer wall, where flow separation could occur, and minimal formation at the inside 
divider of the bifurcation [90].  Several in vitro studies have using glass arterial models to 
study the effect of the hemodynamic forces support clinical results.  For example, using 
pulsatile flow with intervals of systolic and diastolic function resulted in changes i  fluid 
velocity and direction in a glass carotid bifurcation model, whereas these were not seen in 
steady flow conditions [92].       
 The presence of large protruding lesions or stent struts can cause alterations in the 
fluid profile.  Although the Reynold’s number may indicate laminar behavior, local are s 
of disturbance can occur.  The flow through the stenosed area, referred to as stenotic 
flow, has areas of flow separation, strong shear layers, recirculation, reattachment and 
turbulence [93].  Turbulent flow within the blood vessel can have several negative effects
besides the previously mentioned effect on the wall shear stress.  In addition, there are 
several other physiologic events are affected such as the tensile stress on the cell 
membrane of endothelial cells, mass transport between the blood and vessel wall, blood 
clot formation, and the blood rheology [94].    
Tensile and Pressure Relationship to Blood Vessel Properties 
Blood vessels are subject to tensile forces as the blood flow is transferred from the 
heart to the peripheral arterial system.  In order to compensate for the large stroke volume 
from the heart, large arteries will expand to compensate for the increased pre sures.  
Following expansion, the elastic recoil in combination with smooth muscle cell 
contraction, brings the artery back to its original shape and provides pressure to maintain 





and collagen content for delivery of the fluid to peripheral tissues [95].  In contrast, small 
arteries and arterioles minimize the pressure drop by having a large lumen-to-wall 
thickness ratio. At the cellular level, high pressures can result in smooth muscle cell 
hypertrophy and hyperplasia.  Wall stiffness can be increased by the contracti  of 
smooth muscle cells [96, 97].  
The tension placed on the blood vessel is commonly represented using LaPlace’s 
law shown in Equation 4, where T is the tension in the wall (dynes/cm), P is the blood 
pressure (dynes/cm2), and r is the radius of the blood vessel (cm).   
PrT =  [98] 
Equation 4. LaPlace’s Law 
In addition to the artery diameter and pressure as suggested in Equation 4, the tensile 
stress can also be dependent upon the distance from the heart [95].  The relationship 
between the tensile stress and the wall tension is that the tensile stress is equal to the wall 
tension divided by the vessel wall thickness [96].  The normal tensile stress lev ls normal 
to the vessel wall are approximately 1000-2000 dynes/cm and the wall thickness ca 
adjust to maintain these stress levels [91, 99].      
Normal healthy blood vessels are generally characterized as being viscoelastic.  
Viscoelasticity refers to the dependence of speed, magnitude, and applied force on the 
elasticity of a material.  In contrast, a purely elastic material returns to its original form 
instantaneously following deformation and commonly referred to as a Hookean elastic
material.  For other material properties, blood vessels are anisotropic and heterogeneous 





properties are not the same throughout the blood vessel due to varying components 
within the walls of the artery [100].  The direction of applied load matters as well, 
anisotropic behavior states that the material properties depend on the direction of applied 
load.  In the case of blood vessels, the direction of both collagen and elastin fibers 
contributes to this material property [100].     
Effect of Atherosclerosis on Stiffness Properties of the Blood Vessel 
In a diseased state, the stiffness of the artery can be altered.  If the artery is 
significantly stiffer, it is more difficult for the artery to expand, resulting in higher 
pressures exerted on the walls of the artery. Plaque formation within the walls of the 
artery causing protrusions can affect blood flow as previously discussed, but thepresence 
of plaque can also effect the compliance of the artery as well.  In late atherosclerotic 
lesions, the high prevalence of plaque generally stiffens the artery [101].  Within the 
plaque, areas of vascular calcification demonstrate decreased elasticity nd compliance 
[102].  Compared to plaque consisting of cellular plaque, calcified atherosclerotic plaque 
is 4-5 times stiffer [103].  
The elastic modulus of the artery is not dependent upon the wall dimensions, 
while the stiffness of the artery depends on both the wall dimensions and material 
elasticity [101].  This is important in the case of atherosclerosis because often the arterial 
wall increases in thickness, which would further alter the mechanical behavior rathe than 
the elasticity modulus of the material alone.  The elasticity of a blood vessel will depend 
on the stage of atherosclerosis, vascular location, and the species involved [101].  As 





collagen production increases and elastin within the artery decreases causing arter al 
stiffening [104].  This is of importance because collagen and elastin in the extracellular 
matrix within the arteries provide mechanical integrity and the elasticity of the artery.  A 
summary of the contributors and locations of arterial stiffness can be seen in Figure 4. 
 
Figure 1.4 Summary of arterial stiffness locations and causes [105]  
The elastic modulus does not change until late stages when the walls have areas of high 
calcification and wall hypertrophy and result in higher values of both the elastic modulus 
and stiffness [101].    
Plaque rupture is always a concern with atherosclerotic lesions.  The stability of 
plaque is determined in part by mechanical stiffness of the artery.  The stability of the 
plaque is affected by the degree of calcification.  Higher points of failure stress, or Von 
Mises stress, tend to occur at the interface between materials with varying material 
properties of stiffness [106].  Biomechanically, the higher the number of interface sites, 
the greater the chance of rupture [82].  As calcification increases, risk of rupture can 





Hypertension is commonly involved in atherosclerosis and increased rigidity of 
arterial walls.  Increased rigidity of the wall in part is due to increased rterial wall 
thickness caused by vascular smooth muscle cell hypertrophy [107].  Vascular smooth 
muscle cell hypertrophy are polyploidal in nature, with a five fold higher mass th n 
diploid vascular smooth muscle cells, higher levels of PDGF A, fibronectin, and collagen 
III [108].  VSMC polyploidy is characteristic of abnormal smooth muscle cells that have 
a malfunctioning spindle cell cycle checkpoint in the mitotic cycle which normally 
prevents the exit of mitosis if chromosomal segregation cannot be complete [109, 110].    
 Effect of Intervention on Blood Vessel Mechanics 
Mechanical forces within the blood vessel play a contributing role to the response 
following endovascular procedure.  Although intimal hyperplasia could contribute to 
restenosis, following angioplasty the lumen diameter does not significantly change from 
intimal hyperplasia.  An additional contributor may result from the surrounding 
mechanical forces that the vessel is exposed to.  The fluid dynamics of the blood vessel in 
stenotic regions can be disturbed which can disrupt normal function.  Intimal thickening  
is generally located in areas of low shear stress or areas of fluctuating w ll shear stress 
[51].  The geometry of poststenotic regions can result in areas of flow separation and 






Figure 1.5  Alterations in fluid profile due to stenotic lesions 
 
This effect is also present following a stent strut.   Alterations in wall shear stress from 
normal function have also been suggested to affect the endothelial monolayer recovery 
which could contribute to increased intimal proliferation [111, 112].   
In the blood flow, stent struts can cause a similar action to immersed bodies 
depending on the level of embedment of the strut.  This immersion in blood flow can 
cause formation of flow separation dependant upon the Reynold’s number of the fluid.  
As the Reynold’s number decreases toward zero, the streamlines of fluid flow are able to 
adapt around the profile and are essentially the same as the streamlines befor  the object.   
The larger the Reynold’s number, the greater the distance of the separated region and 
increase of the importance of viscous effects [83].  The areas of separation are 
characterized by local turbulence and recirculation causing times of stagnan  flow and 
varying wall shear stresses.     
 Restenosis of smaller diameter vessels is usually more common than restenosis of 
larger vessels.  This could partly be due to the inverse relationship of the rate of blood 
flow to intimal proliferation.  As the flow rate increases, the rate of intimal proliferation 
Lesion acts as  
immersed body Areas of flow 
separation and vortex 





decreases.  In relationship to wall shear stress, there is a direct relationship between 
increasing wall shear stress and flow rate as indicated in Equation 2.  Additionally, the 
increased size of the lumen allows for a smaller ratio of occlusion, allowing for a 
sufficient cross-sectional area of the lumen for blood flow.  Generally, the vess l will 
adapt with local dilation or constriction to normalize the wall shear stress.  In contrast to 
being controlled by the smooth muscle cells, it is believed that a sustained lumen 
diameter increase is primarily controlled by the endothelium, particularly by 
endothelium-derived relaxing factor (EDRF) production or release [113].  However, it 
has also been shown that vessels with denuded endothelium or abnormal endothelium in 
atherosclerotic arteries can still adjust lumen diameter to increased or d creased flow 
rates [114, 115]. 
 There are several possible contributing mechanical factors to restenosis.  
According to Liu and collaborators, the following series of events are proposed for 
coronary restenosis.  Following the balloon angioplasty, intimal proliferation 
immediately occurs along with a new flow pattern of the vessel.  If there is a residual 
stenosis, the area will be subject to areas of flow separation.  Areas of flow separation 
will continually be subject to low wall shear stress, which could enhance proliferation 
and lead to further disrupted flow.  Overall, the dilated segment after angioplasty can 
narrow due to disturbed flow and low shear stress which can cause intimal growth and 
wall structural changes that can decrease the lumen.  Restenosis is less likely to occur if 
normal levels of shear stress are maintained and intimal thickening regresses after acute 





 In addition to abnormal low shear stresses and flow patterns, there are other 
factors that lead to increased rates of restenosis including residual stenosis greater than 
30% [117].  Areas with higher flow rates with the same degree of residual stenosis, can 
result in larger areas of flow separation, and therefore increased neointimal hyperplasia.   
 
1.4.4. Vascular Cell Mechanics and Response 
The field of cellular mechanics has grown significantly over the last several years 
with refined techniques and increasingly lower scale measurements.  There are several 
cell components that determine the mechanical properties of the cells, with the most 
influential being those that constitute the cytoskeleton of the cell including microtubules, 
actin filaments, and intermediate filaments [118].   
 Cells can either be considered as continuous or discrete structures dependent upon 
the application.  On a whole cell scale, cells can be modeled on a continuum, but local 
deformation of cells cannot due to discontinuities in the mechanical behavior [118].  
Cellular biomechanics are showing to be an important method of investigation for 
examining mechanical signals as interpreted and relayed by the cytoskelet n and cell-
ECM interactions [118].  Although the work of this project is based upon the treatment of 
cells as a continuum and examining whole-cell deformations in response to applied 
mechanical forces, it is important to be present other approaches of cell mechanics.  
Mechanotransduction 
The conversion of mechanical signals to biological signals involves the important 





be involved in mechanotransduction.  These include: cytoskeleton components, G 
proteins, receptor tyrosine kinases (RTKs), integrins, mitogen-activated protein kinases 
(MAPKs), and stretch-activated ion channels [119].   
Cells are in contact with other cells and surrounding extracellular matrix.  Cell-
matrix adhesions come in the form of focal adhesions, focal complexes, fibrillar 
adhesions, and three-dimensional matrix adhesions [120].  Focal adhesions are the best 
characterized and largest of these interactions.  Integrins link the extracellular matrix to 
the cytoskeleton and regulate the formation of focal adhesions and function to regulate 
signals across the cell membrane and are involved in cell functions like migration, 
attachment, migration, and differentiation in addition to the recruitment of kinases for 
pathways [121, 122].  The clustering of integrins causes recruitment of scaffold proteins 
and trigger cytoplasmic signaling [120, 122].  With increased focal adhesion formatins 
due to increases in cytoskeletal tension, downstream signaling suggest a proliferative 
effect on cells [123].  In part, proliferation is controlled by focal adhesions by relating to 
cell spreading.  Cell spreading regulates tension within the actin cytoskeletn and along 
with other factors can arrest the cell cycle downstream [120, 124].  In summary, cell-
matrix interactions through the relationship of focal adhesions and tension can have 
downstream effects on cell responses such as proliferation and migration through 
signaling in the Rho family [120].  
At cell-cell contacts, there are similar mechanisms of mechanotransduction that 
occur.  Cell-cell adhesions can be in the forms of adherens junctions, tight junctions, and 





Mechanical forces have been suggested to increase formation of adherens junctions but 
determining the effect of tension is difficult since isolating effects of cell-cell contacts 
can be difficult due to the simultaneous effects of cell-matrix interactions [120].  
Contradicting results have been seen in response to increases in tension affecting th  
morphology and permeability of adherens junctions and other cell-cell junctions [128-
131].  Between both focal adhesions and adherens junctions, there appears to be an 
antagonistic behavior where cell-cell adhesion competes and can decrease cell-substrate 
adhesion [132, 133].             
 Vascular Calcification 
 Vascular calcification plays a significant role in atherosclerosis.  In atheroclerosis, 
vascular calcification occurs in the intima, whereas calcification in the media occurs in 
medial or Mönkeberg’s sclerosis [102].   In advanced atherosclerosis, there are calcium
deposits located throughout the vessel [102].   
 Vascular smooth muscle cells are involved in later stages of vascular calcification 
in atherosclerosis and the formation of atherosclerotic lesions.  Smooth muscle cell  in
atherosclerotic lesions demonstrate a synthetic phenotype, referring in part to inc eased 
proliferation and migration and it has been suggested that a third phenotype for smooth 
muscle cells is present for a calcifying SMC phenotype which are higher prone to 
calcification [134].  It is theorized that macrophages are involved in this phenotypic shift 
for increased calcification [135].  Apoptotic smooth muscle cells have been shown to 
crystallize calcium and apoptosis has been suggested to the promotion of vascular 





 Vascular calcification has been linked to share common characteristics and 
components with bone calcification.  Some of the calcification-regulating proteins that 
overlap between the two processes include: bone morphogenetic protein 2-a (BMP2-a), 
osteopontin (OPN), and bone Gla protein, which are present within atherosclerotic plaque 
[138-140].  These calcification factors can be due to loss of calcification inhibit on.  
Contributions in atherosclerosis appear to be a combinatory event between several 
factors.  These involve the cell to cell interaction as with smooth muscle cells and 
macrophages, increased expression of calcification-regulating proteins or decreased 
calcification inhibition, cytokines and growth factors such as tumor necrosis factor (TNF-
α), and circulating lipids and inorganic phosphates (Pi) [102].        
In Vitro Vascular Force Application and Cell Response 
Physiologic conditions involve a synergistic combination of forces that can be 
difficult to mimic in vitro or isolation of individual or dual force effects may be desired.  
For these reasons, mechanical force systems are constructed for the purpose of 
mechanical stimulation similar to what the cells may experience in vivo.  The arterial 
system is a system of tensile and shear force applications applied to the blood vessel as 
previously established.  At the cellular level, cells within the blood vessel are subject to 
these forces and respond to them, causing changes within the cell.  Mechanobiology 
refers to how cells convert mechanical signals into biological responses [119].  
Cellular response to applied mechanical stimulation has been investigated in a 





stretch, bending, Out-of-plane and in-plane substrate distension, fluid shear, and 
combination of above [141].   
 
In Vitro Compressive loading 
Compressive loading can basically be divided into indirect and direct loading.  
Hydrostatic pressurization is an indirect force application which utilized applied fluid 
pressure to cells and is physiologically present to most cells.  In terms of iplementation 
in the laboratory setting, its advantages include: relative simplicity, stimulus 
homogeneity, multiple sample adaptation, static or transient loading, no local 
compaction, independence of adhesion effects, and no impedance of transport process 
[141].   
The disadvantages of applied hydrostatic pressurization are that the pO2 and 
pCO2 levels in the media may become elevated in the media and the fact that many cells 
are under greater influence of different forces than hydrostatic pressure [141, 142].  
Direct displacement models are good for direct load bearing and contact articulation 
models for bone and cartilage, respectively, and for investigation of the cell/matrix 
interaction [141].  Direct Platen displacement has the disadvantages of Poisson-effect 
anisotropy of strain, friction effects at the interface, and impediment of nutrie t t ansport 








Figure 1.6 Compressive Loading  (a) Hydrostatic Pressurization (b) Direct Platen  [141] 
 
In Vitro Tensile Applications 
There are a variety of modifications of deformable devices to apply strain to a 
substrate.  Unidirectional or longitudinal stretch systems either directly attach to opposing 
ends or function with four-point substrate bending (Figure 7a).  Both of these have been 
developed with mostly homogeneous strain fields but have usually been used for lower 
levels of strain less than 10% [141].  Deformable substrates are also highly utlized for 
bidirectional and circumferential deformation applications in the in-plane and out-of 
plane distension models.  Out-of plane distension models function by direct application 
of positive or negative pressures, such as fluid and vacuum, respectively, or by direct 
platen or prong displacement [141].  In-plane distension devices, such as that present in 
the developed simulator can work through direct platen displacement, direct bi-
directional stretch (Figure 7b), or a combination of vacuum and platen deformation with a 





but can be compensated by localized placement of cultured cells in mostly homogenous 
application area.    
 
 
a)     b)      c) 
Figure 1.7 Tensile strain application a) Uniaxial b) Bi-axial c) Radial and Circumferential 
[141] 
 
In Vitro Shear Application 
The last testing system that will be directly addressed is the fluid shear ystem.  
There are two basic configurations, the cone and plate system and the parallel l te flow 










Figure 1.8  Shear stress testing systems a) Cone and plate system b) Parallel plate flow 
chamber [141] 
 
The range of shear force applied in the cone and plate system (Figure 8a) depends on the 
conic taper and angular velocity [141].  The applied fluid shear stress is spatially 
homogeneous since the local velocity and distance between the two components varies 
linearly with radial position [141].  The parallel plate configuration (Figure 8b) works on 
the premise of a pressure gradient across the system through the use of gravity heads or 
active pumps [141].  The applied shear of the parallel plate flow chamber is also 
homogeneous in nature with additional advantages of equipment simplicity, ease of 
sampling, and ease of culture [141].         
As previously discussed, there are several forces involved in the natural dynamic 
blood vessel.  One of the purposes of in vitro testing is the isolation of factors to narrow 
in on the behavior of cells in response to stimuli.  For this reason, the effects of in vitro 
shear force and cyclic displacement applications will be the areas of focus sin e they are 







Response to Shear  
 Applied shear force to vascular cells causes many changes to the morphology of 
the cells, gene expression, alignment, and differentiation.  Under normal conditions, the 
smooth muscle cells are protected from direct exposure to shear forces by th  
endothelium, but following endothelial denudation, the smooth muscle cells are placed in 
direct contact with blood flow.  The level of dilation of the vessel and the flow behavior 
can both severely affect the smooth muscle cell response.  In one clinical study, smooth
muscle cell proliferation was lower in widely dilated lesions than in insufficiently dilated 
lesion areas [117].   
 The application of shear force to smooth muscle cells can have various effects on 
the cell response.  For example, the flow behaviors as laminar or turbulent can invoke 
different responses along with the magnitude of the shear rate. There are numerous shear 
studies which demonstrate the inhibition of  in vitro VSMC proliferation with high levels 
of shear stress [143].  In general, shear stress levels above 10 dyne/cm2 ar  onsidered 
high and atheroprotective [144].  In contrast, areas of low shear stress (<10 dyne/cm2) 
promote atherogenic response and increased smooth muscle cell proliferation [144].  
Areas of low shear can result from disturbed geometry and resultant areas of turbulence 
or flow separation causing decreased velocity profiles.  
 There have been several studies to identify the mechanisms involved in both 
increased and decreased smooth muscle proliferation in response to shear.  One of the 
proteins that may be involved with shear stress transduction is Transforming Growth 





such as VSMCs [145].  TGFβ1 is a cytokine that has been shown to suppress VSMC 
proliferation [143].  TGFβ1 works by causing cell cycle arrest in the G1 phase [146].  In 
one study of Ueba et. al, when a high shear stress of 28 dynes/cm2 was applied using a 
cone-and-plate configuration to VSMC for 24 hours, gene expression of TGFβ1 increased 
twofold, and its activator tissue-type plasminogen activator (TPA) increased fivefold 
[143].  Shear stress also has been shown to upregulate TPA in endothelial cells [147].      
 Smooth muscle cell migration has been shown to be directly dependent to the 
substrate on which the cells were grown by DiMillia and collaborators [148].  The 
migration of smooth muscle cells is partly regulated by the p38 MAPK pathway and 
relates to actin remodeling [149].  Migration of smooth muscle cells continues to be an 
important issue in restenosis.  Liu and collaborators have shown that the exposure of 
shear stress in a laminar velocity profile inhibts SMC migration and maximum SMC 
migration occurs in areas of stagnation, flow separation, and vortexes [150]. 
The alignment of smooth muscle cells in vivo is normally regulated by tensile 
force since smooth muscle cells are normally not exposed to shear force.  When shear is 
applied to smooth muscle cells to simulate conditions following endothelial denudation, 
alignment of the stress fiber orientation occurs.  Lee and collaborators have shown canine 
vascular SMCs to align their stress fibers perpendicular to flow in response to sh ar with 
24 hours exposure with a physiologically equivalent shear stress [151].  This is in 
contrast to endothelial alignment parallel to shear.  In addition, Lee and collaborators also 
demonstrated that the alignment of vascular smooth muscle cells depends on the 





calcium for SMC alignment [151].  However, SMC alignment results have not been 
consistent in literature.  In addition to perpendicular alignment, both parallel and random 
orientation have also been documented in bovine and human aortic cells, respectively 
[152, 153].  Liu and collaborators have shown SMC alignment parallel in high shear 
stress regions and perpendicular in low shear stress regions [150].  Overall, alignment of 
smooth muscle cells in response to shear appears to be highly dependant upon the type of 
cells used and the level of applied shear.       
Response to Cyclic Tensile Force 
The application of tensile force applied to cells is usually in the form of 
circumferential, uniaxial, or biaxial application.  The direction applied is usually adjusted 
to the application.  In the case of vascular cells, they are cyclically deformed from the 
dilation and relaxation of the blood vessel, usually represented by either circumferential 
or uniaxial testing.  The cyclic strain response of vascular cells is important to both 
normal and abnormal cell function.  It can effect cell proliferation, migration, apoptosis, 
morphology, and alignment [154]. 
The cell response to applied cyclic tensile forces can vary with different 
parameters such as the cell type, species, vascular bed, and the extracellula  matrix [154].  
In terms of mechanics, the frequency, amplitude, and time exposed to tension could also 
affect the response of cells.  The effect of cyclic forces on both endothelial and smooth 
muscle cell proliferation is inconsistent, and seems to depend highly on the species and 





Apoptotic response of both endothelial and smooth muscle cells depend on the 
level of applied cyclic forces.  Tensile forces corresponding to low physiologic strain (5-
10%) has been shown not to induce cell apoptosis [155-157], while higher levels (10-
15%) have been shown to induce cell apoptosis [157, 158].  One theory is that the high 
level of applied force results in significantly higher stresses and causes cell death and 
invoking an inflammatory response [159].  
Smooth muscle cell alignment in vivo corresponds to the direction of applied 
tensile forces.  In response to cyclic tension, and in contrast to applied shear, both 
endothelial and smooth muscle cells align their actin filaments perpendicular to the 
applied force usually within 12-48 hours [154].  Unlike the response to shear, this is also 
consistently seen in various vascular cell types and species [154].  This property has also 
been shown to be magnitude dependent, with low levels of strain (0-7%) resulting in 
random orientation and higher levels (7-24%) resulting in perpendicular alignment in the 
case of bovine smooth muscle cells [160].  Protein kinases A and C have been shown to 
play important roles in stretch-mediated alignment [160].  For smooth muscle cells, this 
perpendicular alignment is contradictory to the physiologic circumferential alignment 
around the blood vessel, acting parallel to the application of tensile application [161]. 
This could be one limitation of 2D in vitro testing.  
Cell differentiation is an important issue in development and in vitro testing.  
When transferred to static culture, contractile vascular smooth muscle cells tend to 
change their phenotypes to a synthetic state.  Cyclic tension has been shown to increase 





In a study by Birukov and collaborators, in addition to h-caldesmon upregulation, 
increased proliferation was seen [162], indicating a contradicting synthetic behavior, but 
the level of stress on the cells was higher than physiologic stress (15%) which could 
affect the proliferation behavior of the cells.  Butcher and collaborators demonstrated a 
phenotype shift in a 3D collagen construct of RASMC subject to tensile forces 
corresponding to 10% strain at 1 Hz for 48 hours using a platen multiaxial strain system 
[163].  The strained group results showed increased cell viability, decreased 
morphological elongation, decreased α-actin and calponin expression, and increased 
vimentin expression compared to the static control.  These results suggest a shift from 
contractile toward a more synthetic phenotype.  In addition to synthetic versus contractile 
phenotype, differentiation toward vascular calcification can be a problem with statically 
grown smooth muscle cells.  Bone differentiation markers as osteopontin, CFFA-1, and 
alkaline phosphatase have been shown be downregulated through the application of 
cyclic stress [164].    
Vascular smooth muscle cell migration due to cyclic stretch has not thoroughly 
been investigated in vitro although there are some well documented cases for endothelial 
cells.  Increased migration rates of endothelial cells have been associated with increased 
cyclic strain response and is mediated by rho p21 [165].  As mentioned previously, the 
application of cyclic stretch in one study to endothelial cells with strain-induced MMP-2 
resulted in decreased smooth muscle cell migration using a transwell migration assay 
[61].  In response to increased cyclic stretch, a key component in smooth muscle cell 





role in actin fiber rearrangement during SMC migration [166].  Since vascular 
hypertension can create up to 30% increase in tension strain within arterial walls in vivo 
[167], it is possible that this increase could result in increased activation of PKCδ and 
increased activation of migratory pathways that could be important in both 








AIM 1- DESIGN AND CALIBRATION 
 
2.1 Introduction  
The purpose of this project is to develop an in-vitro model to simulate the induced 
mechanical forces on the blood vessel during balloon angioplasty and evaluate cell 
damage and response.  This model is aimed for potential implementation as a test bed for 
the study of drug delivery, surface treatment systems for balloon angioplasty, and 
endovascular stents and minimizing restenosis to aid in the reduction of deleterious 
vascular responses.  During balloon angioplasty, surrounding smooth muscle cells lining 
an artery are subject to both tensile stress from the balloon deployment and shear stress 
from blood flow.  Balloon angioplasty increases the arterial diameter by a circumferential 
stretching meant to compress the plaque within the wall of the blood vessel and 
consequently irreversibly stretches the collagen fibers within the wall. 
The designed system consists of two simulators.  Laminar fluid flows from a 
multi-channel peristaltic pump across a location of cells simulating shear str ss.  
Concurrently, a vacuum chamber suctions a silicone membrane where the cells are 
located over a static platform, which essentially stretches the cells and imulates tensile 
stress.  In this system, cells are grown onto the flexible silicone membranes to simulate 
the distensibility of the blood vessel.  In the presented work, the design parameters are 













Figure 2.1 Vascular Mechanics Simulator System Configuration  
 
2.2 Simulator Design 
This simulator system consists of six independent channels allowing for six 
independent cell populations to be assessed for increased statistical applicability and 
multiple analysis techniques.  The system is comprised of two apparatuses each with 
three channels, as demonstrated in Figure 1.  Design parameters were considered to 
resemble physiological conditions with minimal compromises, including laminar flow, 
developed flow at the cells, and applied shear stresses.  Cells are grown on a flexible 
silicone membrane which oscillates at 60 cycles/min (1 Hz) during mechanical testing.  
As the vacuum from the FlexerCellTM strain unit is applied from an underneath chamber, 
the silicone membrane is stretched over a circular rigid Lexan post (0.875”, or 2.22 cm 
diameter), therefore applying tensile force to the cells grown on the silicone as shown in 















Figure 2.2  Application of Concurrent Forces in System 
 
A parallel plate geometry was chosen for this application for the shear component 
of the system.  Figure 3 provides a pictorial explanation of the designed mechanical 
simulator.  The entrance length of the channel to ensure fully developed flow at the site 
of the cells was governed by the resultant Reynold’s number of 151 from the volumetric 
inlet flow (Qin) of 350 ml/min although the flow is laminar for the majority of the range 
for the fluid pumps.  The Reynold’s number, Re, was determined from the equation 





=Re  [83] 
where b is the width of the channel (cm) , ρ is the density of the fluid (kg/cm3), and µ is 
the fluid viscosity (dynes*s/cm2).  The Reynold’s number was also used to establish the 
channel flow as laminar.  This was considered highly laminar inflow since the Reynold’s 
number was much less than 2000 for this rectangular channel [83].  This equation 
assumes that the fluid behaves as an incompressible Newtonian fluid.   
 
Radial tensile force 










Figure 2.3 Demonstration of individual channel of vascular mechanics simulator: a) 
System configuration b) One of the vascular mechanics simulators during 
experimentation c) Top view of individual channel with entrance length and location of 
cell culture on silicone d) Side view of entrance side indicating cross-sectional area of 
channel. 
 
The minimum entrance length parameter for a fully developed velocity profile, Le 
(cm), was estimated by:     
eR05.=eL  [168] 
where Re is the Reynold’s number.  The calculated required minimum entrance length of 
7.55 cm was manufactured to 13.95 cm to assure a fully developed velocity profile at the 
site of the cells as shown in Figure 3 (c).  
 Several accessories to the system were also designed.  To run tensile tests alon , a 
tensile force isolation bar shown in Figure 4 was designed to provide sufficient media for 
tensile testing alone.  To obtain a sufficient seal, a principal of O-rings with applied 
pressure was implemented and secured with four stainless steel screws paird with wing 
nuts on alternating sides of the culture bar for evenly distributed pressure.   
 
 
Figure 2.4 Tensile Force Isolation Bar a) 3D CAD design b) 3D CAD assembly with 
baseplate c) Manufactured tensile bar with baseplat   
Cells are grown on the surface of the silicone membranes which are held into 
place by compressive force into the 
membrane plate and the membrane to be flush with the surface of the bioreactor which 
aides in a laminar flow pattern.  In order to remove the membrane plates after use, a tool 
had to be designed to push the
membrane plates through ports in the vacuum chamber which are plugged during testing.  
The two-pronged device shown in Figure 5 b) gently pushes t membrane plate up for 
easy removal without disturbi
Figure 2.5 System accessories a) Silicone Membrane Plate b) Membrane Plate 






m mbrane plates (Figure 5a).  This allows for the 
m up and out of the depression.  This tool accesses the 















When the cells are being cultured, the exposed channels need to be covered to maintain
sterility.  A two-part Lexan cover has been designed to cover both the channels and the 
culture bar (Figure 5c).  The first piece fits the cell culture bar with a lip t the junction 
with the cell culture bar.  A top cover fits over the lip of the protective plate and the cell 
culture bar to maintain sterility.  Original 2D CAD drawings for the primary parts of this 
system are provided for reference in Appendix A. 
 
2.3 Calibration 
The next step for the tensile system was the calibration of the computer interface 
with the bioreactor.  For calibration, a radial grid with known distances was cre ted in 
AutoCAD (Figure 6a) and placed on the rigid loading posts in the simulator.  The 
provided drawing is not to scale.     
 
           
Figure 2.6  Calibration of Tensile Strain in Simulator a) Reference Grid System b) 
Implementation of reference grid in calibration 
  
A circle was drawn on the silicone membrane drawn on each individual 
membrane and the amount that the circle stretches will be directly proportional to the 






silicone.  Both static and dynamic calibrations have been examined.  For static 
calibration, the FlexCell programs for 2.5%, 5%, 7.5%, and 10% strain were applied.  For 
each case, pictures were taken before, during, and following strain.  An exampl  setup of 
calibration is shown in Figure 6 b).  For dynamic calibration, a regimen of 1 Hz 0-5% 
strain was applied and a movie file was collected.  ImageJ provided by NIH was used for 
imaging processing and calculations.  In the case of dynamic simulations, the movie files 
were first converted into a series of pictures using the Easy Video Converter and the 
maximum and minimum images were evaluated by converting relating known distances 
to the number of pixels within the pictures.  Using ImageJ, the area of each circle was 
calculated.  From there, a radius was determined and the actual percentage of elongation 













Data in Figure 7 represents data of static calibrations over all 6 plates.  Static calibration 
was repeated over 3 independent trials.  The mean value of calibration for the 
programmed values of 2.5%: 2.3 ±0.30 SD, 5%: 5.0 ±0.47 SD, 7.5%: 7.3± 0.57 SD, 10%: 
10.1± 0.87.  Measurements immediately following stretch agreed with initial 






Figure 2.7  Static calibration comparison of programmed values versus experimentally 
determined values 
 
Given the very similar results in static calibration, dynamic calibration of the system was 
performed for the regimen of interest of 0-5% strain.  Results of dynamic calibration 
determined a maximum deformation of 4.43% ± 0.67 SD.  Although slightly lower values 
were determined, these were within reasonable tolerances of error and compensated for 
with slight increases in programmed values.     
 
2.4 Comparison of Experimental Calibration to Solid Modeling Analysis 
The design of the tensile application in this work was based upon the principle of the 
FlexercellTM strain unit with minimal variations in dimensions.  The experimentally 
determined strain values were compared to comparable computational analysis within the 


























2.4.1 Summarized Methods 
In the work by Vande Geest et. al, computational analyses were performed on both the 
biaxial and uniaxial membrane configuration, although for this work we were only 
interested in comparing the biaxial configuration [169].  To summarize the applied 
methods, the finite element solver Abaqus (Version 6.2 Abaqus Inc.) was implemented to 
run simulations with vacuum pressures of 20, 40, 60, and 80 kPa applied to the underside 
of the membrane.  The two surfaces had an applied friction coefficient of 0.03 [170] to 
account for the silicone lubricant grease in between the surfaces, which is the same 
lubricant applied in our custom setup as well.  Boundary conditions with similar 
representation to Figure 8 were applied with the loading post being modeled as an 
analytic rigid body and the edges of the silicone membrane as fixed, where both 
rotational and translation degrees of freedom were assigned a zero value.  After 
establishing mesh independence, a first order, quadrilateral, reduced integration shell 
elements configuration was used for analysis with 5830 elements.  Experimental 
comparisons in the work of Vande Geest were performed in a similar methodology of 
picture and movie capture with the difference being their experimental values wer  
measured near the center of the loading post.           
 








Theoretical applied vacuum pressures of 20, 40, 60, and 80 kPa corresponds to 
approximate theoretical elongation percentages of 2.6, 6.6, 14.1, and 20.65, respectively 
according to the Loading Station Conversion Chart from FlexCell provided in Appendix 
B.  The area where cells should be plated to receive uniform strain is provided by the 
following equation in the FlexCell manual: 
 
Radius = (Diameter of Loading Station (1+ (Max%Elongation/100)) 
  
For the FlexCell loading post, these areas to receive uniform strain for the respective 
elongation values of 2.6, 6.6, 14.1, and 20.65 for the BioFlex and for the custom designed 
simulator are provided in Table 1.  Diameters for the loading posts BioFlex and custom 
vascular mechanics simulator were 25 (12.5 radius) and 22.4 (11.2 radius) mm 
respectively.   
 
Table 2.1 Theoretical Uniform Strain Distances along BioFlex and the custom Vascular 









20 2.6 12.18 10.8 
40 6.6 11.75 10.4 
60 14.1 10.95 9.75 







Comparing the geometries of the FlexCell setup to the custom setup demonstrated 
minimal geometrical differences. The diameters for the loading posts and membrane for 
the Flexcell were 25 and 35 mm, respectively.  For the custom setup, the diameters were 
22.4 and 33.8 mm, respectively.  The resultant outer diameter/inner diameter ratios fo  
the Flexcell and custom setup vascular simulator were 1.4 and 1.5, respectively.  These 
values and ratio are similar, with the largest difference being the determinant of the gap 
between the fixed edges which is suctioned downward with application of the vacuum 
pressure depicted in Figure 9.  This value is within 0.75 mm of the FlexCell dimension 
and additional effects were considered negligible.  The computational values were 





                                
 
Figure 2.9 Comparison of FlexCell membrane to custom simulator membrane setup  
a) Flexcell dimensions (mm) b) Vascular Simulator setup dimension (mm)  
(Drawings not to scale, black represents area of the static post and the patterned area 








Loading Post  
Φ= 25mm 
Silicone Membrane   
Φ= 33.85 mm 





The experimentally measured % elongation for both dynamic and static measurements in 
the work of Vande Geest were found to be within 26% of the manufacturer’s 
specifications and 16% of the finite element analysis [169].  The finite element analysis 
indicated more uniform patterns of strain along the loading post in cases of lower vacuum 
pressures (Figure 10).  However, it is important to note that the “0” position indicated in 
Figure 10 represented the center of the silicone membrane.  Due to geometrical symmetry 
of the loading post, only the radius characterization was provided.  The contours of 
Figure 10 also demonstrated that the radial and circumferential strains were imilar in 
magnitude over the loading posts, particularly at the lower vacuum pressures of 20kPa 
and 40 kPa.  Additionally, the guidelines for uniform strain from Table 1 demonstrated 
agreement with the strain behaviors along the loading post (Figure 10).    
 
Figure 2.10  Strain contours along x for biaxial membrane (Figure 2 from Vande Geest, 






 In comparison of our custom system calibration, our measured strain values were 
within 11% for both the static and dynamic measurements.  During the testing regimens 
applied in this work, we were mainly interested on dynamic behaviors from 0-5% at 1 Hz 
corresponding to the normal cyclic regimen that is applied to the cells during the duration 
of mechanical testing in addition to static behavior of 12% strain applied to simulate 
balloon angioplasty.  These strain values corresponded to approximate FlexCell appli d
vacuum pressures of 33 and 55 kPa.  In our setup, the cells are confined for culture to a 
diameter of 18.44 mm, or 9.22 mm radius.  According to equation 1 and data from Table 
1, we are within the limits of cell area to assure a uniform strain profile, particul ly with 
the strain values applied in this work.  In comparison to the strain distribution along the 
x-axis of the membrane in Figure 10, strain can be assumed as fairly constant over the 
cells at 5% (33 kPa) strain interpolated in between the cases of 20 and 40 kPa.  
Interpolation of the case of balloon angioplasty deployments of 12% (55 kPa) would lie 
just below the case of 60 kPa, showing some variation along the distribution of cells 
within approximately 2% strain.  In either case, the % elongation, or strain, can be 
assumed fairly uniform over the cells with agreement between theoretical, computational, 
and experimental values.       
 
2.4.4 Conclusion   
Through the presented design we were able to construct a vascular mechanics 





cell response to applied stimuli.  We were also able to calibrate the applied strain and 
correlate a relationship with the external FlexCell software in addition to visually confirm 
fairly uniform strain behavior of the silicone upon deformation.  Comparison with a 
computational study with a comparable geometry verified the uniform strain behavior 






AIM 2- COMPUTATIONAL CHARACTERIZATION OF VASCULAR 
SIMULATOR 
 
3.1 Introduction  
  The designed vascular mechanics simulator was developed to provide 
physiologically significant levels of strain in addition to shear stresses applicable 
following a stent strut contact.  In order to characterize the resultant wall she r stresses at 
the cells associated with this design, Computational Fluid Dynamics (CFD) simulations 
were performed using the commercially available FLUENT.  FLUENT is frequently used 
to study alterations in shear stress within vascular geometries due to stent plac ment and 
atherosclerosis [171-173], making it an optimal tool to investigate the fluctuations in wall 
shear stresses due to suction in our custom designed vascular mechanics simulator.  The 
particular parameters of interest were the wall shear stresses and the fluid velocity 
profiles at the location of the cells following suction of the silicone membrane simulat ng 
balloon angioplasty.  A two-dimensional approach was used for the modeling with the 
assumptions of: fully developed flow at the channel inlet, incompressible flow, 
Newtonian fluid flow, no-slip wall conditions, and 2-dimensional flow, since the channel 
height was much less than the channel width [174]. 
3.2 Materials and Methods 
Theoretical wall shear stresses were calculated by the following formula where Q 
is the volumetric flow rate, w and h are the width and height of the channel respectively, 











τ =  
Current analysis worked under the assumption of fully developed laminar flow (Re=151-
160) at the entry into the section.  When examining the velocity profile, the two vacuum 
suction areas before and after the location of the cells were distinguished as the leading 
and lagging edges, respectively.  
 
3.2.1 Steady State Simulations 
Two-dimensional meshes were created in GAMBIT with the simplified steady 
state geometry of 5.0 cm by 0.635 cm.  A triangular mesh was implemented at a spacing
of 0.015, with 5736 and 6194 total elements for the non-suction and suction meshes, 
respectively.  A denser mesh was implemented at the site of the cells and at the moving 
walls.  The wall shear stress of the cases of the suction and non-suction model were 
compared to the theoretical calculation.  In addition, the velocity profile following the 
leading edge suction area was examined to verify the fluid profile recovery at the site of 
the cells.  The inlet velocity was initialized to 1.61 cm/s and the temperature to 37 
degrees Celsius, corresponding to in vitro media temperature conditions in addition to 
body temperature.  A user-defined function (UDF) altered from the FLUENT UDF 
manual was incorporated in FLUENT to provide a steady-state velocity profile for the 








3.2.2 Unsteady Moving Wall Geometry Dynamic Simulations    
A parallel plate geometry was constructed in GAMBIT with increased edge 
densities at the cell wall and the 71326 elements.  The geometry of the channel used in 
simulation was 12.0 cm x 0.635 cm, representative of the physical measurements in the 
simulator.  The dynamic motion of the wall was defined using a User Defined Function 
(UDF) incorporated into the FLUENT software.  The dynamic motion was defined using 
the DEFINE_CG_MOTION function which is implemented for translational and 
rotational motion for a rigid body.  The motion was simplified to a plug, or moving wall 
deformation motion rather than parabolic deformation to provided initial evidence that 
dynamic behavior affects velocity and wall shear stress behavior on surrounding cells.  
The movements of the deforming walls were assigned to 1 Hz deformation with two 
cases of deformation examined, low deformation of 0.0175 cm, and high deformation of 
0.035 cm. 
       Dynamic simulations were performed using a segregated implicit solver with a small 
time step of 0.002 seconds in order to accurately resolve the dynamic mesh in addition to 
obtaining refined periodic oscillatory agreement for the applicable number of itations.  
Periodic agreement was demonstrated after 10,000 iterations corresponding to 20 seconds









3.2.3 Unsteady Parabolic Dynamic Simulations    
To better model the deformation of the silicone membrane, the shape of 
deformation was assumed to be parabolic in nature.  Therefore, the function of 







= +  
where “a” is the distance from the vertex to the focus and k and h are the x and y 
coordinates of the vertex of the parabola, respectively.  To determine the unsteady 
solution of deformation, it was first assumed that the y coordinate of the vertex changes 
with time oscillating from -0.016 to 0 cm global positions in the y-direction based upon 
experimental measurement during deformation.  Boundaries for the x-coordinates of 
deformation were based upon assumptions of fixed boundaries where the silicone 
interfaced with the rigid Lexan material at the loading post and retaining rig. By 
assuming a linear relationship of deformation at time points within one deformation cycle 
of 1 second, a function of “h” in relation to the current time of simulation was 
determined.  The function values of “h” were then implemented to determine functions at 
later time points.  With “h” determined, and a constant (x,y) coordinates true for all 





It is important to note that a higher (4th) order function was implemented because the 
simulation can only approach the minimum y position of 0 cm due to the function of “a”.  





assumption is valid since it only accounts for approximately 1% of the maximum 
deformation. Additionally, it is unlikely that the silicone membrane ever fully reaches the 
minimum position point (y=0) in the experimental case due to the high frequency of 
oscillation of 1 Hz.  Given calculations of both “a” and “h”, the function is then able to 
sweep across the nodes on the deforming wall and calculate the corresponding “y” 
positions using the original parabola equation.  This implemented C source code is 
provided in Appendix C. 
 Having the deforming boundary during simulation requires the use of dynamic 
meshing.  There are three methods of dynamic meshing used in FLUENT which include: 
layering, spring smoothing, and local remeshing.  Layering involves the creation and 
destruction of cells.  This method is available for quad, hex, and wedge mesh elements.   
This method was not used in the presented simulation case since it is not available for 
triangular mesh element. Spring smoothing allowed th  nodes to move as connected by 
springs and the connectivity remains unchanged and is generally limited to small 
deformations.  Local remeshing can be used for larger boundary motions.  In local 
remeshing, the cells/faces are remeshed according to user specified skewness and size 
limits.  Both of these methods are used with triangular and tetrahedral mesh elements and 
are typically used in conjunction with each other.  A combination of the spring smoothing 
and local remeshing was implemented in this model and the settings particular to each 
method will be refined as needed to optimize the solution. 
 In order to implement the parabolic deformation fuction in FLUENT, the use of 





The three UDFs available include: DEFINE_CG_MOTION, DEFINE_GEOM, and 
DEFINE_GRID_MOTION.  DEFINE_CG_MOTION is generally implemented to 
provide translational or rotational motion to a rigid body as previously used in the 
simplified case while DEFINE_GEOM is used to project nodes onto a deforming 
boundary [175].  DEFINE_GRID_MOTION allows the most control over the deforming 
mesh and allows movement of any defined nodes [175].  This function was called at 
every time step and was implemented for the application of the deforming silicone 
membrane.  The implemented code for the deforming zo es is available in Appendix C 
and pictorial example of deformation is depicted in Figure 1 over the course of one 
deformation cycle.      
The parallel plate geometry measuring 5.0 cm by 0.635 cm was constructed in 
GAMBIT with four different meshes consisting of 8338, 21666, 67614, and 342720 
elements, referred to as Mesh 1,2,3 and 4 respectively, n the presented work.  
Simulations were run with a time step of 0.005 s and 10000 iterations for simulation time 
of 50 seconds.  To establish mesh independence, fluid velocities at three points were 
charted over time.  The velocities also provided insight to the velocity behavior over time 
in response to dynamic oscillation.  Once the mesh independence was established, the 
wall shear stress at the cells over 10 full deformation cycles was compared to ensure 




Figure 3.1  Parabolic function deformation at points over 1 cycle. (a) Original shape of 
entire geometry (b) Magnified view at first (leading) edge of deformation of original 
geometry (c) Deformation at 0.25 s, h= 
at 0.25s (e) Deformation at 0.5 s, h= 
Deformation at 0.75 s, h= -0.08 cm (h) Magnified view of deformed region at 0.75 s (i) 

















time =0 s 
 
 
time =0.25 s 
 
time =0.5 s 
 
time = 0.75  




-0.08 cm (d) Magnified view of deformed region 
-0.00018 cm (f) Magnified view at 0.5 s (g) 




















3.3.1 Steady State Simulations 
The theoretical wall shear stress was calculated to be 0.23 dynes/cm2, using a 
kinematic viscosity of 0.018 dynes*s/cm2 which was measured using the Paar Physica 
MCR 300 rheometer with a shear rate sweep from 0-750 s-1.   The 2D non-suction profile 
of wall shear stress in Figure 2(a) was linear, with overlapping values for the bottom and 
top walls due to symmetry.  There was an average value of 0.23 dynes/cm2, which agreed 
with the theoretical value.  The 2D suction model in Figure 2(b) displayed a less constant 
profile, but resulted in similar shear stress values in the range from 0.23-0.29 dynes/cm2.  
The top curve represents the wall shear stress profile across the cells.   
 
                         
                             
Figure 3.2 Steady State Simulations (a) Minimum deformation velocity profile (cm/s) (b) 
Maximum deformation velocity profile (cm/s)  (c) Minimum deformation WSS at cell 







3.3.2 Unsteady State Moving Wall Dynamic Deformation 
 
Minimum velocity profiles in Figure 3-4 (a) fairly resembled laminar profiles.  
For the case of high deformation, the wall shear stres  tended to range from 0.0-0.8 
dynes/cm2 at the site of the cells (Figure 3c-d).  For the case of low deformation, the 
range was 0.05-0.5 dynes/cm2 at the site of the cells (Figure 4c-d), demonstrating that the 
degree of deformation can affect the resultant WSS profile.  In the case of high 
deformation, there was also some reversed flow vectors at points during simulation. 
Oscillatory effects resulted in 2-4 times the maximum WSS of theoretical solution.  Mesh 
independence was not performed in the deformation of these geometries, but rather used 
as a preliminary simplified testing simulation to evaluate effects of deformation.  The 
results indicated a variation of wall shear stress (WSS) solution values (Figures 3 and 4) 












                  
                             
Figure 3.3 Unsteady Simulation of High Level of Deformation (a) Minimum velocity 
profile (b) Maximum velocity profile (c) Minimum deformation WSS at cell location (d) 
Maximum deformation WSS at cell location 
 
 
               
                        
Figure 3.4 Unsteady Simulation of Low Level of Deformation (a) Minimum velocity 
profile (b) Maximum velocity profile (c) Minimum deformation WSS at cell location (d) 











3.3.3 Unsteady Parabolic Simulations 
Deformation Functionality  
The deformation functions were based on a linear pek d formation assumption.  Each 
cycle was divided into two functions corresponding to the ascending and descending 
behavior of the silicone over each full deformation.  Maximum deformation was 
measured experimentally to be 0.16 cm and used in as the maximum deformation in each 
function.  Linear patterns of deformation over time w re assumed to be the minimum 
deformation approaching zero.  To verify the deformation function, the y-coordinate 
corresponding to the apex of the parabola was documented every 0.25 seconds and 
compared according to the point of deformation for each cycle (Table 1) and clarification 
of each point of deformation is shown in Figure 5.  The average deformation for each 
point in the cycle were: P1, P5: -1.597 x 10-1 cm ± 3.156 x 10-4 SD (0.21% from 
theoretical), P2: -7.89 x 10-2 cm ± 4.601 x 10-4 SD (1.38 % from theoretical), P3: -7.2766 
x 10-6 cm ± 2.384 x 10-6 SD, P4:  -7.89 x 10-2 ± 4.72 x 10-4 SD Percentages of the 
displacement comparisons versus the theoretical values were: P1, P5 0.21%, P2: 1.38% , 
P4: 1.33%.  For the case of P3, ideally the value would zero, making it unable to 
determine a percentage difference.  However, the diff rence between the small 
deformation to the negative sixth power and the theoretical value of zero was negligible 












Figure 3.5  Deformation points through cycle for analysis of minimum grid position 
corresponding to maximum deformation at apex of parabola 
 
Table 3.1  Descriptive Statistics for Each Point in Cycle Deformation 
 
P1, P5 P2 P3 P4 
Theoretical displacement 
(cm) -0.160 -0.080 0.000 -0.080 
Avg Exp. displacement 
(cm) -1.60E-01 -7.89E-02 -7.28E-06 -7.89E-02 
Standard Deviation 3.16E-04 4.60E-04 2.38E-06 4.72E-04 
Maximum -1.60E-01 -7.97E-02 -9.86E-06 -8.01E-02 
Minimum -1.59E-01 -7.78E-02 -1.21E-06 -7.81E-02 
Mean difference (T vs E) -3.38E-04 -1.11E-03 7.28E-06 -1.07E-03 
% Difference (T vs E) 0.21 1.38 NA* 1.33 
 
Velocity Tracking 
The three points that were chosen for velocity tracking were a function of the height of 








number of nodes for each mesh was: Mesh 1: 8338, Mesh 2: 21666, Mesh 3: 67614, and 
Mesh 4: 342720.  Point locations of were based upon nodal global positions with slight 
deviations between mesh densities.  Deviations in positions would result in different 
velocity readings at each time point.  Coordinates of the nodal positions for the four mesh 
densities is shown in Table 2.  Differences were mini al and considered negligible.   
 
 
Figure 3.6  Relative velocity tracking points over g ometry 
 
Table 3.2  Global Coordinates of Nodes for Reference Velocity Readings  
  Mesh 1 Mesh 2 Mesh 3  Mesh 4 
Point A 
x (m) -9.22E-03 -9.25E-03 -9.24E-03 -9.24E-03 
y (m) 1.38E-03 1.35E-03 1.34E-03 1.36E-03 
Point B 
x (m) 3.57E-05 3.33E-05 3.24E-05 -4.07E-06 
y (m) 3.37E-03 3.48E-03 3.42E-03 3.43E-03 
Point C 
x (m) 9.14E-03 9.25E-03 9.25E-03 9.24E-03 
y (m) 5.12E-03 5.13E-03 5.18E-03 5.20E-03 
 
The theoretical minimal resonance time for the soluti n was 3.8 seconds.  To verify 
convergent solution behavior, no values prior to 18 seconds were considered in 
comparative study.  Velocities were recorded every 1.5 seconds over the 50 seconds 
simulation time to capture velocity readings corresponding to minimum and maximum 
deformation with the cycles.  Velocities for Point A ranged from 1.5-2.0 x 10-2 m/s with 
















meshes were minimal and the averages were within 1.7%.  Velocities at Point B were 
highest and ranged from 2.2-2.7 x 10-2 m/s with the average being 2.48 x 10-2 m/s 
between the four meshes (Figure 8) and the averages wer  within 0.5% of the average.  
Point C velocities were the lowest and ranged from 1.2-1.8 x 10-2 m/s with the mean of 
all four meshes as 1.5 x 10-2 m/s with the meshes within 3.3% (Figure 9).  For all three 
points, the velocities for all three points resulted in lower values corresponding to the 
maximum deformation and higher values corresponding to the minimum geometrical 
deformation.  Given that minimal differences existed b tween the varying meshes and 
discrepancies were under 5%, the solutions were considered independent.      
 
                                                              (a)  
  Mean (m/s) Std. Dev Minimum Maximum 
Mesh 1 0.0178 0.0021 0.0157 0.0202 
Mesh 2 0.0177 0.0023 0.0155 0.0201 
Mesh 3 0.0174 0.0025 0.0149 0.0200 
Mesh 4 0.0178 0.0024 0.0156 0.0203 
b) 
 Figure 3.7  Point A velocity a) Graphical patterns for the four meshes with dotted line 
representing point where values were first considere  for analysis b) Descriptive statistics 
for respective meshes  

































  Mean (m/s) Std. Dev Minimum Maximum 
Mesh 1 0.0247 0.0027 0.0221 0.0275 
Mesh 2 0.0247 0.0024 0.0223 0.0272 
Mesh 3 0.0249 0.0024 0.0225 0.0274 
Mesh 4 0.0249 0.0022 0.0227 0.0271 
b) 
Figure 3.8  Point B velocity a) Graphical patterns for the four meshes with dotted line 
representing point where values were first considere  for analysis b) Descriptive statistics 
for respective meshes  
 
 
































 Mean (m/s) Std. Dev Minimum Maximum 
Mesh 1 0.0155 0.0028 0.0129 0.0184 
Mesh 2 0.0153 0.0028 0.0126 0.0182 
Mesh 3 0.0149 0.0028 0.0123 0.0178 
Mesh 4 0.0146 0.0025 0.0122 0.0172 
b) 
Figure 3.9  Point C velocity a) Graphical patterns for the four meshes with dotted line 
representing point where values were first considere  for analysis b) Descriptive statistics 
for respective meshes 
 
Velocity Contours 
Velocity contours over each deformation cycle indicated local fluctuations in velocities 
(Figure 10).  Investigation of velocity vectors indicated positive velocities in the x-
direction over the location of the cells with the exc ption of the areas of suction in which 
flow tended to move in both directions, particularly during suction. 






























               
                                     a)                                                                 b) 
 
                                     c)                                                            d) 
 
Figure 3.10 Velocity Profiles Over Deforming Geometry a) P1 and P5, b) P2 c) P3 
d) P4 (All velocities to normalized scales m/s) 
 
Wall Shear Stress (WSS) 
After establishing mesh independence through the velocity studies, Mesh 4 was 
implemented in further analysis for the characterization of the wall shear stress at the site 
of the cultures cells and at the deforming walls.  It was desired to establish periodic 
independence, or in other words verify that each cycle displayed similar wall shear stress 
behaviors.  To achieve this, wall shear stresses were compared over 10 cycles from 30-
40s simulation run time.  Wall shear stresses were compared for both deforming walls 
and along the cell location as depicted in Figure 11a.  An example WSS profile 
demonstrated the variation of WSS in the areas of suction (W1 and W3) (Figure 11b) and 
P4 P3 





recovery at the site of the cells.  Points 1-5 in deformation explained previously (Figure 











Figure 3.11  Wall shear stress deformation along deforming boundaries and cell location 
a) Pictorial representation of the geometry b)WSS profiles for one cycle at points of 
deformation 
 
For WSS comparison, the averages over the site of the cells were compared at 
each point in deformation of the 10 cycles of interest.  As Table 3 demonstrates, there 
was minimal difference between WSS between cycles at ach point.  There was variation 
in the WSS over the cells at the varying points within each cycle due to variations in 
velocity.  The average WSS at each point were: P1: 0.164, P2: 0.486, P3: 0.410, P4: 
0.099, and P5: 0.164 dynes/cm2.  WSS contours over the cells in Figure 12 showing 
cycles 1 (30-31s), 5 (34-35s), and 10 (39-40s) demonstrated the differences in WSS due 
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demonstrating periodic agreement between cycles.  Analysis illustrated that WSS 
oscillated from 0.1-0.5 dynes/cm2 compared to the theoretical WSS of 0.3 dynes/cm2, 
corresponding to the volumetric flow rate of 400 ml/min.  The maximum and minimum 
wall shear stresses occurred at P2 and P4, respectively.  Comparison in Figure 12 was 
limited to the actual cell location during cell culture.  Figure 13 incorporates both this 
length in addition to the entire wall (W2 from Figure 11a) that extends up to the walls 
that are suctioned downward (W1 and W3).  Wall shear stresses over the entire wall were 
affected within the 2mm space before the cell locati n (Figure 13).  Increased WSS 
ranges for this area for each deformation point were: P1, P5: 0.2-0.35 dynes/cm2, P2: 0.5-
.9 dynes/cm2, P3: 0.4-0.55 dynes/cm2, and P4: 0.1-.25 dynes/cm2.  P3 demonstrated a 
decrease range of WSS at W3 of 0.4-0.3 dynes/cm2.  At each point of deformation, there 
were patterns of increased wall shear stresses within this range demonstrating the 
importance of limiting the region of cultured cells to obtain uniform distribution at each 
point in the deformation cycle.        
      
Table 3.3  Comparison of WSS Over 10 Deformation Cycles 
   WSS at site of cells (dynes/cm2) 
  Start (s) end (s) P1 P2 P3 P4 P5 
Cycle 1 30 31 1.65E-01 4.87E-01 4.13E-01 9.84E-02 1.64E-01 
Cycle 2 31 32 1.64E-01 4.87E-01 4.09E-01 9.71E-02 1.63E-01 
Cycle 3 32 33 1.63E-01 4.87E-01 4.12E-01 9.73E-02 1.63E-01 
Cycle 4 33 34 1.63E-01 4.86E-01 4.10E-01 9.87E-02 1.64E-01 
Cycle 5 34 35 1.64E-01 4.87E-01 4.09E-01 9.92E-02 1.64E-01 
Cycle 6 35 36 1.64E-01 4.86E-01 4.11E-01 9.89E-02 1.64E-01 
Cycle 7 36 37 1.64E-01 4.85E-01 4.09E-01 9.97E-02 1.64E-01 
Cycle 8 37 38 1.64E-01 4.84E-01 4.10E-01 9.92E-02 1.64E-01 
Cycle 9 38 39 1.64E-01 4.84E-01 4.10E-01 1.01E-01 1.65E-01 


















Figure 3.12 WSS Contours over cells at points of deformation a) Cycle 1 (30-31s) b) 
Cycle 5 ( 34-35s) c) Cycle 10 (39-40s) 
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Figure 3.13 WSS Contours Over
 
3.4 Discussion 
In summary, the static steady
theoretical design values and also demonstrated that the suction profile of the
membrane did not interfere with the velocity profile at the site of the cells, but did 
however affect the wall shear stress profile.  The av rages for the theoretical, non
suction, and suction model wall shear stresses wereall 0.23 dynes/cm
cultured cells for the case of 350 ml/min volumetric flow rate
wall unsteady dynamic simulations indicated that the oscillation of the silicone 
membrane resulted in a range WSS from approximately 0.0
dynes/cm2 for high and low levels of deformation, respectively over the location of the 





 Whole Cell Wall (W2) and Restricted Cell Location a) 
P1, P5 b) P2 c) P3, d) P4 
-state case simulations demonstrated agreement with 
2 at the site of the 










Parabolic deformation over the 1 Hz deformation cycle indicated changes in WSS 
in dynamic simulations occur due to localized increases/decreases in fluid velocity from 
dynamic channel geometry changes.  The velocity profiles and wall shear stresses at each 
point of deformation suggest local increases in velocity as the silicone membrane ascends 
upward to the point of minimum deformation and loca decreases in velocity occur as the 
silicone membrane is suctioned downward.  These alterations result in an oscillating 
range of WSS of 0.1-0.5 dynes/cm2, corresponding to the theoretical WSS of 0.3 
dynes/cm2.  Simulations also illustrated that cells should be cultured to a limited range in 
order to be exposed to a fairly constant WSS at each point of deformation.   
The presented simulations were limited to a cross-sectional plane across the 
center of the channel as designated by the dashed line in Figure 14a.  Cells are cultured 
over a larger area, so two other cases are briefly addressed here for discussion, a cross-
section at the cell culture radius/2 (Figure 14b) and  cross-section at the cell culture 
radius (Figure 14c).  Only one side is considered due to symmetry. The width of 
deformation gaps for each of these cases increases moving away from the centerline and 
the length of the loading post wall decreases (Table 3).   





Figure 3.14 Reference for cross-sectional analysis a) Centerline r= 0 b) r= R/2 c) 
r= R (R=radius of cell culture area) 
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Table 3.4 Comparison of Reference Planes 
  Post (cm) (radial) Gap (cm) Ratio 
r= 0 1.10 0.58 1.89 
r= R/2 1.01 0.63 1.59 
r= R 0.65 0.80 0.81 
 
Wall shear stress analysis illustrated that distances between the edge of the 
loading post and the cell location were subject to increased wall shear stresses 
comparative to the area of the cells (Figure 14).  Application of this principle to cells in 
the z-direction in Figure 15 suggests implications for the decreased ratio of the post 
distance to the gap near the outer limits of the cultured cells.  At r= R/2, the ratio is fairly 
similar and would demonstrate minimal effects without large peaks in WSS.  However, at 
the outer boundary of r=R, the gap length is greate than the wall length and would result 
in non uniform WSS profiles and peaks of increased wall shear stresses.  These could be 
areas of concern; however, these areas are minimal relative to the entire area of cell 
culture.  The area of the circle between Radius/2 and R is 0.17 cm2 compared to the 
whole circular cell culture area of 3.84 cm2.  Multiplying this area by 2 due to symmetry 
of the circle indicates that less than 10% of the area is possibly subject to high and 
variable shear stresses.       
 
3.5 Conclusion  
Computational analysis characterized the effect of yclic deformation on resultant 
local changes in velocity within the geometry and the resultant wall shear stress which 
the cultured cell are subjected to.  This 2D analysis not only showed oscillating wall 





over the length of the cultured cells.  Computational characterization of the mechanical 
environment assists to better correlate the observed responses of cells to the applied 









AIM 3- ACUTE SMC RESPONSE FROM CONCURRENT TENSILE AND 





In order to study Smooth Muscle Cell response in vitro, a concurrent shear and 
tensile forces simulator has been developed to provide clinically significant levels of 
strain and shear stresses in addition to simulating forces similar to those during balloon 
angioplasty.  In this acute study (8 hours), rat aor ic SMC demonstrated significant cell 
proliferation following applied increased tensile forces of angioplasty injury and shear 
exposure when compared to lower levels of tensile exposure similar to a normal 
physiologic level with an average of 75% increase in the number of cells of the injury 
group compared to the normal dynamic group.  The smooth muscle cells exposed to 
balloon angioplasty injury and concurrent shear and te sile mechanical forces resulted in 
a decreased expression of the contractile phenotypic marker SM α-actin.  These findings 
demonstrate the efficacy of the developed model for in-vitro angioplasty and the 
simulated mechanical environment to the cells.  This model provides an in vitro model to 
isolate the effects of concurrent mechanical forces and could also potentially act as a 
preliminary step toward use in pharmaceutical research for reduction or prevention of 
SMC proliferation due to altered mechanical forces during endovascular procedures.    
With this model, the mechanical forces can be isolated from the biochemical 
signals and their influence on the SMC response to injury.  The use of this 





pharmaceutical manipulation of SMC, and research into the reduction, and eventually the 
prevention, of SMC hypertrophy and proliferation following endovascular procedures.   
 
4.2 Materials and Methods 
 
 An equibiaxial strain profile was applied along the silicone membrane using 
vacuum similar to the technology implemented by Flexcell International (Hillsborough, 
NC).  The Flexcell 3000 software was used to control s ain and regulate vacuum 
pressure.  Others have shown that approximately the outer 20% of the silicone 
membranes located over the static post in the Flexce l system does not follow constant 
radial and circumferential strain profiles [169].  Since the designed system utilized in this 
study implemented a similar static post geometry, cells were confined to the center of the 
membrane to promote constant radial and circumferential strain at the site of the cultured 
cells during mechanical testing by using a Teflon ring with an inner cross sectional area 
of 2.75 cm2 and an approximate height of 1.75 cm centered onto the silicone surface over 
the center Lexan post during the period of cell culture.   This Teflon ring was removed 
prior to mechanical testing and only acted to confine the cells during cell culture.   
 
Cell Culture 
Rat aortic smooth muscle cells (RASMC) (Passage 11-14) obtained from VEC 
Technologies were maintained with Dulbecco’s Modificat on of Eagle Medium (DMEM) 
(Mediatech, Inc., 10-013-CV, Herndon, VA) supplemented with 10% heat inactivated 





Antimycotic (Sigma-Aldrich, A5955, St. Louis, MO).  Cells were trypsinized with 0.25% 
Trypsin with 0.2 mg/mL EDTA (Sigma Chemical Company, E6511, St. Louis, MO). 
 
Cell Seeding for Mechanical Testing 
Silicone membranes (5.25 cm in diameter) for each station were cut from biomedical 
grade silicone sheets (Lot SM04106803, Specialty Manufacturing, Inc. Saginaw, MI) of 
.015" thickness and 40 durometer.  These were sonicated in deionized water and 
assembled with the designed station plates.  The assembled plates were steam sterilized 
(Tuttnauer Brinkmann, 3870M, Jerusalem, Isreal) at 121 degrees Celsius for 30 minutes 
and then placed into the simulator apparatus over approximately 0.2 cc of Silicone 
lubricant (Loctite Corporation, 51360, Rocky Hill, CT).  The lubricant was distributed 
using a sterile silicone stopper and application of 5% mechanical strain from the 
FlexerCell strain system (FlexCell International). The assembled system was then UV 
sterilized for 3 hours.  Following sterilization, sterile Teflon rings were centered onto the 
silicone surface.   The center area of silicone encompassed by the Teflon rings was 
collagen coated with Type I Collagen (Vitrogen 100, 3mg/ml, Cohesion Tech, Palo Alta, 
CA) diluted with sterile water to 50.0 µg/mL and allowed to dry for 72 hours in a sterile 
laminar flow hood according to Cohesion Tech protocl for formation of a thin collagen 
film.  Prior to cell seeding, the membranes were rinsed with 1.0 ml of Dulbecco’s 
Phosphate Buffered Saline (DPBS) (Media Tech, Inc.,21-031 CM,168).  Cells were 





104 cells/mL and incubated for 48 hours.  One additional milliliter of media was 
supplemented after 24 hours.                
 
Simulation Experiment Groups 
Two experimental groups simulating in vivo conditions were investigated in this 
study in addition to a control group where cells where not exposed to shear or tension.  
The injury model (IM) group consisted of cells exposed to high strains generated during 
balloon angioplasty followed by concurrent shear and tensile exposure.  These cells 
represented the smooth muscle cells that are directly xposed to blood flow upon the 
denudation of the endothelial monolayer.  The cycli tension group (CT) simulated a 
physiological control where cells are cyclically strained from 0 to 4% and not directly 
exposed to flow.  Unloaded static controls (U) were us d as adhesion and phenotypic 
behavior controls.  Adhesion controls (A), which were fixed and counted prior to testing, 
assisted in determining problems of adhesion due to exp sure of mechanical forces.    
 
Mechanical Testing 
Prior to mechanical testing, confluency was assessed by microscopy of the unloaded 
static controls.  The media with 10% FBS was removed and the RASMC were 
maintained in quiescent media consisting of DMEM without FBS supplementation for 
the duration of mechanical testing.  Media without FBS supplementation is commonly 
used in dynamic testing to investigate effects of changes in proliferation.  During the 





a preconditioning regimen of 0-4% cyclic strain for 2 hours at gradually increasing 
frequencies of 0.1 Hz (30 min), 0.5 Hz (30 min), and 1.0 Hz (60 min). Following this 
preconditioning regimen, the CT group (n=6) was subject to 0-4% cyclic strain for 8 
hours, and the IM group (n=6) was subject to two 12% static circumferential static 
stretches held for 75 seconds each with a 30 second interval between stretches as 
commonly performed during balloon angioplasty procedur . Following simulated balloon 
deployment, shear flow was resumed at 350 ml/min and cyclic strain was applied at 0-4% 
for 8 hours.  The flow rate of 350 mL/min provided low wall shear stress (0.25 
dynes/cm2) to promote cell proliferation.  Static Unloaded (U) samples which were not 
subject to dynamic force exposure served as a control ( =6) and adhesion controls (A) 
(n=6) which were fixed prior to dynamic testing served to determine the number of cells 
lost to problems of cellular adhesion. 
 
Evaluation of Cellular Response 
Cell Proliferation 
Each experimental group allowed for six samples. Cell proliferation was assessed 
using a quantitative (n=3) and a qualitative (n=3) method.  The quantitative approach 
involved staining of cell nuclei with 4',6-diamidino-2-phenylindole (DAPI) (Molecular 
Probes, D-1306, Eugene, OR).  For this method, cells were rinsed with DPBS following 
mechanical testing and fixed with 100% ethanol for 30 minutes and rinsed again with 
DPBS.  Samples were covered with 0.5 ml DAPI solutin for 10 minutes and rinsed with 





Melville, NY) at ten locations distributed throughout the sample.  ImagePro Plus 
Analysis software (Media Cybernetics, Inc., Version 5.1, Silver Spring, MD) was used to 
quantify the number of cells present.   
The qualitative analysis involved the use of Cell Titer 96 AQueous ONE Solution 
Cell Proliferation Assay (MTS) (Promega Corporation, G-3580, Madison, WI) in which 
1.25 mL was added to each well and incubated for 3 hours.  The supernatant was 
collected individually, dispensed into cuvettes, and gently vortexed to promote sample 
uniformity.  Four 125µL samples from each supernatant were placed into a 96-well UV 
spectrophotometer plate.  The Optical Density was determined at 490 nm (Beckman 
Instruments, Inc., Model# DU 640B, Fullerton, CA).  
 
Phenotypic Marker 
SM α−actin as a marker cellular phenotype [2] was assessed in cell extracts using 
standard western blotting techniques.  The expression of GAPDH was also evaluated and 
was used as a normalization and control of protein loading.  Cells were removed from the 
silicone membrane and lysed using an extraction buffer consisting of 0.5% Triton X-100 
(Sigma-Aldrich, T-9284, St. Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L-
4522, St. Louis, MO), 20 mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL 
protease cocktail inhibitor (Sigma-Aldrich, P8340, St. Louis MO).  The BCA Protein 
Assay Kit (Pierce, 23225, Rockford, IL) was then used to determine the total protein 
content of each sample.  These samples were then diluted to 10 µg/µL using sample 





Blue, glycerol and distilled water.  Each sample was normalized to 1 µg/µL.  Prior to gel 
electrophoresis, the samples were boiled for 5 minutes to linearize the proteins.  A 10% 
polyacrylamide gel (BIORAD, 161-0158, Hercules, CA) was used in electrophoresis with 
17.5 µL cell solution loaded per lane.  Western Blot analysis was performed using 
transfer to a PVDF membrane (BIORAD, 162-0184, Hercul s, CA).  WesternBreeze® 
chromogenic Western Blot Immunodetection Kit (Invitrogen, WB7103, Carlsbad, CA) 
was used to detect levels of α-actin and GAPDH expression.  The WesternBreeze 
Chromogenic Immunodetection Protocol was followed with the primary antibody Mouse 
monoclonal [SPM332] to alpha smooth muscle Actin (Abcam, ab18460-1, Cambridge, 
MA) at a dilution of 1:1000 and with the primary antibody Anti-GAPDH Mouse mAb 
(6C5) (Calbiochem, CB1001, San Diego, CA) at a dilution of 1:1500.  Densitometry was 
performed on the developed Western Blots to evaluate the SM α-actin expression 
differences between the Unloaded (U) (n=3), Cyclic Tension (CT) (n=3), and Injury 
Model (IM) (n=6) groups.  The integrated optical density (IOD) of the bands was 
determined using a Imaging Densitometer (BIORAD, GS-700, Hercules, CA ) paired 
with Quantity One analysis software version 4.1.1 (BIORAD, 170-9600, Hercules, CA).   
The ratios of SM α-actin to GAPDH were evaluated to normalize the data and these 










An ANOVA statistical analysis paired with Tukey analysis was performed using 
SigmaStat (Systat Software, Inc., San Jose, CA) for the statistical analyses examining 
data of cell proliferation and SM α-actin with p<0.05 indicating a significant difference.      
 
4.3  Results 
Cell Quantification 
Acute studies (8 hours) using rat aortic SMC demonstrated significant cell proliferation 
following angioplasty injury and shear exposure (IMgroup) when compared to 
“physiological function” cyclic tensile exposure (CT).  DAPI analysis indicated a 75% 
increase in the number of cells of the IM group compared to the CT group (p=0.001).  
The cell number averages for the DAPI cell count were 3.45 x 104 (± 1.7 x103 SD) 
cells/mL for the cyclic tensile (CT) group, 6.07 x 104 (± 5.0x103 SD) cells/mL for the 
injury model group (IM), and 10.0 x 104 (± 15.8 x103 SD) cells/mL for the combined 
averages of the static unloaded (U) group, and 8.2 x 104 (± 16.1 x103 SD) cells/mL for the 
adhesion group (A) as shown in Figure 1 (a).  As shown in Figure 1 (b), MTS results 
supported the trends of the DAPI results with mean r sultant absorbance levels at 490 nm 
of 0.062 (± 0.028 SD) for the cyclic tensile (CT), 0.153 (± 0.04 SD) for the injury model 
groups (IM), and 0.345 (± 0.034 SD) for the unloaded (U) groups.   
 
 
Figure 4.1 Cell proliferation comparison between cyclic tensile (CT), injury model (IM), 
unloaded (U), and adhesion (A) (for DAPI only) test groups 
indicated significant difference with IM and U being dif




Western Blot analysis was performed to detect levels of the contractile phenotype marker 
SM α-actin.  Decreased levels of SM 
phenotype of the smooth muscle cells.  The results of the Western Blot analysis are 
shown in Figure 2.  The static unloaded (U1
actin integrated optical density (IOD) of 1.038 (± 0.103 SD).  The normal function 
simulation in the cyclic tensile group (CT1
actin with IOD levels of 1.162 (± 0.098 SD), however these results were not significantly 
different.  Significant differences were observed with the balloon angioplasty injury 
(IM1-IM3) model with a decreased normalized SM 
0.841 (± 0.046 SD) (p=0.006), a 19% decrease in SM 
the injury model to the static unloaded samples.     
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Figure 4.2  Western Blot results for SM α-actin for cyclic tensile (CT), injury model 
(IM), and unloaded (U) test groups: (a) Densitometry picture of SM α-actin used to 
evaluate integrated optical density to compare expression (b) Densitometry picture of 
GAPDH acting as protein loading control (c) Normaliz t on of SM α-actin expression to 
loading control GAPDH  indicating significant difference of SM α-actin expression in the 
injury model (p=0.006).   
 
4.4 Discussion 
The effects of individual mechanical forces on smooth muscle cell behavior in an 
in vitro setting have been well documented by others.  However, the presented model has 
been developed with the capability to more accurately represent concurrent mechanical 
forces due to the additional injury response from balloon angioplasty deployment on the 
reaction of smooth muscle cells in addition to low wall shear stress exposure that 
stimulates smooth muscle cell proliferation.   
  One purpose of the injury model was to simulate increased balloon deployment 





flow.  During balloon angioplasty, high deployment forces of 5-10 atmospheres can 
negatively affect surrounding smooth muscle cells.  Often, the procedure of balloon 
angioplasty is described as the compression of arteri l plaque within the blood vessel to 
restore nominal lumen diameter.  However, the higher rigidity of the plaque within the 
vessel walls compared to surrounding tissue results in greater transfer of the deployment 
force to surrounding tissue and smooth muscle cells[51].  Further exposure of the smooth 
muscle cells to a physiological tensile dynamic force of 0-4% for less elastic arteries at 1 
Hz resembled the normal tensile forces that smooth muscle cells are subjected to in vivo.   
The phenotype shift of smooth muscle cells from a contractile to a more synthetic 
phenotype has a significant role in intimal hyperplasia following endovascular procedure.  
In vivo, normal non-diseased smooth muscle cells reside primarily in the media layer of 
the blood vessel and are of a contractile phenotype.  Following balloon angioplasty, 
medial smooth muscle cells can change from a contractile to a synthetic phenotype [1].  
These changes in the cell result in the cellular loss f ability to contract, increased protein 
secretion, and increased reaction to autocrine and p racrine growth factors [3-5].  
Contractile smooth muscle cells contain relatively more SM α-actin than synthetic 
smooth muscle cells which is why it was the chosen marker in this study [2].    
Mechanically, the stiffness of contractile smooth muscle cells has been shown to be 
higher than synthetic smooth muscle cells proposed to be from an increased amount of 
actin within the cell [62].      
In vitro cell lines are generally characterized as a synthetic phenotype.  When 





phenotypes to a synthetic state.  Increased levels of applied tensile forces (>10%)  have 
been shown to result in increased smooth muscle cell proliferation  in addition to 
decreased expression of markers such as SM α-actin [163].  When examining the results 
of this study, the static unloaded smooth muscle cel s, normal to in vitro culture, served 
as a baseline for SM α-actin expression.  Even at a short time point of eight hours 
following injury, a low level of tensile forces similar to in vivo forces resulted in a higher 
level of SM α-actin expression as seen in Figure 3.  Although not significant, this 
suggests that the application of an applied low level of tensile forces could stimulate 
differentiation toward a more contractile phenotype ov r time.  Investigation of increased 
time points would be needed to explore this hypothesis.  The significant decrease in SM 
α-actin expression shown in Figure 3 at the early time point of 8 hours exposure to shear 
and tensile forces following in vitro balloon angioplasty provides valuable insight to the 
early phenotypic shift due to the applied mechanical forces.   
Proliferation results indicated in Figure 2 supported he concept of an early 
phenotypic shift.  Comparing the dynamic groups of cyclic tensile (CT) and the injury 
model (IM), DAPI results indicated a significantly different 75% increase in the number 
of cells present in the injury model compared to the CT group simulating normal arterial 
function, indicating that the injury and exposure to concurrent shear and tensile forces 
resulted in increased proliferation of the injury model.  As cell adhesion is a concern 
associated with dynamic experiments in the case for both the cyclic tensile (CT) and the 
injury model (IM) groups, a direct proliferation comparison of both groups with the static 





a significant loss of cells due to dynamic exposure.  For this reason, the static unloaded 
group (U) was not included in this comparison.   
The application of shear force to smooth muscle cells an have various effects on 
the cell response.  Variations in flow behavior caninvoke different responses along with 
the magnitude of the shear rate.  Shear studies demonstrate the inhibition of in vitro 
smooth muscle cell proliferation with high levels of shear stress [143].  In general, shear 
stress levels above 10 dyne/cm2 are considered high and atheroprotective [144].  In 
contrast, areas of low shear stress (<10 dyne/cm2) promote an atherogenic response and 
increased smooth muscle cell proliferation [144].  Alterations in arterial geometry can 
result in areas of flow separation, stagnation, and recirculation.  These disturbances in the 
velocity profile can result in areas of low wall shear stresses, therefore promoting smooth 
muscle cell proliferation.  
The application of tensile force applied to cells is usually in the form of 
circumferential, uniaxial, or biaxial application.  The direction applied is usually adjusted 
to the application.  In the case of vascular cells, they are cyclically deformed from the 
dilation and relaxation of the blood vessel, usually represented by either circumferential 
or uniaxial testing.  The cyclic strain response of vascular cells is important to both 
normal and abnormal cell function.  It can affect cell proliferation, migration, apoptosis, 
morphology, and alignment [154]. 
Cell differentiation is an important issue in development and in vitro testing.  
When transferred to static culture, contractile vascular smooth muscle cells tend to 





the expression of some of the markers of the differentiated state of smooth muscle cells.  
In a study by Birukov and collaborators, in addition t  h-caldesmon upregulation, 
increased proliferation was seen indicating a contradicting synthetic behavior, but the 
level of stress on the cells was higher than physiolog c stress (15%) which could affect 
the proliferation behavior of the cells [162].  Butcher and collaborators demonstrated a 
phenotype shift in a 3D collagen construct of RASMC subject to tensile forces 
corresponding to 10% strain at 1 Hz for 48 hours using a platen multiaxial strain system 
[163].  The strained group results showed increased cell viability, decreased 
morphological elongation, decreased α-actin and calponin expression, and increased 
vimentin expression compared to the static control.  These results suggest a shift from 
contractile toward a more synthetic phenotype. 
There are different in vitro systems in use to study the effects of applied 
mechanical forces.  For example, shear stresses are generally fluid induced using a 
parallel plate flow chamber based on pressure differences or by a cone on plate rotational 
device.  In vitro tensile testing is modeled in vitro using devices which apply tensile 
forces in unidirectional, bidirectional, and radial/circumferential directions.  The 
advantage of this system in this study is the combinatory effect of force application 
through use of combined principles of radial/circumferential tensile application and 
parallel plate shear application.   
Although the developed system is an improved in vitro model, there are 
limitations of this study that will be addressed in further studies.  As previously stated, 





migration, hypertrophy, differentiation, and proliferation.  Further studies of cell analysis 
will investigate the possible responses of apoptosis, proliferation, and cell hypertrophy.  
Additionally, as discussed previously, there are other phenotypic markers that indicate 
synthetic or contractile behavior.  Investigating other markers in addition to SM α-actin 
will assist in better characterization of the differentiation effects of applied mechanical 
forces on vascular smooth muscle cells. 
          
4.5 Conclusion 
This study presents an in vitro model to simulate in vitro balloon angioplasty 
followed by applied tensile and shear forces to exposed smooth muscle cells.  The 
findings within this study demonstrate the efficacy of the developed model for in-vitro 
angioplasty and the simulated mechanical environment to the cells.  Additionally, the 
significant response at a short point stimulates further investigation for increased forces 
and time points for increased smooth muscle cell response.  
The clinical significance of this in vitro cell proliferation model is the ability to 
mimic clinically relevant mechanical stresses and to apply a more complex applied 
regimen to simulate clinical intervention combined with normal exposure.  Hopefully this 
model could ultimately be implemented for use in early pharmaceutical research for 
potential anti-proliferative agents for smooth muscle cells in attempt to prevent 








AIM 4- INCREASED SYNTHETIC PHENOTYPE BEHAVIOR OF SMOOTH 







In order to study smooth muscle cell (SMC)  response i  vitro, a concurrent shear and 
tensile forces simulator has been developed to provide clinically significant levels of 
strain and shear stresses in addition to simulating forces similar to those exerted during 
balloon angioplasty.  After 24 hours of force exposure, rat aortic SMC demonstrated 
significant synthetic behavior following applied increased tensile forces of angioplasty 
injury and shear exposure.  These responses included increased proliferation, apoptosis, 
and smooth muscle cell hypertrophy when compared to the dynamic control of applied 
strain alone.  All dynamic groups demonstrated a decrease in contractile protein 
expression, although the injury model maintained a significantly greater expression of the 
synthetic marker vimentin.  These in vitro findings agree with in vivo occurrences and 
present a refined dynamic model to be implemented for better understanding of smooth 




Restenosis remains a common problem following balloon angioplasty and stent 
placement occurring in 30-60% of cases with balloon angioplasty alone [45] and in 13-





which can begin immediately after balloon angioplasty followed by smooth muscle 
proliferation in the next 24-72 hours for up to two eeks [51].  Increased production of 
the extracellular matrix and cellular hypertrophy further increases intimal hyperplasia [9].   
These initial events of restenosis can be attributed in part to shifts in behavior of 
medial vascular SMCs from a contractile to a synthetic phenotype [1].  Contractile SMCs 
are quiescent, morphologically smaller and more elongated, express increased contractile 
protein expression, and maintain the ability to contract [2].   In contrast, synthetic SMCs 
are marked by higher proliferation, higher cell turnover, increased extracellular matrix 
production, increased cell hypertrophy, increased synthetic protein expression, and loss 
of the ability to contract [2].  Thus, blocking of SMC phenotype shift may be a useful 
way to reduce the incidence of restenosis following balloon angioplasty.    
   While the exact triggering mechanism is yet unknow , it has been speculated 
that changes in the mechanical environment for SMCs due to angioplasty and placement 
of stents can result in shifts in SMC phenotype.  During balloon deployment, both 
atherosclerotic and healthy smooth muscle cells in the medial layer are exposed to higher 
radial and circumferential forces followed by normally unseen direct shear forces from 
blood flow due to the denudation of the endothelium.    
In addition, disturbances in blood flow due to atherosclerotic lesions and stent 
struts can cause further smooth muscle cell response.  Vascular locations with disturbed 
blood flow are more prone to plaque formation, vessel remodeling, and endothelial cell 
activation [91, 176-178] and are most frequently associated with intimal thickening 





activation is shear and time dependent; studies have shown that intimal thickness results 
in areas of high shear at early time points while low wall shear was associated with 
advanced intimal thickening, demonstrating negative eff cts in both cases deviated from 
an optimum range [85, 86].  These results were further substantiated by in vitro studies 
that demonstrated SMC proliferation decreases when exposed to well-defined steady flow 
[153] and increased proliferation when exposed to oscillatory or orbital shear stress 
patterns [178, 180, 181].   
Cyclic strain due to the dilation and contraction of bl od vessels is just as an 
important mechanical stimulus as blood flow-induce sh ar stress to SMC function, such 
as cell proliferation, migration, apoptosis, morphology, and alignment [154].  While 
numerous studies have investigated the in vitro SMC response to applied cyclic strain, the 
results obtained to date are mixed.  Responses can vary with different parameters such as 
the SMC vascular location, animal species, and the extracellular matrix [154] as well as 
with the frequency, amplitude, and time exposed to strain can also affect the response of 
cells.  For example, cyclic strain has been shown to i duce cell arrest in vascular SMCs, 
therefore reducing rates of proliferation [155, 156].  Both low (< 5%) and high (>10%) 
cyclic strains evoke a more synthetic SMC phenotype while normal physiologic (5-10%) 
strain promote a quiescent contractile phenotype [182, 83].  In addition, SMC apoptosis 
has been shown to be magnitude dependent with low physiologic strain (5-10%) do not 
induce cell apoptosis [155-157], while higher levels (10-15%) induce cell apoptosis [157, 
158].  The application of cyclic strain has been shown to increase expression of some 





caldesmon upregulation, increased proliferation was seen [162], demonstrating how 
changes in phenotype marker expression and proliferativ  response can act independently 
of one another. 
 Previous in vitro studies provided many important fi dings, however the models 
are generally limited to the simulation of either cyclic strain or shear force on SMCs.  To 
simulate the complex arterial mechanical environment, our lab has designed and 
fabricated a novel in vitro vascular intervention model which incorporates concurrent 
shear and tensile forces to evaluate the response of SMCs to the mechanics of 
endovascular intervention.  Using this setup, we previously demonstrated increased 
proliferation of SMCs after only 8 hours in response to our concurrent mechanical stimuli 
when compared to cyclic strain alone [185].  In addition, our study demonstrated a 
significant decrease in the contractile protein marker of SM α-actin expression in the 
concurrent mechanical stimuli group compared to both the static and the cyclic strain 
groups [185].  Given these results, we hypothesized that the early time point of 24 hour 
concurrent force exposure following balloon angioplasty would result in further synthetic 
behavior of SMCs.  To characterize the phenotype shifts in response to the concurrent 
forces applied, the present study focused on evaluating SMC responses of proliferation, 









5.3 Materials and Methods 
Cell Culture 
Rat aortic smooth muscle cells (RASMC) (Passages 4-6) harvested from 10-12 weeks old 
male Sprague-Dawley rats were a generous gift from the laboratory of Dr. Anand 
Ramamurthi, Department of Bioengineering, Clemson University.  The RASMCs were 
cultured in Dulbecco’s Modification of Eagle Medium (DMEM) (Mediatech, Inc., 10-
013-CV, Herndon, VA) supplemented with 10% heat inactiv ted fetal bovine serum 
(FBS) (Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-Antimycotic (Sigma-
Aldrich, A5955, St. Louis, MO) under standard cell cu ture conditions (37ºC, 5% CO2 
with 95% air, humidified environment).   
 
Exposure of RASMCs to Mechanical Stimuli 
Our custom-designed, concurrent force, vascular mechani s system was set up and 
sterilized as previously described [185].  Prior to cell seeding, collagen (50 µg/ml) coated 
silicone membranes were rinsed with 1.0 ml of Dulbecco’s Phosphate Buffered Saline 
(DPBS) (Media Tech, Inc., 21-031 CM, Herndon, VA).  RASMCs were seeded at a 
density of 2.8 x 104 cells/cm2 (P4-6) and incubated for 24 hours in DMEM containing 
10% FBS and 1% Antibiotic-Antimycotic.  At 24 hours, the medium was changed to 
DMEM containing 1% FBS, 1% Antibiotic-Antimycotic, and 1% Dextran for an 
additional 24 hours prior to testing.  During mechanic l stimulation, the RASMCs were 





to the medium at 1% (w/v) to adjust the media viscosity and resultant wall shear stresses 
on the cells at the prescribed level [174]. 
Three experimental dynamic groups simulating in vivo conditions were 
investigated in the present study in addition to a static unloaded (U) control group where 
cells where exposed neither to shear nor tensile forc s.  Prior to the application of 
mechanical stimuli of interest, the dynamic experimntal groups were subject to a 
preconditioning regimen of 0-4% cyclic strain at gradually increasing frequencies of 0.1 
Hz (15 min), 0.5 Hz (15 min), and 1.0 Hz (15 min).  The cyclic tensile group (CT) 
simulated a physiological dynamic control and RASMCs were cyclically strained from 0-
5% at a frequency of 1 Hz for 24 hours.  The second group that simulates the clinical 
balloon angioplasty (BA) regimen was subjected to simulated in vitro balloon angioplasty 
consisting of two 12% static circumferential stretches held for 90 seconds each with a 30 
second rest interval between stretches. The injury model (IM) group simulated smooth 
muscle cells that are directly exposed to blood flow upon the denudation of the 
endothelial monolayer and was exposed to the same blloon angioplasty regimen as BA.  
Following simulated balloon angioplasty, shear flow was resumed at 400 ml/min and 
cyclic strain was applied at 0-5% for 24 hours.  The flow rate of 400 mL/min provided a 
theoretical low wall shear stress of 0.3 dynes/cm2.  Our own computational simulation of 
this flow using a finite volume analysis software package, FLUENT, verified that the 
resultant wall shear stress at the cells falls within is range, but oscillates between 0.1-






Evaluation of RASMC Response to Applied Mechanical Stimuli 
Cell Number Quantification 
The number of cells was assessed using the CyQuant Cell Proliferation Assay Kit 
according to the manufacturer’s protocols (Molecular Probes, C7026).  Briefly, cell 
samples of each group (n=6) were rinsed in PBS and incubated with 0.25% trypsin for 10 
min at 37ºC.  A cell scraper was used to gently lift the cells from the collagen coated 
silicone surface and centrifuged at 1500 rpm for 5 minutes.  Following aspiration of the 
supernatant, the cell pellets were washed with DPBS to remove any remaining phenol red 
from the trypsin solution and centrifuged again at 1500 rpm for 5 minutes.  The 
supernatant was aspirated and the cell pellets were lysed at -80ºC.  When thawed, the 
samples were each diluted with 400 µL of CyQuant GR dye/cell-lysis buffer.  Two 
samples of 200 µL were transferred to a black 96-well microplate and fluorescence 
intensity was measured at 535 nm using a plate reade  (GENios, Tecan, Research 
Triangle Park, NC).  The two readings were averaged and the number of cells present for 
each sample was calculated by comparing to the standard curve prepared at the time of 
the assay.      
 
Apoptosis 
Apoptosis was evaluated using the DeadEnd Fluorometric TUNEL System (Promega, 
TB235).  In this process, fragmented DNA of apoptotic cells was stained green with 
fluorescein and imaged at 535 nm and the DNA of all cel s was stained red with 





apoptotic cells in each group was determined by counting the number of apoptotic 
(green) cells and total (red) cells imaged 5-7 fields per sample providing a range of 25-29 
fields per experimental group (n=5 samples).  For a positive control of apoptosis, cells 
were subjected to UV exposure for 30 minutes [186-18].  Negative controls were 
performed with rTdT incubation buffer prepared without the rTdT Enzyme according to 
the manufacturer’s protocol.        
 
Quantification of Phenotypic Marker Proteins 
Protein expressions of SM α−actin, calponin, SM22α, and vimentin in cell lysates were 
quantified using standard western blotting techniques and digital image analysis.  The 
expression of GAPDH was also quantified to ensure equal loading of protein samples in 
SDS-PAGE gel.  Briefly, cells were removed from thesilicone membrane and lysed 
using an extraction buffer consisting of 0.5% Triton X-100 (Sigma-Aldrich, T-9284, St. 
Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L-4522, St. Louis, MO), 20 
mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL protease cocktail inhibitor 
(Sigma-Aldrich, P8340, St. Louis MO).  The BCA Protein Assay Kit (Pierce, 23225, 
Rockford, IL) was then used to determine the total protein content of each sample.  These 
samples were then diluted to 40 µg/µL using sample buffer consisting of a reducing 
agent, β-mercaptoethanol, 0.5 M Tris-HCl, 10% SDS, 0.5% Bromophenol Blue, glycerol 
and distilled water.  Prior to gel electrophoresis, the samples were denatured by boiling 
for 5 minutes.  A 10% polyacrylamide gel (BIORAD, 161-0158, Hercules, CA) was used 





separated on the SDS-PAGE gel were transferred to a PVDF membrane (Biorad, 162-
0184) which was incubated with the following primary ntibodies with specified 
dilutions:  SM α-actin (Abcam, ab18460-1, 1:1000), SM22α (Abcam, ab10135-100, 
1:500), calponin (Abcam, ab46794, 1:500), vimentin (Abcam, ab7752, 1:750), and 
GAPDH (Santa Cruz Biotechnologies, FL-335, 1:250).  The blots were then incubated 
with appropriate secondary antibodies at 1:5000 dilution and Precision Streptactin-HRP 
conjugate (Biorad, 161-0380) at 1:20000 dilution.  Chemiluminescent labeling of the 
PVDF membranes was performed with Immun-StarTM HRP substrate kit (Biorad, #170-
5040) according to the manufacturer’s instructions.  The western blots were imaged using 
the FluorChem SP imager (Alpha Innotech); Densitomery of the bands in the digital 
images was performed using the AlphaEaseFC (FluorChem SP) software to evaluate the 
protein expression level differences between the U (n=6), CT (n=6), BA  (n=6) and IM 
(n=6) groups.  The Integrated Density value (IDV) expr ssion of the markers was 
normalized that of GAPDH and statistically evaluated.   
 
Quantification of  Cell Size and Aspect Ratio 
At the end of each experiment, the cells were fixed in a 2% paraformaldehyde solution 
and the cytoskeletal F-actin and cell nuclei were stained using Rhodamine-Phalloidin 
(Invitrogen, R415) and DAPI, respectively.  Measurements of the cells including cell 
area, length, width, minor axis, major axis, and aspect ratio were performed using 
ImagePro Plus Analysis software (Media Cybernetics, Inc.  Version 5.1, Silver Spring, 





from four samples of each experimental group.  The combined number of cells was 
statistically compared according to the area and aspect ratio of the cells.  Histograms of 
each group were also compared to evaluate trends in data.        
 
Statistical Analysis 
Analysis of variance (ANOVA) paired with Student-Newman-Keuls (SNK) analysis was 
performed using SigmaStat (Systat Software, Inc., San Jose, CA).  In the case of failed 
normality as determined by SigmaStat, the Kruskal-Wlis One-Way ANOVA on Ranks 
was used with Dunn’s Method to detect statistical differences between groups.  The 
presented data is representative of samples combined from two independent experiments 
to provide a minimum of four samples available for c mparison per simulation group for 




CyQuant Cell Proliferation  Assay 
Cell quantification using the CyQuant Assay resulted in CT: 8.35 x 104 cells ± 2.80 x 
104 SD, BA: 8.15 x 104 cells ± 1.10 x 104 SD, IM: 12.41 x 104 cells ± 1.16 x104 SD, 
and U: 13.10 x 104 cells ± 2.33 x104 SD.  ANOVA indicated a significant difference 
between samples (p<0.001) and SNK analysis determind that the CT and BA groups 






Figure 5.1  CyQuant Proliferation Assay for 24 hour cell quantification. From left to 
right: U: 13.10 x 104 cells ± 2.33 x104 SD (n=6), IM: 12.41 x 104 cells ± 1.16 x104 SD  
(n=6), BA: 8.15 x 104 cells ± 1.10 x 104 SD (n=5), CT: 8.35 x 104 cells ± 2.80 x 104 SD 
(n=6). (* indicates statistical significance, p=0.01) 
 
Apoptosis TUNEL assay 
The TUNEL assay revealed that a few, but measurable cells were apoptotic after 24 hours 
in all experimental groups (Figure 2).  The resultant percentage of the ratio of apoptotic 
to total cells were: CT: 3.43 ± 3.50 SD (n=29), BA: 5.05 ± 3.156 SD (n=28), U: 6.07 ± 
4.32 SD (n=27), and IM: 6.86 ± 3.89 SD (n=25).  The IM and U groups contained 
significantly (p=0.002) greater percentages of apoptotic cells compared to the CT group 























Figure 5.2  TUNEL assay images at 100x magnification a) CT apoptosis b) CT 
Propidium iodide c) BA apoptosis d) BA Propidium iodide e) IM apoptosis f) IM 





Figure 5.3 Apoptosis comparison using TUNEL assay.  Statistical Analysis performed 
with Kruskal-Wallis One Way Analysis of Variance onRanks (p=0.002). Mean values 
(% of cells) and standard deviation (SD) for the groups were: U: 6.07 ± 4.32 SD (n=27), 










Densitometry analysis of western blots demonstrated decreased expression of contractile 
proteins (SM22α, SM α-actin, and calponin) for all three dynamic groups compared to 
static Unloaded control.  The expressions of SM22α (Figure 4b) and SM α-actin (Figure 
4c) in CT, IM, and BA groups were significantly lower by approximately 50% compared 
to the static (U) cells.  Calponin expression indicated the significantly (p=0.001) highest 
expression in the U group and the significantly lowest expression in CT group (Figure 
4d).  The expression of calponin for the dynamic groups was lower by almost 40% for IM 
and BA, and about 66% for CT compared to the static control (U).  The expression of the 
synthetic phenotype marker vimentin (Figure 4e) wassignificantly (p=0.001) highest in 




















Figure 5.4 Western blot analysis for RASMC phenotype characterization. a) 
Representative images for each of the groups for the expression of SM22
calponin, vimentin, and GAPDH. 
control (U), n=6 samples per treatment gro










(b-e) Densitometry results normalized relative to static 
up, error bars depict standard d














Cell Area Measurements 
The mean cell areas determined using phalloidin staing of fixed SMCs and ImagePro 
software (Figure 5) for the respective groups were: U: 4948
4928 µm2 ± 2646 SD (n=117), BA: 3212 
1730 SD (n=127).  ANOVA paired with Dunn’s method in icated that areas of both the 
BA and CT groups were both significantly (p=0.001) lower than both U and IM groups 
(Figure 6a).   
 
Figure 5.5  Phalloidin staining with DAPI overlay of rat aortic smooth muscle cells used 
for cell measurements and aspect ratio at 100x magnification a) Static Unloaded (U) b) 





µm2 ± 3511 SD (n=126), IM: 

















Figure 5.6  Cell measurement comparison of mean cell area and cell aspect ratio for 24h 
experiment groups with error bars representing standard deviation a) Mean cell area U: 
4947.8 µm2 ± 3511 SD (n=126), IM: 4928 
2060 SD (n=146), and CT: 2415 
ratio: U: 2.71 ± 1.31 SD (n=126),  IM: 2.49
CT 3.62 
 
The histogram analysis with 7 bins of cell areas in the ranges of: 0
2000-3000, 3000-4000, 4000
further insight to the behavior of these cell groups.  The histogram distribution indicated 
the majority of cells for U (63.5%) was between 2000
(70.1%) between 3000-8000 µ
was between 1000-4000 µm2
(Figure 7d).  The primary differences between BA and CT were the substantially higher 
frequencies of CT cells in the lowest bin of 0
cells in subsequent bin ranges greater than 2000 
IM group had greater frequencies at higher area ranges and exhibited a shift toward 
higher cell areas compared to the other groups.
128 
µm2 ± 2646 SD (n=117), BA: 3212 
µm2 ± 1730 SD (n=127) (p=0.001) b) Mean cell aspect 
± 0.85SD (n=117), BA: 3.15 ± 1.50
± 1.67 SD (n=127) (p=0.001) 
-1000, 1000
-6000, 6000-8000, and >8000 µm2 (Figure 7) provided 
-6 00 µm2 (Figure 7a) and for IM 
m2 (Figure 7b).  In contrast, the majority of BA (71.9%) 
 (Figure 7c) and for CT (69.3%) between 0-3 00 
-1 00 µm2 and the lower percentages of 













Figure 5.7 Histogram representation distribution of cell area measurements a) U area 
histogram b) IM area histogram c) BA area histogram d) CT area histogram 
 
Aspect Ratio Determination 
Analysis of smooth muscle cells using Image Pro analysis defined the average aspect 
ratios as the ratio of the measurement of the major axis to the minor axis.  The aspect 
ratios of the U and IM groups were similar with mean v lues of 2.71 ± 1.31 SD (n=126) 
and 2.49 ± 0.85 SD (n=117), respectively.  In contrast, both the BA (3.15 ± 1.50 SD) and 
CT (3.62 ± 1.67 SD) groups were both significantly (p<0.001) higher from both the U 






Figure 5.8  Histogram representation of the aspect ratio in the experiment groups a) U 
aspect ratio b) IM aspect ratio c) BA aspect ratio d) CT aspect ratio  
 
The histogram analysis with 7 bins at aspect ratios ranges of: 1-1.5, 1.5-2.0, 2.0-2.5, 2.5-
3.0,3.0-3.5, 3.5-4.0, and >4.0 (Figure 8) provided further insight into the behavior of the 
cells.  The U group (Figures 8a) exhibited the narrowest range of aspect ratios with the 
majority (49.2%) between 1.5 and 2.5.  The majorities for both IM (70.1%) and BA 
(51.4%) were in the range of 1.5-3.0 (Figure 8a and 8c, respectively).  The primary 
differences between the aspect ratio distributions of IM and BA was the lower 
percentages of the BA cells within the respective range and the high percentage of cells 





CT in which the majority (45.7%) of the aspect ratios for the CT group (48%) (Figure 8d) 
was greater than 3.5.   
 
5.5 Discussion 
The concurrent force model in the presented study simulates several mechanical 
events encountered in clinical settings while maximizing the early synthetic SMC 
response following balloon angioplasty.  The combinatory model implemented in this 
work combined current shear and tensile forces in addition to the increased injury of 
balloon angioplasty.  Tensile strain of 5% was included to simulate arterial vessel dilation 
and a balloon angioplasty regimen including two bouts of high strain was included to 
simulate two-staged balloon deployments, which is a common clinical practice [19].  
Arterial regions with wall shear stress  (WSS) values of about 5 dynes/cm2 are more 
prone to restenosis [144, 171, 189]; the much lower oscillating wall shear stress used in 
the study (0.1-0.5 dynes/cm2) was integrated to elicit a SMC response.  The complex 
effects that SMCs are subjected to in vivo have been simulated in vitro for SMC 
phenotype characterization in response to mechanical st muli.   More specifically, we 
evaluated changes in cell proliferation, apoptosis, phenotype markers, and morphological 
measurements. 
Increased cell proliferation and apoptosis are characte istics of synthetic 
phenotype of smooth muscle cells.  The present study resulted in significant increase in 
the number of cells in the U and IM groups when compared to smooth muscle cells 





groups (Figure 2) was also greater compared to CT and suggests that proliferation of 
these groups may be greater due to the greater numbers of cell in U and IM was to 
increased proliferation.  Increased rates of apoptosis and proliferation suggest a higher 
cell turnover rate, a characteristic of synthetic behavior in SMCs; while proliferative 
activity of the SMCs may be increased, increased apoptosis decreases the number of total 
cells.  These results are in agreement with our previous observations of increased 
proliferation in the IM group and decreased proliferation in the CT group at 8 hours 
[185].  Other in vitro studies also found that SMCs exposed to physiologic strain alone 
and demonstrated cell arrest in vascular smooth muscle cells [155, 156] and cyclic stretch 
less than 7% did not induce SMC apoptosis [158].  The increase in both cell proliferation 
and apoptosis of the injury model SMCs in the present tudy is in agreement with clinical 
occurrences, and further demonstrates that the addition of shear results in proliferative 
and apoptotic responses compared to strain alone.  Following balloon angioplasty in vivo, 
increased SMC proliferation and apoptosis in the art ry have been observed [51, 190, 
191].  Smooth muscle cells in vivo have been shown to become apoptotic in as little as 30 
minutes following balloon angioplasty [191].   
The protein expression of the dynamic groups (IM, BA and CT) in this study 
demonstrated a decrease in contractile markers after 24 hours of mechanical stimulation 
compared to the static control.  The decrease in SM α-actin in the injury model (IM) was 
shown to continue beyond 8 hours that was reported in our previous study [185].  
Additionally in the previous study, 8 hours of mechanical stimulation did not result in 





stimulation resulted in a significant decrease of SM α-actin in CT, therefore implying that 
the duration of mechanical stimulation has a key role in cell protein expression.  In 
addition to SM α-actin, other contractile markers of SM22α and calponin were also 
decreased in all of the dynamic models.  The decrease in these markers associated with 
SMC contraction demonstrate the loss of ability to contract, a common characteristic 
associated with synthetic SMCs [2].   
Changes in the expression of the synthetic marker vimentin were also observed in 
this study.  Like the expression of the contractile markers, the static U group exhibited 
the highest expression of vimentin.  High expressions f both contractile and synthetic 
markers suggest a general trend of increased protein production and possible variation 
within the population of low passage cells.  In contrast to U, the lowest expression of 
both marker categories was exhibited in CT with an overall trend of decreased protein 
expression.  Others have found increased synthetic b havior in response to strain alone 
characterized by increased cell viability, decreased morphological elongation, decreased 
α-actin and calponin expression, and increased viment n xpression compared to the 
static control [163].  The IM group which was subjected to balloon angioplasty injury and 
concurrent shear and tensile forces expressed increased vimentin demonstrating that the 
SMCs exposed to concurrent shear and tensile forces resulted in an increase in the 
synthetic marker expression compared to CT.  The increase in the synthetic marker 
vimentin expression and decrease in contractile markers is in agreement with other 
oscillating shear studies [180].  Compared to in vivo conditions, the variation in protein 





muscle cells present in vivo [192-194] and cells are generally not categorized as purely 
synthetic or contractile but rather as a spectrum [183].   
  Cell hypertrophy, as another indicator of SMC phenotypic shift, is one of the 
important characteristics of synthetic SMCs, which are generally larger in size and more 
rhomboidal in shape compared to contractile SMCs, which are smaller and more 
elongated spindle shaped [2].  The present study evaluated the morphological changes 
representative of the phenotypic shift of SMCs in response to mechanical stimuli.  The 
results of the present study provided evidence that cells in the CT group exhibited a 
significantly lower cell area compared to both U and IM (Figure 6a) which suggested that 
strain alone does not induce a hypertrophy response t  mooth muscle cells at 24 hours 
exposure to mechanical stimulation, but rather a smller more elongated cell morphology.  
The significantly greater cell area in the BA group compared to the CT group suggested 
that the higher strain levels from simulated balloon angioplasty led to early hypertrophic 
behavior of SMCs.  This response was further amplified with the addition of shear as 
represented in the IM group with significant increas s in cell size to the identical level of 
the static control (U), suggesting the highest hypertrophic effect of the injury model.  In 
addition to cell area, the aspect ratio (the major vs. minor axes of the cell) provided 
additional insight to the phenotypic behavior of the SMCs; a highly synthetic phenotype 
of the cell would tend to have a lower aspect ratio, with more of a round and irregular 
rhomboidal shape.  Our analyses of the aspect ratio (Figures 6b and 8) supported similar 
trends as the cell area analyses.  The mean aspect ratios (Figure 6b) were significantly 





that U and IM groups contained higher percentages of cells in the low aspect ratio range 
of 1.5-2.0, suggesting that cells exhibit morphologically a more synthetic phenotype.  
Thus, our image-based analysis of smooth muscle cell morphology following dynamic 
exposure had a more contractile morphological behavior with strain alone but underwent 
a phenotypic shift to become more morphologically synthetic with the addition of balloon 
angioplasty and shear.  
The results of the present study provide evidence that mechanical stimulation of 
smooth muscle cells evokes phenotypic responses in proliferation, apoptosis, 
morphology, and protein expression.  The comparison of numerous cell responses 
between all of the three dynamic testing groups (CT, BA, and IM) and the static group 
(U) was important for characterization of the develop d injury model incorporating 
concurrent shear and tensile forces.  Cells exposed to tensile strain only in the CT group 
exhibited the lowest proliferation, apoptosis, and cell area and the highest aspect ratio, all 
of which are properties indicative of contractile SMCs, but was also characterized by the 
lowest expression of contractile and synthetic protein markers.  CT was important for 
comparison to verify that the cell responses of IM were attributed to the combinatory 
force exposure and not simply strain.  BA was valuable to show that increased strain 
injury of balloon injury may work in part to trigger a SMC response but the additive force 
effects of the injury model incorporating shear resulted in the highest synthetic response.   
The statically grown U group was essential to demonstrate the differences between the 
static and mechanically stimulated groups.  All of the groups demonstrated the wide 





and synthetic characteristics [192].  For example, CT exhibited the lowest proliferation, 
apoptosis, and cell area, and expressed the lowest levels of both the contractile any 
synthetic markers while U exhibited higher proliferation, apoptosis, and cell area but also 
expressed the highest level of both the contractile and synthetic markers.    
The primary objective of this study was to elicit the highest synthetic response 
from the injury model (IM) incorporating balloon angioplasty and concurrent shear and 
tensile forces.  The combination of balloon angioplasty with applied shear in the injury 
model demonstrated a synergistic effect of the combination of forces, resulting in not 
only a loss of contractile markers unlike the static control, but also in increased synthetic 
behavior with high vimentin expression, increased proliferation and apoptosis, and 
increased synthetic morphology, therefore providing a  improved in vitro model to 
further investigate the role of clinical mechanical forces and the relationship to resultant 
SMC responses in early stages of restenosis.   Apoptosis, cell number, and morphological 
measurements were similar between the dynamic injury model (IM) and the static control 
(U).  However, the morphological histograms demonstrated that the IM group had the 
highest range of cell area and a narrower range of aspect ratios.  These combined effects 
demonstrate the greatest synthetic SMC response.  Th  differences in responses and 
mechanisms of the developed injury model demonstrates the need for dynamic 
mechanical in vitro testing to investigate SMC responses associated with early stages of 







5.6 Conclusion  
The present study has demonstrated that vascular SMCs in vitro exhibit behaviors 
similar to clinical occurrences in the simulated model of balloon angioplasty which 
accounted for SMC injury and concurrent mechanical forces.  SMC responses including 
apoptosis, cell proliferation, cell hypertrophy, and the overall synthetic phenotype 
behavior were all significantly increased within the simulated injury model (IM).  In this 
study, varying phenotype responses to the simulated injury occurred independently of 
each other, demonstrating the complicated spectrum of s ooth muscle cell phenotype 
markers.  Using the IM in vitro model of smooth muscle cell response following clinical 
intervention, early mechanisms of intimal thickening and restenosis may be studied and 
treatment methods to promote a healthier smooth muscle cell response may be developed.  
Further studies with the concurrent shear and tensile force model with incorporated 
balloon injury will provide additional insight into the role of the mechanical regimen of 
endovascular intervention and the incorporation of pharmacological agents will enhance 














AIM 5- THE EFFECTS OF HEPARIN ADMINISTRATION IN CONCURRENT 
FORCE INJURY MODEL 
 
6.1 Abstract 
Heparin is an anti-coagulant agent commonly administered during vascular 
procedures such as balloon angioplasty.  Heparin has been shown to also have an anti-
proliferative effect but does not prevent against long-term restenosis.  In this study, the 
effect of the administration of heparin on smooth muscle cells (SMCs) after 24 hours was 
investigated using a dynamic in vitro balloon angioplasty injury model in which the 
SMCs were exposed to higher strains of balloon angioplasty simulation followed by 
concurrent shear and tensile force stimulation.  A local administration of 100 µg/ml was 
compared to a clinically relevant bolus of 10,000 units for 5 minutes prior to balloon 
angioplasty followed by 100 µg/ml administration over the course of 24 hours.  It was 
found that the heparin bolus dynamic group resulted in a decreased number of cells while 
the 100 µg/ml administration had no effect.  Additionally, heparin was shown to 
significantly decrease calponin expression, a calcium binding protein that inhibits the 
ATPase activity of myosin in the case of the injury model, and increase calponin 
expression in static samples.  Significant variations in responses demonstrate the 









Heparin and heparan sulfates are glycosaminoglycans and anti-coagulant agents 
naturally produced by various cell types.  Anti-coagul tive and anti-platelet therapies 
such as heparin are administered to patients prior, during, and following endovascular 
procedures to reduce blood coagulation.  A common clinical protocol consists of a three 
to five minute IV bolus administration of 10,000 units of heparin applied immediately 
prior to balloon angioplasty [195].   In the addition to preventing blood coagulation, 
heparin has been shown to affect cell adhesion, differentiation, and cell proliferation 
[195, 196].  Heparin has been shown to reduce smooth muscle cell proliferation and 
migration [52, 70] by arresting the cell cycle through the G1 mitotic phase [197, 198].   
Heparin regulates SMCs through both extracellular and intracellular actions.  
There are approximately 100,000 binding sites for heparin on a vascular smooth muscle 
cell (VSMC) [199].  Growth arrested SMCs are 100 times more sensitive and can bind 
eight times more heparin [200].   Heparin has been shown to be most effective when the 
cells are released from growth arrest by stimulation with media containing higher 
percentages of heparin [201, 202].  It has been shown t  be involved in multiple kinase 
cascades including the mitogen activated protein kinase (MAPK) and protein kinase C 
(PKC) pathways.  Other investigators have found that heparin suppresses extracellular 
signal-regulated kinase (ERK) ½ activation in response to agonists of G protein-coupled 






Although heparin has been shown to have an anti-proliferative effect [52, 70]on 
smooth muscle cells in vitro using static cultures, tenosis remains a significant 
problem following clinical endovascular procedures.  In this study, a dynamic in vitro 
injury model [185] was used to compare the effects of  both constant and bolus heparin 
administration on VSMC proliferation and phenotype marker expression over 24 hours 
following simulated balloon angioplasty.  Additionally, the role of heparin administration 
on ERK ½ pathway was investigated.  
 
6.3 Materials and Methods 
Cell Culture 
Rat aortic smooth muscle cells courtesy of Dr. Anand Ramamurthi were cultured in 
standard culture conditions consisting of Dulbecco’s modification of Eagle’s Medium 
(DMEM) (Mediatech, 10-013-CV) supplemented with 10% fetal bovine serum (FBS) 
(Sigma Aldrich, F4135) , 1% antibiotic/antimycotic (Mediatech, A5955) and kept in 5% 
CO2 humidified incubator. 
   
Heparin Dosage Studies 
SMCs (P4-6) were plated on at a concentration of 2.8 x 104 cells/cm2 in 96-well plates or 
48-well plates with DMEM supplemented with 10% FBS, 1% antibiotic-antimycotic.  At 
24 hours, the media was changed to DMEM with 0.5% FBS, 1% Antibiotic-antimycotic, 
and 1% dextran.  At 48 hours, the media was changed to 2% FBS, 1% antibiotic-





150, 200, 300, and 500 µg/ml with n=4 per dosage.  After an additional 24 hours, the 
SMC were evaluated using Live/Dead assay (Invitrogen, L-3224), CyQuant Cell 
Proliferation assay (Invitrogen, C7026), and DeadEnd Fluorometric TUNEL System 
apoptosis assay (Promega, TB235).  Dosage studies are representative of 3 independent 
experiments across several techniques.     
 
Cell Viability for Heparin dosage 
After heparin dosage treatment, cell viability and quantification were evaluated through 
the LIVE/DEAD Viability/Cytotoxicity Kit (L-3224), CyQuant cell proliferation assay, 
and the TUNEL apoptosis assay.  For the LIVE/DEAD assay, SMCs were plated in a 
black 96-well cell culture plate and treated as previously described.  Following heparin 
dosage treatment after 24h, cells were and handled according to the manufacturer’s 
protocol for the microplate reader.  Briefly, the cells were rinsed in DPBS and incubated 
with 100 µl of a 2 µM calcein AM and 4 µM EthD-1 working solution for 30 minutes.  
Fluorescence intensity was measured using the fluorescent plate reader (GENios, Tecan, 
Research Triangle Park, NC) with excitation/emission at 494/574 nm for calcein to detect 
fluorescence levels for live cells, and 528/617 for EthD-1 to detect fluorescence levels for 
dead cells. 
 CyQuant heparin samples were cultured in black 96-well microplates and the 
media was removed following heparin treatment.  Thecell plate was treated according to 
the manufacturer’s protocol in which it was frozen at -80 ºC to induce cell lysis.  After 48 





microplate and the fluorescence intensity was measur d at 535 nm using a plate reader 
(GENios, Tecan, Research Triangle Park, NC).  The number of cells present for each 
sample was calculated by comparing to the standard curve prepared at the time of the 
assay.      
SMCs were cultured on 12-well plates to evaluate the effects of heparin on SMC 
apoptosis.  Apoptosis was evaluated using the DeadEnd Fluorometric TUNEL System 
(Promega, TB235).  In this process, fragmented DNA of apoptotic cells was stained green 
with fluorescein and imaged at 535 nm and the DNA of all cells was stained red with 
propidium iodide (Sigma-Aldrich, P486) and was imaged at 620 nm.  The percentage of 
apoptotic cells in each group was determined by counting the number of apoptotic 
(green) cells and total (red) cells imaged 5 fields per sample providing a range of 15 
fields per experimental group (n=3 samples).  For a positive control of apoptosis, cells 
were subjected to UV exposure for 30 minutes [186-18].  Negative controls were 
performed with rTdT incubation buffer prepared without the rTdT Enzyme according to 
the manufacturer’s protocol.        
 
 Exposure of RASMCs to Mechanical Stimuli 
A custom-designed, concurrent force, vascular mechani s system was set up and 
sterilized as previously described [185].  Biomedical grade silicone sheets (5.25 cm in 
diameter) for each station were cut from biomedical gr de silicone sheets of .015" 
thickness and 40 durometer (Specialty Manufacturing, 70P001-100-015) and were 





collagen film was allowed to dry for 48 hours in a sterile laminar hood.  Prior to cell 
seeding, the films were rinsed and rinsed with 1 ml of Dulbecco’s Phosphate Buffered 
Saline (DPBS) (Mediatech, 21-031 CM).  RASMCs were se ded at a density of 2.8 x 104 
cells/cm2 (P4-6) and incubated for 24 hours in DMEM containing 10% FBS and 1% 
antibiotic-antimycotic (Sigma-Aldrich, A5955).  At 24 hours, the medium was changed 
to DMEM containing 0.5% FBS, 1% antibiotic-antimycoti , and 1% Dextran for an 
additional 24 hours prior to testing to promote more quiescent behavior of the smooth 
muscle cells.  The media used during mechanical testing consisted of DMEM 
supplemented with 2% Fetal Bovine Serum, 1% Antibioic/Antimycotic, 1% Dextran 
(Sigma Aldrich,   D4876).  Heparin (Sigma Aldrich, H3149) was dissolved to the 
appropriate concentration in DMEM and filter sterilized. Dextran was added to the 
medium at 1% (w/v) to adjust the media viscosity and resultant wall shear stresses on the 
cells at the prescribed level [174].  
Six testing groups were compared in this experiment.  The injury model (IM) 
group simulated smooth muscle cells that are directly xposed to blood flow upon the 
denudation of the endothelial monolayer following balloon angioplasty [20].  Prior to the 
application of mechanical stimuli, the dynamic experim ntal groups were subject to a 
preconditioning regimen of 0-4% cyclic strain at gradually increasing frequencies of 0.1 
Hz (15 min), 0.5 Hz (15 min), and 1.0 Hz (15 min).  Balloon angioplasty was simulated 
by subjecting cells to two 12% static circumferential stretches held for 90 seconds each 
with a 30 second rest interval between stretches.  Following simulated balloon 





from 0 to 5% with a sinusoidal regimen at1 Hz frequncy for 24 hours.  The flow rate of 
400 mL/min provided a theoretical low wall shear stre s of 0.3 dynes/cm2.  A 
computational simulation of this flow using a finite volume analysis software package, 
FLUENT, verified that the resultant wall shear stres at the cells falls within this range, 
but oscillates between 0.1-0.5 dynes/cm2 due to the 1 Hz cyclic straining of the silicone 
membrane.  Three groups were subjected to the injury model regimen; the Injury Model 
(IM) acted as the dynamic control to evaluate potential effects of heparin.  The Injury 
Model-Heparin (IMH) group was exposed to the same dynamic regimen but also subject 
to constant administration of 100 µg/ml heparin dosage in DMEM following balloon 
angioplasty for the duration of 24 hours.  The Injury Model-Bolus (IMB) group simulated 
a more clinically relevant regimen with 10,000 units of heparin dissolved in DPBS 
administered as a bolus for 5 minutes prior to balloon angioplasty followed by 
administration of 100 µg/ml heparin dosage in DMEM following balloon angioplasty for 
the duration of 24 hours.  Three statically grown groups were implemented for 
comparison with static Unloaded (U) being cultured un er the same culture conditions 
without heparin as IM, Unloaded-Heparin (UH) was exposed to DMEM with 100 µg/ml 
heparin dosage, and Unloaded-Bolus (UB) was exposed t  the bolus heparin in DPBS for 
5 minutes followed by 100 µg/ml heparin dosage in DMEM.  All experiments were 








Cell Number Quantification 
Following 24 hour testing, the number of cells was as essed using the CyQuant Cell 
Proliferation Assay Kit according to the manufacturer’s protocols (Molecular Probes, 
C7026).  Briefly, cell samples of each group (n=5) were rinsed in PBS and incubated 
with 0.25% trypsin for 10 min at 37ºC.  A cell scraper was used to gently lift the cells 
from the collagen coated silicone surface and centrifuged at 1500 rpm for 5 minutes.  
Following aspiration of the supernatant, the cell pets were washed with DPBS to 
remove any remaining phenol red from the trypsin solution and centrifuged again at 1500 
rpm for 5 minutes.  The supernatant was aspirated and the cell pellets were lysed at -
80ºC.  When thawed, the samples were each diluted with 600 µL of CyQuant GR 
dye/cell-lysis buffer.  Three samples of 200 µL were transferred to a black 96-well 
microplate and fluorescence intensity was measured at 535 nm using a plate reader 
(GENios, Tecan, Research Triangle Park, NC).  The three readings were averaged and 
the number of cells present for each sample was calculated by comparing to the standard 
curve prepared at the time of the assay.      
 
Quantification of Phenotypic Marker Proteins 
Expression of phenotype markers SM α−actin, calponin, and vimentin in SMC lysates 
were quantified using standard western blotting techniques and digital image analysis.  
The expression of GAPDH was also quantified to ensure equal loading of protein 
samples in SDS-PAGE gel.  Briefly, cells were removed from the silicone membrane and 





9284, St. Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L-4522, St. Louis, 
MO), 20 mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL protease cocktail 
inhibitor (Sigma-Aldrich, P8340, St. Louis MO).  The BCA Protein Assay Kit (Pierce, 
23225, Rockford, IL) was then used to determine the total protein content of each sample.  
These samples were then diluted to 40 µg/µL for phenotype proteins or 80 µg/µL for 
p44/42 proteins using sample buffer consisting of a reducing agent, β-mercaptoethanol, 
0.5 M Tris-HCl, 10% SDS, 0.5% Bromophenol Blue, glycerol and distilled water.  Prior 
to gel electrophoresis, the samples were denatured by boiling for 5 minutes.  A 10% 
polyacrylamide gel (BIORAD, 161-0158, Hercules, CA) was used in electrophoresis with 
15 µL protein samples loaded per lane.  The protein samples separated on the SDS-PAGE 
gel were transferred to a PVDF membrane (Biorad, 162-0184) which was incubated with 
the following primary antibodies with specified dilut ons:  SM α-actin (Abcam, ab18460-
1, 1:1000), calponin (Abcam, ab46794, 1:500), vimentin (Abcam, ab7752, 1:750),  
GAPDH (Santa Cruz Biotechnologies, FL-335, 1:250), p44/22 (Cell Signaling 
Technologies, 4695, 1:1000), and phos p44/42 (Cell Signaling Technologies, 4370, 
1:1000).  The blots were then incubated with appropriate secondary antibodies at 1:5000 
dilution and Precision Streptactin-HRP conjugate (Biorad, 161-0380) at 1:20000 dilution.  
Chemiluminescent labeling of the PVDF membranes was performed with Immun-StarTM 
HRP substrate kit (Biorad, #170-5040) according to the manufacturer’s instructions.  The 
western blots were imaged using the FluorChem SP imager (Alpha Innotech).  
Densitometry of the bands in the digital images wasperformed using the AlphaEaseFC 





U (n=3), UH (n=3), UB (n=3), IM (n=3), IMH (n=3), and IMB (n=3) groups.  The 
Integrated Density value (IDV) expression of the markers was normalized that of 
GAPDH and statistically evaluated.   
 
Statistical Analysis 
Analysis of variance (ANOVA) paired with Student-Newman-Keuls (SNK) analysis or 
the Fisher LSD Method was performed using SigmaStat ( ystat Software, Inc., San Jose, 
CA) to detect statistical differences between groups.   
 
6.4 Results 
Heparin Dosage Studies 
The Calcein portion of the LIVE/DEAD assay indicated significant difference between 
some of the heparin dosages (p=0.001).  The first significant decrease was present at 100 
µg/ml compared to the control without heparin (p=0.001) (Figure 1a) with all remaining 
higher concentrations also being significantly lower (150 µg/ml: p=0.001, 250 µg/ml: 
p=0.001, 500 µg/ml: p=0.034).  Fluorescence of EthD-a indicative of dead cells also 
demonstrated significant differences across several groups (p=0.001).  The concentration 
of 500 µg/ml was significantly lower than that all other groups (Figure 1b).  Although 
there were significant differences, all fluorescence values were low and the intensity at 
100 µg/ml was not significantly different from the control 0 µg/ml (p=0.403). 
 The CyQuant cell proliferation assay (Figure 1c) (n=4) demonstrated decreases in 





of cells present at 100 µg/ml.  Mean cell numbers of the respective groups are provided in 
Table 1.  Differences between groups were not significa t (p=0.843) due to the high 
variability between samples in each group. 
 
Table 6.1 CyQuant Cell Quantification in Heparin Dosage (n=4) 
Heparin Concentration 
(µg/ml) 
Cell Number Standard Deviation 
0 2.02 x 104  1.54 x 104  
1 1.96 x 104  1.55 x 104  
5 1.63 x 104  6.34 x 103  
10 1.88 x 104  7.00 x 103 
50 1.32 x 104  9.45 x 103  
75 1.14 x 104  9.26 x 103  
100 1.05 x 104  5.10 x 103 
250 1.27 x 104   2.10 x 103 
500 1.63x 104 ± 8.83 x 103 
 
 Apoptosis percentages of SMCs due to heparin were not significant (p=0.761) and 
were low with all groups having 3.0% or less apoptotic cells (Figure 1d).  The 100 µg/ml 
concentration (0.8%) was very similar to the control 0 µg/ml concentration (0.6%), 














Figure 6.1  Heparin Dosage 
Cell Assay c) CyQuant cell proliferation d) TUNEL apoptosis
significance, p<0.05) ** not all statistical differences are noted in Figure 1(a
multiple differences a
 
Cell Quantification in Dynamic Testing
 
 Differences in cell quantification were observed due to clinical heparin effects (p=0.003) 
(Figure 2).  Mean cell number values for the respectiv  groups are provided in Table 2.









The decreased number of cells of UH (100
17% and 31% inhibition, respectively, compared to U.  In comparison to IM, IMH 




Cell Viability  a) Calcein Live Cell Assay b) EthD
 (* indicates statistical 
cross several groups.  
 
 
 Cell Number Standard Deviation
7.94 x 104 1.51 x 104 
 6.59 x 104   1.39 x 104 
 5.49 x 104 1.15 x 104  
 7.00 x 104 9.42 x 103 SD 
 7.56 x 104 7.14 x 103 
 4.63 x 104 1.57 x 104 
µg/ml)  and UB (Bolus + 100µg/ml) indicated 
µg/ml) exhibited a -8% and 34% inhibition.
 
-1 Dead 







There were significant differences in IMB compared to both IM and IMH, p=0.032 and 
p=0.01 respectively, and in IMB compared to U (p=0.005) (Figure 2).




Mean densitometry values were normalized to the static unloaded (U) expression (Figure 
3).  A significant decrease in SM 
(IM, IMH, IMB) was observed when compared to the static groups (U, UH, UB) 
(p=0.003, Figure 3b), consistent with 
have any apparent effect on the expression of SM 
constant administration or the clinical bolus model.  In comparison, calponin levels
demonstrated significant differences (p=0.036) and decreases in injury model expression 
compared to the static groups (Figure 3c).  In contrast, the IMB group demonstrated a 
significant decreased in calponin expression compared to the static counterp
(p=0.045).  Although not significant, an increasing trend of increased calponin expression 
151 
  
statistical significance p<0.05) 
α-actin expression for the dynamic injury model groups 
previous findings (see Chapter 5).   Heparin did not 







due to heparin in the UH (14%) and UB (24%) groups compared to the U group was 
observed.  Vimentin expression differences among all roups was not significant
(p=0.802, Figure 3d), although there was an increasing trend (10
administration in both the static and dynamic conditions.     






-15%) with heparin 













Figure 6.3  Western blot protein expression a) Representative western blot images b) SM 
α-actin densitometry  c) Calponin densitometry d) Vimentin densitometry (* denotes 
p44/42 Activity 
 
The ratios of phos p44/42 to total p44/42 representative of p44/42 activity, or ERK ½ 
activity, were significantly different (p=0.046).  Mean densitometry values were 
normalized to the basal static unloaded (U) expression and represented in Figure 4.  
There was a general trend of decreased p44/42 activity in all three of the injury model 
groups (IM, IMH, and IMB) compared to the static groups (U, UH, UB).  Fisher LSD 










p=0.023, UB: p=0.029).  There was also a significant difference between U and IMB 
(p=0.025).  Overall, there was a general trend of decreased p44/42 activity due to the 
dynamic injury model conditions over significant effects of heparin.  Decreases in 
activity were in the range of around 20% and demonstrated similar trends to decreases in 
SM α-actin expression.  
U 
 
Figure 6.4  Effect of heparin on p44/42 activity a) Western blot images representative of 
phos p44/42 (top) and total p44/42 (bottom) b) Densitometry ratio analysis (n=3) 
























Decreases in SMC proliferation due to heparin exposure as observed by others 
both in vivo and in vitro is not surprising since SMCs are naturally exposed to heparan 
sulfates produced by endothelial cells  in a healthy vessel, but upon denudation of this 
endothelial layer, SMC proliferate and cause lesion formation [196, 200].  Although 
heparin has been shown to decrease SMC proliferation, varying degrees of inhibition 
have been observed depending on the cell type and heparin dosage [200].  Traditionally, 
heparin resistant VSMCs are defined by proliferation ≤ 25% in low serum conditions for 
48-72 hours followed by presence in high serum conditions (10%) with heparin at 100 
µg/ml for 4-5 days [200].  SMCs would be considered h parin sensitive with proliferation 
>25% under the same conditions.  Based upon previous w rk conducted by the authors 
(reference), these culture conditions were adapted to a shorter time period and a lower 
serum concentration to help isolate influences of mechanical forces rather than only 
serum evoked reactions.   
In this study, anti-proliferative effects of heparin were confirmed after only 24 
hours of heparin treatment.  Initial dosage studies w re performed to verify the 
effectiveness of the commonly used 100 µg/ml concentration with adapted serum 
conditions without evoking an excessive negative SMC response.  Results from the 24h 
studies dynamic studies demonstrated an inhibitory effect of the bolus group (IMB) 
within the injury model while the low 100 µg/ml administration (IMH) resulted in a slight 
increase in the number of cells (Figure 2).  This is in contrasts to the inhibitory effect 





exposure to the concurrent mechanical stimuli limited the anti-proliferative effects of 
heparin at this administered concentration.   
A decreasing trend in the number of cells present dmonstrated the effect of the 
bolus administration, even if its application lasted for a short duration of 5 minutes.  In 
the case of static samples (U) the 31% inhibition in UB compared to the 17% inhibition 
of UH indicated that exposure to higher concentrations for even a brief time.  Injury 
model trends support this with the 34% inhibition of the bolus (IMB) compared to the -
8% inhibition of IMH.  Rinsing of the cells in DPBS following the 5 minutes higher 
concentration bolus effect eliminated possibilities of residual heparin remaining in the 
presence of the SMCs.   
 Protein expression results further demonstrated differences due to the dynamic 
culture and heparin exposure.  In vitro studies have shown that heparin stimulates 
differentiation and increases contractile protein expr ssion [205].  A significant decrease 
in SM α-actin expression was exhibited in the dynamic injury model as compared to the 
static control [185].  No increase in SM α-actin expression due to heparin was observed, 
however there was in increase in calponin in the cas  of the static samples and a decrease 
in calponin in the case of the injury model after 24 hours.  Heparin treatment has been 
shown to increase SM α-actin and calponin expression after 3 days in static in vitro 
conditions at 100 U/ml in both myometrial and leiomyo al SMC [206].  Decreases in 
SM α-actin and calponin in the cases of the injury model groups (IM, IMH, IMB) is 
important because these proteins are associated with the contractile apparatus of SMCs 





in decreased SM α-actin after 24 hours and that heparin does not prevent the actin 
degradation at this timepoint [208].  Increasing trends of the synthetic marker vimentin 
expression with heparin exposure would suggest increased synthetic behavior of the 
SMCs, so although heparin may decrease proliferation nd migration, an increase in the 
synthetic marker could partially attribute to restenosis. 
The ERK 1/2 pathway is commonly associated with proliferative activity of 
SMCs, with activation resulting in increased proliferation.  Overall an approximate 20% 
decrease in p44/42, or ERK ½, activity due the effect of the injury model was observed 
(Figure 4).  This decrease in p44/42 activity suggests that other mechanotransductive 
pathways must be involved in the increased cell count attributed to the injury model 
combining concurrent shear and tensile forces compared to tensile forces alone.  
Significant decreases in p44/42 activity were detect d after 24 hours in the injury model 
heparin groups (IMH, IMB) compared to the static contr l, but these differences were 
more likely attributed to the decrease activity from the mechanical environment rather 
than decreased activity from the effects of heparin.  Lack of difference suggests other 
mechanisms of heparin are involved in the inhibitory mechanism of heparin in both static 
and dynamic culture conditions.  Heparin has been shown to inhibit activation of ERK1 
and ERK2 in response to serum and thrombin [204] [209].  Heparin is also known to 
interfere with the protein kinase C (PKC) pathway [202, 210]; the PKC pathway has been 
shown to be an ERK-dependent pathway [211].  However, heparin has been shown to 
inhibit proliferation through both ERK-dependent and ERK-independent pathways [212, 





conditions resulting in higher degrees of activation [201] or the degree of activation could 
be time-dependent.    
The primary purpose of the presented work was to demonstrate the need for 
dynamic in vitro testing for pharmaceutical agents through evoking differing SMC 
responses in response to mechanical stimulation versus static culture and to further show 
that modeling a clinically implemented regimen in vtro can lead to better understanding 
and characterization of SMC behavior and response.  In summary, after 24 hours, the 
administration of 100 µg/ml demonstrated differing effects compared to the bolus groups 
incorporating the higher concentration administration before balloon angioplasty.  In 
comparison of the static versus dynamic in vitro simulation, proliferation inhibition 
effects in the bolus groups (UB and IMB) were similar, but protein expression of 
calponin exhibited opposing behaviors, therefore demonstrating the need for dynamic in 
vitro conditions which can evoke varying SMC response.  Through implementation of the 
dynamic in vitro model and clinical bolus administration, we confirmed the anti-
proliferative effect of heparin for use in endovascular intervention.  However, the 
implemented model also indicated that the use of heparin could promote some synthetic 
activity, such as decreased calponin expression which could be important clinically in the 
development of restenosis.    
 
6.6 Conclusion 
The presented work has incorporated the use of a clinical y used pharmaceutical agent 





clinically relevant bolus administration of heparin followed by administration of 
100µg/ml heparin resulted in the largest decrease in cell number and some differing 
effects in expression of the contractile marker calponin after 24 hours compared to the 
static equivalent.  The combination of results represents the need for dynamic in vitro 
testing conditions for better SMC characterization and clinically relevant phenotypic 
behavior which could lead to better understanding of the mechanotransduction responses 

























Previous work from our lab showed similar patterns of ERK ½ expression and the loss of 
contractile markers.  In this study we investigated if the loss was directly attributed to the 
decrease in ERK ½ activity within our developed injury model and compared to our static 
control.  We confirmed decreases in ERK ½ activity in the concurrent force injury model 
to similar levels as with the ERK ½ inhibitor U01826.  The inhibited and uninhibited 
injury models resulted in similar expressions of SM22α and SM α-actin.  However, 
comparison to the inhibited and uninhibited static control (U) demonstrated that the large 
differences in ERK ½ activity were not attributed to inhibition.  ERK ½ may be partially 
involved, but other mechanotransduction pathways mut be involved to evoke these SMC 
responses.   
 
7.2 Introduction 
  Mitogen activated protein kinase (MAPK) cascades ar  important in the 
regulation of cell proliferation, cell differentiaton, cell movement, and cell death [214].  
The MAPK subfamilies are the ERK, JNK/SAPK, and p38 athways.     Phenotype 
modulation and proliferation of smooth muscle cells in controlled in part by the 
Extracellular signal-regulated kinase (Erk) pathway [183].  Erk ½, or p44/42, is important 





proliferation has been shown to be blocked by inhibition of this pathway (Robinson, 
1997).   
Stress-activated protein kinases (SAPK)/Jun amino-terminal kinases (JNK)  have 
been shown to play an active role in transmitting transmembrane signals resulting in 
cellular apoptosis and cell differentiation [215, 216].  The JNK/SAPK cascade affects 
apoptosis in part due to the downstream interaction with p53 [217].  The role of the p53 
suppressor gene is to prevent uncontrolled proliferation and to induce apoptosis [218].  
Upstream signal activation of the JNK/SAPK is transl ted by small GTPases of the Rho 
family including Rac, rho, and cdc42 [219].  The role f p38 MAPK also suggests a 
negative role in regards to proliferation, it plays an active role in apoptosis and the 
inhibition of p38 MAPK results in increased proliferation [220].  
  Although both SAPK/JNK and p38 MAPK play significant roles in cell response, 
the work in this study focuses on the role of ERK ½ in SMC response to concurrent force 
stimulation.  Work by others have shown ERK ½ activation by stretch [221-223] 
resulting in cell proliferation.  Increased shear-dependant migration of venous SMCs has 
been shown to be related to increased ERK ½ phosphorylati n after 3-5 days [224].  
Higher shear stresses have been associated with decreas d ERK ½ phosphorylation while 
lower shear stresses were associated with increased ERK ½ phosphorylation [224]   
  Previous work by the authors demonstrated similar proliferation levels between 
the developed injury model and static control after both 8 hours [185], and 24 hours (see 
Chapter 5) mechanical stimulation and both demonstrated significantly greater 





contractile markers (SM α-actin, calponin, and SM22α) was also observed in both 
samples exposed only to strain and the injury model exposed to both shear and strain 
compared to the static control.  In addition, decreased p44/42 activity was observed in 
studies incorporating heparin, with similar behaviors in contractile marker expression.  In 
this study, we hypothesized that a decreased p44/42 activity is directly correlated to the 
differences in contractile protein expression.  TheERK ½ inhibitor U0126 (1,4-diamino-
2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene) was used to test the involvement of 
ERK ½ in the protein expression.  U0126 and PD98059 are both used MEK 1 and MEK2 
inhibitors implemented in ERK ½ pathway inhibition.  However, U0126 inhibits both 
MEK1 and MEK 2 strongly, while PD98059 has a higher affinity for inhibition of MEK1 
over MEK2 [225].  For this reason, U0126 was chosen for use in this study.      
 
7.3 Materials and Methods 
Cell Culture 
Rat aortic smooth muscle cells (RASMC) (Passages 5-7) harvested from 10-12 weeks old 
male Sprague-Dawley rats were a generous gift from the laboratory of Dr. Anand 
Ramamurthi, Department of Bioengineering, Clemson University.  The RASMCs were 
cultured in Dulbecco’s Modification of Eagle Medium (DMEM) (Mediatech, Inc., 10-
013-CV, Herndon, VA) supplemented with 10% heat inactiv ted fetal bovine serum 
(FBS) (Sigma-Aldrich, F-4135, St. Louis, MO) and 1% Antibiotic-Antimycotic (Sigma-
Aldrich, A5955, St. Louis, MO) under standard cell cu ture conditions (37ºC, 5% CO2 





Exposure of RASMCs to Mechanical Stimuli 
A custom-designed, concurrent force, vascular mechani s system was set up and 
sterilized as previously described [185].  Prior to cell seeding, collagen (50 µg/ml) coated 
silicone membranes were rinsed with 1.0 ml of Dulbecco’s Phosphate Buffered Saline 
(DPBS) (Media Tech, Inc., 21-031 CM, Herndon, VA).  RASMCs were seeded at a 
density of 2.8 x 104 cells/cm2 (P4-6) and incubated for 24 hours in DMEM containing 
10% FBS and 1% Antibiotic-Antimycotic.  At 24 hours, the medium was changed to 
DMEM containing 1% FBS, 1% Antibiotic-Antimycotic, and 1% Dextran for an 
additional 24 hours prior to testing.  During mechanic l stimulation, the RASMCs were 
maintained in DMEM with 1% FBS and 1% Antibiotic-Antimycotic;   
Four groups were investigated in the present study with a static unloaded (U) 
control group where cells where exposed neither to shear nor tensile forces.  The injury 
model (IM) group simulated smooth muscle cells thatare directly exposed to blood flow 
upon the denudation of the endothelial monolayer.   SMCs were first preconditioned for 
30 minutes as previously described with increasing frequencies up to 1 Hz and 5% cyclic 
strain.  Following preconditioning, two balloon deployments were simulated with 10% 
static strain for 1.5 minutes each with 30 seconds rest in between deployments.  
Following simulated balloon angioplasty applied to IM, shear flow was resumed at 400 
ml/min and cyclic strain was applied at 0-5% for 24 hours.  The flow rate of 400 mL/min 
provided a theoretical low wall shear stress oscillating between 0.1-0.5 dynes/cm2 due to 
the 1 Hz cyclic straining of the silicone membrane verified in our lab using a finite 





p44/42 inhibited groups for U and IM referred to as Uinh and IMinh.  Samples in these 
groups were pretreated for 1.5 hours with U0126 (Cell Signaling Technologies, 9903, 10 
µM) and then rinsed prior to application as in the case of the uninhibited counterparts.   
 
Quantification of Phenotypic Marker Proteins 
Expression of phenotype markers SM α−actin, SM22α, and vimentin in SMC lysates 
were quantified using standard western blotting techniques and digital image analysis.  
The expression of GAPDH was also quantified to ensure equal loading of protein 
samples in SDS-PAGE gel.  Briefly, cells were removed from the silicone membrane and 
lysed using an extraction buffer consisting of 0.5% Triton X-100 (Sigma-Aldrich, T-
9284, St. Louis, MO), 1% Sodium dodecyl sulfate (Sigma-Aldrich, L-4522, St. Louis, 
MO), 20 mM Tris (BIORAD, 161-0716, Hercules, CA), and 10 µL/mL protease cocktail 
inhibitor (Sigma-Aldrich, P8340, St. Louis MO).  The BCA Protein Assay Kit (Pierce, 
23225, Rockford, IL) was then used to determine the total protein content of each sample.  
These samples were then diluted to 80 µg/µL using sample buffer consisting of a 
reducing agent, β-mercaptoethanol, 0.5 M Tris-HCl, 10% SDS, 0.5% Bromophenol Blue, 
glycerol and distilled water.  Prior to gel electroph resis, the samples were denatured by 
boiling for 5 minutes.  A 10% polyacrylamide gel (BIORAD, 161-0158, Hercules, CA) 
was used in electrophoresis with 15 µL protein samples loaded per lane.  The protein 
samples separated on the SDS-PAGE gel were transferred to a PVDF membrane (Biorad, 
162-0184) which was incubated with the following primary antibodies with specified 





1:1000), vimentin (Abcam, ab7752, 1:750), GAPDH (Santa Cruz Biotechnologies, FL-
335, 1:500), p44/42 (Cell Signaling Technologies, 4695, 1:1000), phos p44/42 (Cell 
Signaling Technologies, 4370, 1:1000) .  The blots were then incubated with appropriate 
secondary antibodies at 1:5000 dilution and Precision Streptactin-HRP conjugate (Biorad, 
161-0380) at 1:20000 dilution.  Chemiluminescent labe ing of the PVDF membranes was 
performed with Immun-StarTM HRP substrate kit (Biorad, #170-5040) according to the 
manufacturer’s instructions.  The western blots were imaged using the FluorChem SP 
imager (Alpha Innotech); Densitometry of the bands i  the digital images was performed 
using the AlphaEaseFC (FluorChem SP) software to evaluate the protein expression level 
differences between the U (n=3), Uinh (n=3), IM (n=3), and IMinh (n=3) groups.  The 
Integrated Density value (IDV) expression of the markers was normalized that of 
GAPDH and statistically evaluated.   
 
Statistical Analysis 
Analysis of variance (ANOVA) paired with Student-Newman-Keuls (SNK) analysis was 
performed using SigmaStat (Systat Software, Inc., San Jose, CA) to detect statistical 
differences between groups.   
 
7.4 Results 
p44/42 Activity of the Dynamic and Static Groups 
The ratio of phos p44/42 to p44/42 indicated a significant decrease of all other groups 





Inhibition of phos p44/42 was not decreased further due to the inhibitor in the case of the 
IM group.  Overall, the mechanical forces in the injury model induced a similar amount 
of decrease in p44/42 activity as the induced inhibitor (p=0.893).  To verify that the 
inhibitor affected only the phos p44/42 and not the total p44/42, the ratio of total p44/42 
to GAPDH was compared.  There was not a significant difference between any of the 
groups (p=0.129) also ensuring equal protein loading per lane.  Protein expression was 
normalized to the static sample (U) and densitometry r sults indicated inhibition of 35%  
in the presence of an inhibitor (Uinh) and inhibition around 20% for injury model both 
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Figure 7.1 Western blot phos p44/42 and p44/42 expression in dynamic and static 
conditions in addition to the presence of p44/42 inhibitor a) Images of phos p44/42, 
p44/42, and GAPDH b) p44/42 activity indicated by ratio of phos p44/42 to total p44/42 
(n=3) (* denotes a statistical significance determent by ANOVA with p<0.05) 
 
Phenotypic Protein expression 
Results supported significant decreases in SM22α expression with the injury model 
(p=0.001) (Figure 2b).  Inhibition of p44/42 did not result in significant differences 
between U and Uinh (p=0.171) or between IM and IMinh (p=0.526) although about a 
20% decrease in activity was consistent between both cases.  There were no statistical 







25% decrease in the expression of alpha actin in the case of the injury model was 
observed.  Inhibited samples resulted in a 33% increase of alpha actin for Uinh compared 
to U and 17% increase of IMinh compared to IM.  Vimentin expression indicated a 
significant decrease in the case of the inhibited groups (p=0.002) (Figure 2d).  However, 
there are other mechanisms contributing to vimentin production given that the IM group 
maintained the same levels of vimentin expression compared to U, compared to the 
decreased expression of both the inhibitor groups (Uinh and IMinh).  Although IM data 
showed a significant decrease in p44/42 activity within similar levels of the inhibitor, the 
increased vimentin expression suggests other signalin  mechanisms were activated for 
vimentin production.   
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Figure 7.2  Western Blot protein Expression in dynamic and static conditions in addition 
to the presence of ERK ½ inhibitor a) Images of protein expression for SM22α, 
Vimentin, SM α-actin, and GAPDH b) SM22α densitometry (n=3) c) SM α-actin 
densitometry (n=3) d) Vimentin densitometry (n=3) (* denotes a statistical significance 




Investigation of p44/42, or ERK ½, activation was hypothesized to be associated with 
alterations in SMC protein expression in this study.  As in previous work, decreases in 
contractile markers were observed [185] in addition o decreased p44/42 activity within 
the injury model compared to the static control (see Chapter 4) after 24 hours.  p44/42 
activity was significantly inhibited with U0126 MEK ½ inhibitor compared to the static 







Suppression of p44/42, or ERK ½, activity somewhat contradicts other mechanical 
environment findings when applied to vascular cells.  Cyclic strain of 10% has also been 
shown to activate ERK, JNK, and p38 pathways strain exposure in both SMCs and 
endothelial cells [226, 227].  Nonlaminar shear stress has been shown to result in ERK ½ 
activation [180, 228].  This ERK ½ activation through shear stress has also been 
associated with the protein kinase C (PKC) pathway [229].  PKC has been shown to be 
required for ERK ½ activation in response to shear stress in endothelial cells as well 
[230].  Strain (0-7%) in bovine aortic SMCs showed increased PKC activity [160].  
Although several in vitro studies have been linked to increased ERK ½ activation, these 
studies are short term duration.  For example, stretch induced activation of ERK, JNK, 
and p38 in SMCs over 2 hours exhibited expression returning to the prestretch levels 
[231].  Results from this study are after 24 hours mechanical stimulation and incorporate 
shear and tensile forces together, conditions that are more physiologically relevant and 
very different from the studies that have been refer d above.  Decreases in ERK ½ 
activity after 24 hours may likely be a functional effect of the concurrent force 
stimulation, further emphasizing the need to verify the contribution of individual forces.     
Phenotypic protein expression results provided further insight into the possible 
influences of ERK ½.  Data did not show a significant decrease in SM α-actin in the 
injury model (IM) compared to the static unloaded (U), however, a similar decrease of 
around 20% SM α-actin expression due to the influence of the injury model was 
observed.  Although there was not a significant difference between any of the groups, 





inhibited static group (Uinh) there was a 25% increase in SM α-actin expression.  This 
would imply that inhibitory activity of p44/42 by the onset of the mechanical forces of 
the injury model is not directly associated with the opposing effect of the decreased SM 
α-actin expression attributed to the injury model.  In response to circumferential 
mechanical strain, degradation of α-actin filaments in venous SMCs has been shown to 
be attributed in part to the role of p38 MAPK and not ERK ½ [232], supporting that 
decreased SM α-actin expression of IM is not attributed to decreased p44/42, or ERK ½ 
activity.     
The significant decrease in SM22α expression in IM compared to U was identical 
in behavior to previous findings reported by the authors (see Chapter 4).  Treatment of 
the samples with inhibitory agents in the cases of Uinh and IMinh resulted in slight 
decreases in SM22α to their respective comparison groups, however differences were 
negligible when compared to differences attributed to exposure of the mechanical forces.  
Decreases in contractile marker in the injury model w re not shown to be primarily 
attributed to inhibition of p44/42 activity since the expression behavior of the inhibited 
static samples (U) did not mimic the injury model (IM) expression even though the 
percentage of inhibition was very similar between these groups.   
 Protein expression results of vimentin introduced other factors for consideration.  
Both static and dynamic groups (Uinh and IMinh) trea ed with the U0126 inhibitory 
agent resulted in significantly lower vimentin expression compared to U and IM, 
implying inhibition of p44/42 activity results in decreased vimentin expression.  





vimentin expression comparable to U, which has been shown in previous studies as well 
(see Chapter 3).  If vimentin is suppressed by inhibitory agents, then again there must be 
additional signaling mechanisms occurring to result in an increase in the synthetic marker 
vimentin expression.  ERK ½ is involved in differentiation and has been shown to affect 
other proteins such as h-caldesmon [233], so these influ nces in protein expression by 
ERK ½ assist to better characterize SMC phenotype. 
ERK ½ is one of the important MAPK to study, which greatly influence SMC 
response both in vitro and in vivo in considering atherosclerosis and restenosis.  
Atherosclerotic lesions have been shown to demonstrate hyperexpression and increased 
activation of ERK ½ emphasizing the importance of ERK ½ activation in cell 
proliferation during atherosclerosis [234].  In vivo studies have indicated a sustained 
increase in ERK 2 and JNK both immediately following balloon angioplasty and up to 14 
days following angioplasty [235].  In vivo SMC migration has also been shown to be 
mediated in part through increased ERK ½ [222, 224].  Enhanced ERK, JNK, and p38 
MAPK has been exhibited following balloon injury in rat carotid arteries [235-237].  In 
this work, there was actually a decrease in ERK ½ activity at 24 hours concurrent force 
mechanical stimulation.  Protein phenotypic expression was affected by the onset of 
mechanical force as described in previous work.  However, further investigation with 
additional time points would be advantageous for better characterization of ERK ½ 
expression and of the resultant effect on phenotypic protein expression of SMCs exposed 









We have shown that after 24 hours of mechanical stimulation through the custom 
developed injury model exposing SMCs to concurrent oscillating shear and tensile forces, 
there was a decrease in p44/42, or ERK ½, activity.  The observed decreased ERK ½ 
activity is contradictory to some of the synthetic phenotypic attributes previously 
observed by others in different conditions.  ERK ½ inhibition exhibited differing degrees 
of effect in different protein expression of the cells in both the static and injury model, 
again suggesting additional signaling mechanisms should be investigated, particularly 
those which influence cell differentiation, proliferation, and apoptosis, such as the other 
MAPK pathways (JNK/SAPK and p38) and upstream signal ng targets such as PKC 
which can influence these cell responses as well.  Through this work we have shown that 
the resultant changes in protein expression after 24 hours exposure to the developed 
injury model was not attributed to ERK ½ inhibition, therefore providing further insight 




















The hypothesis of this project was that balloon angioplasty endovascular 
intervention exposing vascular smooth muscle cells to an altered mechanical environment 
would evoke a cell phenotype change.  The exposure of smooth muscle cells to 
concurrent shear and tensile forces following balloon angioplasty did result in a more 
synthetic phenotype behavior marked by such characteristics as increased synthetic 
morphology, increased proliferation, increased apoptosis and decreased expression of 
contractile markers.  Each aim of this project greatly contributed to this work.  Through 
the system design and CFD channel characterization (Aims 1 and 2), a six-independent-
channel system providing low oscillating wall shear stress (WSS) was manufactured to 
apply concurrent shear and tensile forces with uniform strain and WSS profiles over the 
cell location.     
 Implementation of the system verified SMC response over 8 hours, with 
variations in cell proliferation and SM α-actin expression of the developed injury model 
(Aim 3).  Extension of testing to 24 hours further d monstrated effects of the concurrent 
force injury model with increased SMC hypertrophy, decreased contractile protein 
expression, increased synthetic protein expression, and increased apoptosis (Aim 4).   
Incorporation of heparin within the model within a clinical bolus regimen resulted in 
promotion of a contractile behavior with decreased proliferation and a contradictory 
synthetic promotion of decreased calponin expression (Aim 5).  Heparin did not 
significantly affect ERK ½ activity, suggesting the d creased proliferation after 24h was 





injury model exposure were not directly correlated with the decreased contractile protein 
expression (Aim 6).   
 Clinical implications for this work suggest that physiological regimens should be 
incorporated into in vitro studies.  We simulated balloon angioplasty through increased 
strains and a clinical heparin bolus administration, both of which evoked different SMC 
responses compared to controls.  SMC response triggred by exposure to the injury 
model resembled in vivo reactions following balloon angioplasty.  Incorporation of the 
dynamic concurrent and shear forces with in vitro testing can lead to better treatment and 








1. Expansion of Computational CFD Characterization 
Computational CFD characterization was limited to a2D analysis and primarily 
focused on a particular deformation and input velocity.  Expansion of this model to 
account for effects of higher input velocities, characterization over entire cell culture 
area, varying degrees of deformation, and varying frequencies would be useful for a 
broader characterization of the system for implemented use.  Additionally, development 
of a three-dimensional model would be the most advantageous computational 
development, although this would result in an increased computational expense requiring 
additional computational resources.  
 
2.  System Adaptation for Varied Force and Time Exposure for Injury Model  
The presented work focused extensively on the 24h response of SMC to 
mechanical forces incorporating an extremely low range of oscillating wall shear stresses 
(0-0.5 dynes/cm2).  Alterations in fluid chamber geometry would be required to expand 
the ranges of investigated wall shear stresses.  It would be of interest to compare cases of 
wall shear stresses around 3-5 dynes/cm2, and at a healthier physiologic amount around 
10 dynes/cm2.  Additionally, extending dynamic testing time points to 48 and 72 hours 
would allow for more points of comparison.  Comparison of uni-axial stretching in 
comparison to the current bi-axial configuration could also be of significant interest, 






3.  Incorporation of Other Cell Types 
 Cell studies in this work used healthy rat aortic smooth muscle cells.  Although 
this work provided insight into the synthetic response of surrounding healthy vascular 
cells, investigation of the response of other cell types would be of interest, particularly 
those of the pathological state.  Atherosclerotic cells may demonstrate different or 
elevated responses pertinent to restenosis.  Additionally, rat SMCs were used in this 
work.  Ideally, investigation of human SMCs would be of most interest since cell 
responses can vary between species.  Comparison between atherosclerotic and normal 
human SMCs would be clinically relevant.   
 
4.  Investigation of Other Clinical Anti-proliferative Agents     
Design of this dynamic model was targeted as an improved in vitro testing bed for 
pharmaceutical testing.  Incorporation of other pharmaceutical agents, both commercially 
available and experimental, could be tested within t is apparatus.  For example, 
sirolomus and paclitaxol, common stent coatings, could be investigated within the 
dynamic in vitro environment and compared to in vivo documented effects.   
The heparin studies could be expanded to investigate the effects of DPBS rinse 
versus immediate altered concentration exposure, the rate of bolus delivery, and effects of 
varying dosages on SMC response.  The investigation of heparin could also incorporate 
the natural anti-coagulant as well, rather than only its synthetic form.  For this 
experiment, plasma would need to be used in place of affected cell proliferation and 





during balloon angioplasty.  With an altered model, h parin dosages could be evaluated 
to optimize heparin administration to maintain anti-coagulant behavior, and maintain or 
promote contractile activity of the SMCs.  For this work, SMCs would need to be of the 
same species origin as the source plasma.      
 
5.  Increased ECM Environment and In-situ Implementation of Vascular Tissue Response 
to Endovascular Intervention  
For this work, a SMC monolayer cultured on collagen coated silicone was used 
for testing.   SMC response on variations of collagen content or a gradient of collagen 
could be altered and may demonstrate additional insight.  SMCs could also be cultured 
longer statically to increase the surrounding collagen and other ECM components 
produced and released from the cells.      
There may be cases where it would be advantageous to take a more in-situ 
approach incorporating arterial tissue into testing.  For example, porcine or bovine 
arterial segments could be bisected and placed flat within the system secured by an 
anastomosis on the outer edges to a material.  Thisconfiguration would allow for 
incorporation of the vascular wall to investigate endovascular intervention.  The 
endothelial wall could be denuded, or partially denuded.  Also, wires simulating stent 
placement could be placed to investigate the injury response within the wall.  Histological 
analysis could be used to evaluate the arterial response within the integrated dynamic 






6. Investigation of Signaling Pathways Affecting Dynamic Response 
Dynamic testing resulted in decreased sustained ERK½ activity.  The significant 
decrease in contractile protein expression was not attributed to this decreased activity, 
suggesting the involvement of other signaling mechanisms.  To evoke the complicated 
SMC responses, it is likely that several pathways are affected.  Upstream MAPK targets 
should be investigated such as Ras or Rho, in addition to Protein Kinase C (PKC), which 
can affect ERK and is involved with its own downstream effects.  Additionally, other 
time points of expression both in short term and sustained activation should be 
investigated.  Different pathways could be influencd at different time points by the 
dynamic model.   
Further evaluation of the mechanisms of heparin inhib tion would also be of great 
experimental interest.  Mitogen-activated kinase phos atase-1 (MKP-1) would be an 
interesting protein of investigation.  MKP-1 dephosphorylates ERK and JNK pathways of 
MAPK [238, 239].  Strain induced MKP-1 expression at 10% cyclic strain through 
Ras/Rac/MAPK pathway [240].  Reduction of MKP-1 is suggested to contribute in part 
to SMC proliferation after injury through decrease in dephosphorylation of p44 MAPK 
[241], however heparin has been shown to suppress th  expression of MKP-1 [242], even 
though heparin has an anti-proliferative effect.  Comparing these effects in the developed 



























































Appendix A-  
CAD Drawings 
 



































































Appendix B-  




















Plating and View Cells With the Loading StationsTM  
 
It should be noted that the only cells that will receive uniform strain are those attached to 
the area of the membrane that is over the post when the membrane is in its fully stretched 
position.  Therefore, it is best to attempt to plate cells only in the uniformly strained area 
or to view or test the cells that are in the uniformly strained area.  To determine this area, 
the following equation can be used: 
 





















Appendix C-  
C Source Code for Fluid Velocity Profile and Parabolic Deformation  
 
/************************************************** ********************* 
   vprofile.c                                                           
   UDF for specifying steady-state velocity profile  boundary condition  
*************************************************** *********************/ 
#include  "udf.h" 
 
DEFINE_PROFILE(inlet_x_velocity, thread, position)  
{ 
  real x[ND_ND];  /* this will hold the position vector */ 
  real y; 
  face_t f; 
 
  begin_f_loop(f, thread) 
    { 
      F_CENTROID(x,f,thread); 
      y = x[1]; 
       
   F_PROFILE(f, thread, position) = 0.0184 - ((y-.0 03175)*(y-
.003175))/(.00635*.00635)*0.0184; 
    } 
  end_f_loop(f, thread) 
}  
 
#include  "udf.h" 
 
/************************************************** *********************/ 
 /*    UDF to define a wall that is initially a max deformation parabola, but then  
 oscillates sinusoidally with time.  */ 
 /************************************************** *********************/ 
 
 
DEFINE_GRID_MOTION(moving_arc, domain, dt, time, dt ime) 
{ 
  Thread *tf = DT_THREAD (dt); 
  face_t f; 
  Node *node_p; 
  
   
 float   a, h, k, x, y; 
  
  int  n; 
   
  /* constant x coordinate of vertex of parabola*/ 
  k= -0.0143002;   
 
/* Set/activate the deforming flag on adjacent cell  zone, which      */ 
/* means that the cells adjacent to the deforming w all will also be  */ 
/* deformed, in order to avoid skewness.                             */ 
  SET_DEFORMING_THREAD_FLAG (THREAD_T0 (tf)); 
    
  /* Solve for h at new time, generic determined func tion good for t 0-1 determined from 
excel function*/ 
   
if  (time <= 0.5) 
   { 
     /*y =0.00049999999999650300x3 + 0.00029999999999730 200x2 + 0.00320000000000079000x - 
0.00160000000000008000*/ 
    h= -0.000499999999996503*pow(time,3) + 0.000299 999999997302*pow(time,2) + 
0.00320000000000079*time - 0.00160000000000008;  





    
  if  (time > 0.5) 
   { 
 /*y = 0.00049999999999705800x3 - 0.0011999999999949 8000x2 - 
0.00230000000000263000x + 0.00140000000000040000*/ 
 h=  0.000499999999997058*pow(time,3) - 0.001199999 99999498*pow(time,2) - 
0.00230000000000263*time + 0.0014000000000004;  
   } 
 
 if  (time >= 1.0) 
   { 
 /*y = -0.00049999999999950100x3 + 0.001799999999998 14000x2 + 
0.00110000000000240000x - 0.00400000000000106000*/ 
 h= -0.000499999999999501*pow(time,3) + 0.001799999 99999814*pow(time,2) + 
0.0011000000000024*time - 0.00400000000000106;  
   }  
 
 
   if  (time > 1.5) 
   { 
 /* y = 0.00049999999999972300x3 - 0.002699999999997 70000x2 + 
0.00159999999999505000x + 0.00200000000000317000*/ 
 h= 0.000499999999999723*pow(time,3) -0.00269999999 99977*pow(time,2) 
+0.00159999999999505*time + 0.00200000000000317;  
   } 
 
   if  (time >2.0) 
   { 
 /*y = -0.00049999999999617000x3 + 0.003299999999973 66000x2 - 
0.00399999999993997000x - 0.00280000000004536000*/ 
 h= -0.00049999999999617*pow(time,3) + 0.0032999999 9997366*pow(time,2) - 
0.00399999999993997*time - 0.00280000000004536; 
   } 
 
   
   if  (time > 2.5) 
   { 
 /* y = 0.00049999999999883500x3 - 0.004199999999991 99000x2 + 
0.00849999999998186000x - 0.00279999999998652000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0041999999 9999199*pow(time,2) + 
0.00849999999998186*time - 0.00279999999998652;  
   } 
 
   if  (time > 3.0) 
   { 
 /*y = -0.00049999999999617000x3 + 0.004799999999962 17000x2 - 
0.01209999999987580000x + 0.00499999999986443000*/ 
 h= -0.00049999999999617*pow(time,3) + 0.0047999999 9996217* pow(time,2) - 
0.0120999999998758*time + 0.00499999999986443;  
   } 
 
   if  (time > 3.5) 
   { 
 /* y = 0.00049999999999883500x3 - 0.005699999999988 49000x2 + 
0.01839999999996230000x - 0.01599999999995920000 */   
 h= 0.000499999999998835*pow(time,3) - 0.0056999999 9998849*pow(time,2) +  
0.0183999999999623*time - 0.0159999999999592;  
   } 
 
   if  (time > 4.0) 
   { 
 /*y = -0.00049999999999894600x3 + 0.006299999999986 21000x2 - 
0.02319999999994000000x + 0.02239999999991310000*/ 
  
 h=-0.000499999999998946* pow(time,3) + 0.006299999 99998621*pow(time,2)- 
0.02319999999994*time + 0.0223999999999131;  







   if  (time > 4.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0072000000000214 1000x2 + 
0.03130000000010220000x - 0.04060000000016320000 */  
    h= 0.000500000000001499*pow(time,3) - 0.0072000 0000002141*pow(time,2) + 
0.0313000000001022*time - 0.0406000000001632;  
 
   } 
  
  
   if  (time > 5.0) 
    { 
     /*y = -0.00049999999999894600x3 + 0.007799999999983 04000x2 - 0.03729999999990920000x 
+ 0.05239999999983820000 */ 
      h= -0.000499999999998946*pow(time,3)+ 0.00779 999999998304*pow(time,2) - 
0.0372999999999092*time + 0.0523999999998382; 
    }   
  
   if  (time > 5.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0087000000000259 1000x2 + 
0.04720000000014960000x - 0.07960000000028830000*/ 
    h= 0.000500000000001499*pow(time,3) - 0.0087000 0000002591*pow(time,2) + 
0.0472000000001496*time - 0.0796000000002883; 
   } 
  
  if  (time > 6.0) 
   { 
 /*y = -0.00049999999999894600x3 + 0.009299999999979 88000x2 - 
0.05439999999987210000x + 0.09799999999972940000*/ 
    h= -0.000499999999998946*pow(time,3) + 0.009299 99999997988*pow(time,2) - 
0.0543999999998721*time + 0.0979999999997294; 
   } 
 if  (time > 6.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0102000000000304 0000x2 + 
0.06610000000020590000x - 0.13600000000046500000*/ 
    h= 0.000500000000001499*pow(time,3) - 0.0102000 000000304*pow(time,2) + 
0.0661000000002059*time - 0.136000000000465; 
   } 
 if  (time > 7.0) 
   { 
 /*y = -0.00049999999999894600x3 + 0.010799999999976 70000x2 - 
0.07449999999982870000x + 0.16219999999958000000*/ 
    h= -0.000499999999998946*pow(time,3) + 0.010799 9999999767*pow(time,2) - 
0.0744999999998287*time + 0.16219999999958; 
   } 
 if  (time > 7.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0117000000000349 0000x2 + 
0.08800000000027120000x - 0.21280000000070300000*/ 
    h=  0.000500000000001499*pow(time,3)- 0.0117000 000000349*pow(time,2) + 
0.0880000000002712*time - 0.212800000000703; 
   } 
 if  (time > 8.0) 
   {   
 
 /*y = -0.00049999999999883500x3 + 0.012299999999971 30000x2 - 
0.09759999999976480000x + 0.24799999999935700000*/ 
    h= -0.000499999999998835*pow(time,3) + 0.012299 9999999713*pow(time,2) - 
0.0975999999997648*time + 0.247999999999357; 
   } 
 if  (time > 8.5) 





 /*y = 0.00049999999999883500x3 - 0.0131999999999697 0000x2 + 
0.11289999999973700000x - 0.31299999999924200000*/ 
    h= 0.000499999999998835*pow(time,3) - 0.0131999 999999697*pow(time,2) + 
0.112899999999737*time - 0.312999999999242; 
   } 
  if  (time > 9.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.013799999999967 80000x2 - 
0.12369999999970400000x + 0.35839999999909200000*/ 
    h= -0.000499999999998835*pow(time,3) + 0.013799 9999999678*pow(time,2) - 
0.123699999999704*time + 0.358399999999092; 
   } 
 
   if  (time > 9.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0146999999999662 0000x2 + 
0.14079999999967300000x - 0.43959999999894800000*/ 
    h= 0.000499999999998835*pow(time,3) - 0.0146999 999999662*pow(time,2) + 
0.140799999999673*time - 0.439599999998948; 
   } 
 
   if  (time > 10.0) 
   { 
    /*y = -0.00049999999999883500x3 + 0.015299999999964 30000x2 - 0.15279999999963600000x 
+ 0.49639999999876200000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.015299999 9999643*pow(time,2) - 
0.152799999999636*time + 0.496399999998762; 
   } 
 
   if  (time > 10.5) 
   { 
    /*y = 0.00049999999999883500x3 - 0.0161999999999627 0000x2 + 0.17169999999960200000x - 
0.59559999999858600000*/ 
    h= 0.000499999999998835*pow(time,3) - 0.0161999 999999627*pow(time,2) + 
0.171699999999602*time - 0.595599999998586; 
   } 
 
   if  (time > 11.0) 
   { 
    /*y = -0.00049999999999883500x3 + 0.016799999999960 80000x2 - 0.18489999999956100000x 
+ 0.66499999999836200000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.016799999 9999608*pow(time,2) - 
0.184899999999561*time + 0.664999999998362; 
   } 
 
   if  (time > 11.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0176999999999592 0000x2 + 
0.20559999999952400000x - 0.78399999999815000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0176999999 999592*pow(time,2) + 
0.205599999999524*time - 0.78399999999815; 
   } 
 
   if  (time > 12.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.018299999999957 40000x2 - 
0.21999999999948000000x + 0.86719999999788300000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.018299999 9999574*pow(time,2) - 
0.21999999999948*time + 0.867199999997883; 
   } 
 
   if  (time > 12.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0191999999999557 0000x2 + 
0.24249999999943900000x - 1.00779999999763000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0191999999 999557*pow(time,2) + 





   } 
 
   if  (time > 13.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.019799999999953 90000x2 - 
0.25809999999939100000x + 1.10599999999732000000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.019799999 9999539*pow(time,2) - 
0.258099999999391*time + 1.10599999999732; 
   } 
 
   if  (time > 13.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0206999999999522 0000x2 + 
0.28239999999934700000x - 1.26999999999703000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0206999999 999522*pow(time,2) + 
0.282399999999347*time - 1.26999999999703; 
   } 
 
   if  (time > 14.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.021299999999950 40000x2 - 
0.29919999999929500000x + 1.38439999999666000000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.021299999 9999504*pow(time,2) - 
0.299199999999295*time + 1.38439999999666; 
   } 
 
   if  (time > 14.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0221999999999487 0000x2 + 
0.32529999999924800000x - 1.57359999999632000000*/ 
   h= 0.000499999999998835*pow(time,3) - 0.02219999 99999487*pow(time,2) + 
0.325299999999248*time - 1.57359999999632; 
   } 
 
   if  (time > 15.0) 
   { 
    /*y = -0.00049999999999883500x3 + 0.022799999999946 90000x2 - 
0.34329999999919200000x + 1.70539999999591000000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.022799999 9999469*pow(time,2) - 
0.343299999999192*time + 1.70539999999591; 
   } 
 
   if  (time > 15.5) 
   { 
  /*y = 0.00049999999999883500x3 - 0.0236999999999452 0000x2 + 
0.37119999999914200000x - 1.92159999999552000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0236999999 999452*pow(time,2) + 
0.371199999999142*time - 1.92159999999552; 
   } 
 
   if  (time > 16.0) 
   { 
 /*y = -0.00050000000000083300x3 + 0.024300000000041 40000x2 - 
0.39040000000068500000x + 2.07200000000378000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.024300000 0000414*pow(time,2) - 
0.390400000000685*time + 2.072000000003780; 
   } 
 
   if  (time > 16.5) 
   { 
  /*y = 0.00050000000000061100x3 - 0.0252000000000305 0000x2 + 
0.42010000000050800000x - 2.31700000000281000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0252000000 000305*pow(time,2) + 
0.420100000000508*time - 2.31700000000281; 
   } 
 





   { 
  /*y = -0.00050000000000083300x3 + 0.025800000000043 90000x2 - 
0.44050000000077100000x + 2.4872000000045100000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.025800000 0000439*pow(time,2) - 
0.440500000000771*time + 2.48720000000451; 
   } 
 
   if  (time > 17.5) 
   { 
    /*y = 0.00050000000000061100x3 - 0.0267000000000324 0000x2 + 
0.47200000000057000000x - 2.76280000000335000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0267000000 000324*pow(time,2) + 
0.47200000000057*time - 2.76280000000335; 
   } 
 
   if  (time > 18.0) 
   { 
  /*y = -0.00050000000000083300x3 + 0.027300000000046 40000x2 - 
0.49360000000086100000x + 2.95400000000532000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.027300000 0000464*pow(time,2) - 
0.493600000000861*time + 2.95400000000532; 
   } 
 
   if  (time > 18.5) 
   { 
    /*y = 0.00050000000000061100x3 - 0.0282000000000342 0000x2 + 
0.52690000000063700000x - 3.26200000000395000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0282000000 000342*pow(time,2) + 
0.526900000000637*time - 3.26200000000395; 
   } 
 
   if  (time > 19.0) 
   { 
  /*y = -0.00050000000000083300x3 + 0.028800000000048 90000x2 - 
0.54970000000095600000x + 3.47540000000623000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.028800000 0000489*pow(time,2) - 
0.549700000000956*time + 3.47540000000623; 
   } 
 
   if  (time > 19.5) 
   { 
 /*y = 0.00050000000000061100x3 - 0.0297000000000360 0000x2 + 
0.58480000000070700000x - 3.81760000000462000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0297000000 00036*pow(time,2) + 
0.584800000000707*time - 3.81760000000462; 
   } 
 
   if  (time > 20.0) 
   { 
    /*y = -0.00050000000000083300x3 + 0.030300000000051 40000x2 - 
0.60880000000105700000x + 4.05440000000724000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.030300000 0000514*pow(time,2) - 
0.608800000001057*time + 4.05440000000724; 
   } 
 
   if  (time > 20.5) 
   { 
    /*y = 0.00050000000000061100x3 - 0.0312000000000379 0000x2 + 
0.64570000000078100000x - 4.43260000000536000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0312000000 000379*pow(time,2) + 
0.645700000000781*time - 4.43260000000536; 
   } 
     if  (time > 21.0) 
   { 
    /*y = -0.00050000000000083300x3 + 0.031800000000053 90000x2 - 





     h=-0.000500000000000833*pow(time,3) + 0.031800 0000000539*pow(time,2) - 
0.670900000001162*time + 4.69400000000835; 
  
   } 
 
if  (time >21.5) 
   { 
 /*y = 0.00050000000000061100x3 - 0.0327000000000397 0000x2 + 
0.70960000000085900000x - 5.11000000000618000000*/ 
 h=0.000500000000000611*pow(time,3) - 0.03270000000 00397*pow(time,2) + 
0.709600000000859*time - 5.11000000000618; 
 
   } 
if  (time >22.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.033300000000056 40000x2 - 0.73600000000127200000x + 
5.39720000000956000000*/ 
  h= -0.00050000000000833*pow(time,3) + 0.033300000 0000564*pow(time,2) - 
0.736000000001272*time + 5.39720000000956; 
 
   }     
 
if  (time >22.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0342000000000415 0000x2 + 0.77650000000094000000x - 
5.85280000000708000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0342000000 000415*pow(time,2) + 
0.77650000000094*time - 5.85280000000708; 
   } 
if  (time >23.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.034800000000058 90000x2 - 0.80410000000138700000x + 
6.16700000001089000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0348000000 000589*pow(time,2) - 
0.804100000001387*time + 6.16700000001089; 
 
   } 
if  (time >23.5) 
   { 
 /*y = 0.00050000000000061100x3 - 0.0357000000000434 0000x2 + 0.84640000000102500000x - 
6.66400000000806000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0357000000 000434*pow(time,2) + 
0.846400000001025*time - 6.66400000000806; 
 
   } 
if  (time >24.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.036300000000061 40000x2 - 0.87520000000150800000x + 
7.00640000001234000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0363000000 000614*pow(time,2) - 
0.875200000001508*time + 7.00640000001234; 
 
   } 
if  (time >24.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0372000000000452 0000x2 + 0.91930000000111300000x - 
7.54660000000913000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0372000000 000452*pow(time,2) + 
0.919300000001113*time - 7.54660000000913; 
 
   } 
if  (time >25.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.037800000000063 90000x2 - 0.94930000000163300000x + 
7.91840000001391000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0378000000 000639*pow(time,2) - 






   } 
if  (time >25.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0387000000000470 0000x2 + 0.99520000000120600000x - 
8.50360000001029000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0387000000 00047*pow(time,2) + 
0.995200000001206*time - 8.50360000001029; 
 
   } 
if  (time >26.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.039300000000066 40000x2 - 1.02640000000176000000x + 
8.90600000001561000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0393000000 000664*pow(time,2) - 
1.02640000000176*time + 8.90600000001561; 
 
   } 
if  (time >26.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0402000000000489 0000x2 + 1.07410000000130000000x - 
9.53800000001154000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0402000000 000489*pow(time,2) + 
1.0741000000013*time - 9.53800000001154; 
 
   } 
if  (time >27.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.040800000000068 90000x2 - 1.10650000000190000000x + 
9.97220000001744000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0408000000 000689*pow(time,2) - 
1.1065000000019*time + 9.97220000001744; 
 
   } 
if  (time >27.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0417000000000507 0000x2 + 1.15600000000140000000x - 
10.65280000001290000000*/ 
     
h = 0.000500000000000611*pow(time,3) - 0.0417000000 000507*pow(time,2) + 
1.1560000000014*time - 10.6528000000129; 
 
   } 
if  (time >28.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.042300000000071 40000x2 - 1.18960000000204000000x + 
11.120000000019400000002*/ 
h= -0.000500000000000833*pow(time,3) + 0.0423000000 000714*pow(time,2) - 
1.18960000000204*time + 11.120000000019400000002; 
 
   } 
if  (time >28.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0432000000000525 0000x2 + 1.24090000000150000000x - 
11.85100000001440000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0432000000 000525*pow(time,2) + 
1.2409000000015*time - 11.8510000000144; 
 
   } 
if  (time >29.0) 
   { 
/*y = -0.0005000000000008330x3 + 0.0438000000000739 000x2 - 1.2757000000021800000x + 
12.3524000000215000000*/ 
 
h= -0.0005000000000008330*pow(time,3) + 0.043800000 0000739*pow(time,2) - 
1.27570000000218*time + 12.3524000000215; 





if  (time >29.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0447000000000544 0000x2 + 1.32880000000161000000x - 
13.13560000001590000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0447000000 000544*pow(time,2) + 
1.32880000000161*time - 13.1356000000159; 
 
   } 
if  (time >30.0) 
   { 
/*y = y = -0.00050000000000083300x3 + 0.04530000000 007640000x2 - 1.36480000000233000000x 
+ 13.67240000002380000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0453000000 000764*pow(time,2) - 
1.36480000000233*time + 13.6724000000238; 
 
   } 
     
if  (time >30.5) 
   { 
/*y = y = 0.00050000000000061100x3 - 0.046200000000 05620000x2 + 1.41970000000172000000x - 
14.50960000001760000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0462000000 000562*pow(time,2) + 
1.41970000000172*time - 14.5096000000176; 
 
   } 
if  (time >31.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.046800000000078 90000x2 - 1.45690000000249000000x + 
15.08300000002620000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0468000000 000789*pow(time,2) - 
1.45690000000249*time + 15.0830000000262; 
 
   } 
if  (time >31.5) 
   { 
 
/*y = 0.00050000000000061100x3 - 0.0477000000000580 0000x2 + 1.51360000000184000000x - 
15.97600000001940000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0477000000 00058*pow(time,2) + 
1.51360000000184*time - 15.9760000000194; 
   } 
if  (time >32.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.048300000000005 60000x2 - 1.55200000000018000000x + 
16.58720000000200000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0483000000 000056*pow(time,2) - 
1.55200000000018*time + 16.587200000002; 
   }     
 
if  (time >32.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0491999999999733 0000x2 + 1.61049999999914000000x - 
17.53779999999080000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0491999999 999733*pow(time,2) + 
1.61049999999914*time - 17.5377999999908; 
 
   } 
if  (time >33.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.049800000000005 70000x2 - 1.65010000000020000000x + 
18.18800000000220000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0498000000 000057*pow(time,2) - 
1.6501000000002*time + 18.1880000000022; 
 
   } 
if  (time >33.5) 





/*y = 0.00049999999999972300x3 - 0.0506999999999724 0000x2 + 1.71039999999909000000x - 
19.19799999998990000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0506999999 999724*pow(time,2) + 
1.71039999999909*time - 19.1979999999899; 
 
   } 
if  (time >34.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.051300000000005 90000x2 - 1.75120000000021000000x + 
19.88840000000240000000*/ 
 h= -0.000500000000000056*pow(time,3) + 0.051300000 0000059*pow(time,2) - 
1.75120000000021*time + 19.8884000000024;   
   } 
if  (time >34.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0521999999999716 0000x2 + 1.81329999999903000000x - 
20.95959999998900000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0521999999 999716*pow(time,2) + 
1.81329999999903*time - 20.959599999989; 
   } 
if  (time >35.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.052800000000006 10000x2 - 1.85530000000022000000x + 
21.69140000000260000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0528000000 000061*pow(time,2) - 
1.85530000000022*time + 21.6914000000026;  
 
   } 
if  (time >35.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0536999999999708 0000x2 + 1.91919999999897000000x - 
22.82559999998800000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0536999999 999708*pow(time,2) + 
1.91919999999897*time - 22.825599999988; 
 
   } 
if  (time >36.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.054300000000006 20000x2 - 1.96240000000023000000x + 
23.60000000000290000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0543000000 000062*pow(time,2) - 
1.96240000000023*time + 23.6000000000029;  
   } 
if  (time >36.5) 
   { 
/*yy = 0.00049999999999972300x3 - 0.055199999999969 90000x2 + 2.02809999999891000000x - 
24.79899999998690000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0551999999 999699*pow(time,2) + 
2.02809999999891*time - 24.7989999999869; 
   } 
if  (time >37.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.055800000000006 40000x2 - 2.07250000000024000000x + 
25.61720000000310000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0558000000 000064*pow(time,2) - 
2.07250000000024*time + 25.6172000000031;  
   } 
if  (time >37.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0566999999999691 0000x2 + 2.13999999999885000000x - 
26.88279999998580000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0566999999 999691*pow(time,2) + 
2.13999999999885*time - 26.8827999999858; 
   } 
if  (time >38.0) 





/*y = -0.00050000000000005600x3 + 0.057300000000006 60000x2 - 2.18560000000026000000x + 
27.74600000000330000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0573000000 000066*pow(time,2) - 
2.18560000000026*time + 27.7460000000033;  
 
   } 
if  (time >38.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0581999999999683 0000x2 + 2.25489999999879000000x - 
29.07999999998460000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0581999999 999683*pow(time,2) + 
2.25489999999879*time - 29.07999999998460; 
 
   } 
if  (time >39.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.058800000000006 70000x2 - 2.30170000000027000000x + 
29.98940000000360000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0588000000 000067*pow(time,2) - 
2.30170000000027*time + 29.9894000000036;  
 
   } 
if  (time >39.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0596999999999674 0000x2 + 2.37279999999873000000x - 
31.39359999998340000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0596999999 999674*pow(time,2) + 
2.372799999998730*time - 31.39359999998340; 
 
   } 
if  (time >40.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.060300000000006 90000x2 - 2.42080000000028000000x + 
32.35040000000390000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0603000000 000069*pow(time,2) - 
2.42080000000028*time + 32.3504000000039;  
 
   } 
if  (time >40.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0611999999999666 0000x2 + 2.49369999999866000000x - 
33.82659999998210000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0611999999 999666*pow(time,2) + 
2.49369999999866*time - 33.8265999999821; 
 
   } 
if  (time >41.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.061800000000007 10000x2 - 2.54290000000030000000x + 
34.83200000000420000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0618000000 000071*pow(time,2) - 
2.5429000000003*time + 34.8320000000042;  
   } 
if  (time >41.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0626999999999658 0000x2 + 2.61759999999859000000x - 
36.38199999998070000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0626999999 999658*pow(time,2) + 
2.61759999999859*time - 36.3819999999807; 
   } 
if  (time >42.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.063300000000007 20000x2 - 2.66800000000031000000x + 
37.43720000000450000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0633000000 000072*pow(time,2) - 





   }     
 
if  (time >42.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0641999999999650 0000x2 + 2.74449999999852000000x - 
39.06279999997920000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0641999999 99965*pow(time,2) + 
2.74449999999852*time - 39.0627999999792; 
 
   } 
if  (time >43.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.064800000000007 40000x2 - 2.79610000000033000000x + 
40.16900000000480000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0648000000 000074*pow(time,2) - 
2.79610000000033*time + 40.1690000000048;  
 
   } 
if  (time >43.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0656999999999641 0000x2 + 2.87439999999845000000x - 
41.87199999997770000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0656999999 999641*pow(time,2) + 
2.87439999999845*time - 41.8719999999777; 
 
   } 
if  (time >44.0) 
   { 
 
/*y = -0.00050000000000005600x3 + 0.066300000000007 60000x2 - 2.92720000000034000000x + 
43.03040000000510000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0663000000 000076*pow(time,2) - 
2.92720000000034*time + 43.0304000000051;  
   } 
if  (time >44.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0671999999999633 0000x2 + 3.00729999999838000000x - 
44.81259999997620000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0671999999 999633*pow(time,2) + 
3.00729999999838*time - 44.8125999999762; 
 
   } 
if  (time >45.0) 
   { 
 
/*y = -0.00050000000000005600x3 + 0.067800000000007 70000x2 - 3.06130000000036000000x + 
46.02440000000550000000*/ 
h = -0.000500000000000056*pow(time,3) + 0.067800000 0000077*pow(time,2) - 
3.06130000000036*time + 46.0244000000055;  
   } 
if  (time >45.5) 
   { 
     
/*y = 0.00049999999999972300x3 - 0.0686999999999625 0000x2 + 3.14319999999831000000x - 
47.88759999997450000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0686999999 999625*pow(time,2) + 
3.14319999999831*time - 47.8875999999745; 
 
   } 
if  (time >46.0) 
   { 
 
/*y = -0.00050000000000005600x3 + 0.069300000000007 90000x2 - 3.19840000000037000000x + 
49.15400000000580000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0693000000 000079*pow(time,2) - 






   } 
if  (time >46.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0701999999999616 0000x2 + 3.28209999999823000000x - 
51.09999999997280000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0701999999 999616*pow(time,2) + 
3.28209999999823*time - 51.0999999999728; 
   } 
if  (time >47.0) 
   { 
 
/*y =y = -0.00050000000000005600x3 + 0.070800000000 00810000x2 - 3.33850000000039000000x + 
52.42220000000620000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0708000000 000081*pow(time,2) - 
3.33850000000039*time + 52.4222000000062; 
   } 
if  (time >47.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0716999999999608 0000x2 + 3.42399999999815000000x - 
54.45279999997090000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0716999999 999608*pow(time,2) + 
3.42399999999815*time - 54.4527999999709; 
   } 
if  (time >48.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.072300000000008 20000x2 - 3.48160000000040000000x + 
55.83200000000660000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0723000000 000082*pow(time,2) - 
3.4816000000004*time + 55.8320000000066; 
   } 
if  (time >48.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0731999999999600 0000x2 + 3.56889999999807000000x - 
57.94899999996910000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0731999999 9996*pow(time,2) + 
3.56889999999807*time - 57.9489999999691; 
   } 
if  (time >49.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.073800000000008 40000x2 - 3.62770000000042000000x + 
59.38640000000700000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0738000000 000084*pow(time,2) - 
3.62770000000042*time + 59.386400000007; 
   } 
if  (time >49.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0746999999999591 0000x2 + 3.71679999999799000000x - 
61.59159999996710000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0746999999 999591*pow(time,2) + 
3.71679999999799*time - 61.5915999999671; 
   } 
if  (time >50.0) 
   { 
 
/*y = -0.00050000000000005600x3 + 0.075300000000008 60000x2 - 3.77680000000044000000x + 
63.08840000000750000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0753000000 000086*pow(time,2) - 
3.77680000000044000000*time + 63.0884000000075; 
   } 
if  (time >50.5) 
   { 






h = 0.000499999999999723*pow(time,3) - 0.0761999999 999583*pow(time,2) + 
3.86769999999791*time - 65.383599999965; 
 
   } 
if  (time >51.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.076800000000008 80000x2 - 3.92890000000046000000x + 
66.94100000000790000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0768000000 000088*pow(time,2) - 
3.92890000000046*time + 66.9410000000079; 
 
 
   } 
if  (time >51.5) 
   { 
 /*y = 0.00049999999999972300x3 - 0.0776999999999575 0000x2 + 4.02159999999783000000x - 
69.32799999996290000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0776999999 999575*pow(time,2) + 
4.0215999999978300*time - 69.32799999996290; 
 
   } 
if  (time >52.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.078300000000008 90000x2 - 4.08400000000047000000x + 
70.94720000000840000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0783000000 000089*pow(time,2) - 
4.08400000000047*time + 70.9472000000084; 
 
   }     
 
if  (time >52.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0791999999999566 0000x2 + 4.17849999999774000000x - 
73.42779999996070000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0791999999 999566000*pow(time,2) + 
4.17849999999774*time - 73.4277999999607; 
 
   } 
if  (time >53.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.079800000000009 10000x2 - 4.24210000000049000000x + 
75.11000000000890000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0798000000 000091*pow(time,2) - 
4.24210000000049*time + 75.1100000000089; 
 
   } 
if  (time >53.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0806999999999558 0000x2 + 4.33839999999765000000x - 
77.68599999995840000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0806999999 9995580000*pow(time,2) + 
4.33839999999765*time - 77.68599999995840000000; 
   } 
if  (time >54.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.081300000000009 30000x2 - 4.40320000000051000000x + 
79.43240000000940000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0813000000 000093*pow(time,2) - 
4.40320000000051*time + 79.4324000000094; 
 
 
   } 
if  (time >54.5) 
   { 






h = 0.000499999999999723*pow(time,3) - 0.0821999999 99955*pow(time,2) + 
4.50129999999756*time - 82.105599999956; 
 
   } 
if  (time >55.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.082800000000009 40000x2 - 4.56730000000053000000x + 
83.91740000000990000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0828000000 000094*pow(time,2) - 
4.56730000000053*time + 83.9174000000099; 
 
   } 
if  (time >55.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0836999999999541 0000x2 + 4.66719999999747000000x - 
86.68959999995350000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0836999999 999541*pow(time,2) + 
4.66719999999747*time - 86.68959999995350; 
 
   } 
if  (time >56.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.084300000000009 60000x2 - 4.73440000000055000000x + 
88.56800000001040000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0843000000 000096*pow(time,2) - 
4.73440000000055*time + 88.5680000000104; 
 
   } 
if  (time >56.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0851999999999533 0000x2 + 4.83609999999738000000x - 
91.44099999995090000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0851999999 999533*pow(time,2) + 
4.83609999999738*time - 91.4409999999509; 
   } 
if  (time >57.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.085800000000009 80000x2 - 4.90450000000057000000x + 
93.38720000001100000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0858000000 000098*pow(time,2) - 
4.90450000000057*time + 93.387200000011; 
   } 
if  (time >57.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0866999999999525 0000x2 + 5.00799999999728000000x - 
96.36279999994830000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0866999999 999525*pow(time,2) + 
5.00799999999728*time - 96.3627999999483; 
 
   } 
if  (time >58.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.087300000000009 90000x2 - 5.07760000000059000000x + 
98.37800000001150000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0873000000 000099*pow(time,2) - 
5.07760000000059*time + 98.3780000000115; 
 
   } 
if  (time >58.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0881999999999517 0000x2 + 5.18289999999719000000x - 
101.45799999994500000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0881999999 999517*pow(time,2) + 
5.18289999999719*time - 101.457999999945; 
   } 





   { 
/*y = -0.00050000000000005600x3 + 0.088800000000010 10000x2 - 5.25370000000061000000x + 
103.54340000001200000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0888000000 000101*pow(time,2) - 
5.25370000000061*time + 103.543400000012; 
 
   } 
if  (time >59.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0896999999999508 0000x2 + 5.36079999999709000000x - 
106.72959999994300000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0896999999 999508*pow(time,2) + 
5.36079999999709*time - 106.729599999943; 
 
   } 
if  (time >60.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.090300000000010 30000x2 - 5.43280000000063000000x + 
108.88640000001300000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0903000000 000103*pow(time,2) - 
5.43280000000063*time + 108.886400000013; 
 
   } 
if  (time > 60.5) 
{ 
/*y = 0.00049999999999972300x3 - 0.0911999999999500 0000x2 + 5.54169999999699000000x - 
112.18059999994000000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0911999999 9995*pow(time,2) + 
5.54169999999699*time - 112.18059999994; 
} 
 
     
/*Need new a, using reference coordinates of edge o f parabola which stays constant (x,y)= 
(-0.011125,0)*/ 
/*double check x coordinate on reference*/ 
    
   /*a= (x-k)^2/(4(y-h)) */ 
     
   a= (-0.011125-k)*(-0.011125-k)/(4*(0-h)); 
 
   
/* Loop over the deforming boundary zone's faces;                    */ 
/* inner loop loops over all nodes of a given face;                   */ 
/* Thus, since one node can belong to several faces , one must guard  */ 
/* against operating on a given node more than once :                 */ 
 
  begin_f_loop (f, tf) 
    { 
      f_node_loop (f, tf, n) 
        { 
          node_p = F_NODE (f, tf, n); 
 
          /* Update the current node only if it has not been         */ 
    /* previously visited:                                     */ 
          if  (NODE_POS_NEED_UPDATE (node_p)) 
            { 
              /* Set flag to indicate that the current node's        */ 
     /* position has been updated, so that it will not b e   */ 
              /* updated during a future pass through the loop:      */ 
              NODE_POS_UPDATED (node_p); 
 
     x     = NODE_X (node_p); 
    
     
    /* equation of parabola*/ 
     






       
    NODE_Y (node_p) = y; 
    
            } 
        
   }  
    } 
  end_f_loop (f, tf);  
     
} 
 
DEFINE_GRID_MOTION(moving_arc2, domain, dt, time, d time) 
{ 
  Thread *tf = DT_THREAD (dt); 
  face_t f; 
  Node *node_p; 
 
  float   a, h, k2, x, y; 
  
  int  n; 
   
  /* constant x coordinate of vertex of parabola*/ 
  k2= 0.0143002;   
 
/* Set/activate the deforming flag on adjacent cell  zone, which      */ 
/* means that the cells adjacent to the deforming w all will also be  */ 
/* deformed, in order to avoid skewness.                             */ 
  SET_DEFORMING_THREAD_FLAG (THREAD_T0 (tf)); 
    
  /* Solve for h at new time, generic determined func tion good for t 0-1 determined from 
excel function*/ 
   
 
 if  (time <= 0.5) 
   { 
     /*y =0.00049999999999650300x3 + 0.00029999999999730 200x2 + 0.00320000000000079000x - 
0.00160000000000008000*/ 
    h= -0.000499999999996503*pow(time,3) + 0.000299 999999997302*pow(time,2) + 
0.00320000000000079*time - 0.00160000000000008;  
   } 
    
  if  (time > 0.5) 
   { 
 /*y = 0.00049999999999705800x3 - 0.0011999999999949 8000x2 - 
0.00230000000000263000x + 0.00140000000000040000*/ 
 h=  0.000499999999997058*pow(time,3) - 0.001199999 99999498*pow(time,2) - 
0.00230000000000263*time + 0.0014000000000004;  
   } 
 
 if  (time >= 1.0) 
   { 
 /*y = -0.00049999999999950100x3 + 0.001799999999998 14000x2 + 
0.00110000000000240000x - 0.00400000000000106000*/ 
 h= -0.000499999999999501*pow(time,3) + 0.001799999 99999814*pow(time,2) + 
0.0011000000000024*time - 0.00400000000000106;  
   }  
 
 
   if  (time > 1.5) 
   { 
 /* y = 0.00049999999999972300x3 - 0.002699999999997 70000x2 + 
0.00159999999999505000x + 0.00200000000000317000*/ 
 h= 0.000499999999999723*pow(time,3) -0.00269999999 99977*pow(time,2) 
+0.00159999999999505*time + 0.00200000000000317;  






   if  (time >2.0) 
   { 
 /*y = -0.00049999999999617000x3 + 0.003299999999973 66000x2 - 
0.00399999999993997000x - 0.00280000000004536000*/ 
 h= -0.00049999999999617*pow(time,3) + 0.0032999999 9997366*pow(time,2) - 
0.00399999999993997*time - 0.00280000000004536; 
   } 
 
   
   if  (time > 2.5) 
   { 
 /* y = 0.00049999999999883500x3 - 0.004199999999991 99000x2 + 
0.00849999999998186000x - 0.00279999999998652000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0041999999 9999199*pow(time,2) + 
0.00849999999998186*time - 0.00279999999998652;  
   } 
 
   if  (time > 3.0) 
   { 
 /*y = -0.00049999999999617000x3 + 0.004799999999962 17000x2 - 
0.01209999999987580000x + 0.00499999999986443000*/ 
 h= -0.00049999999999617*pow(time,3) + 0.0047999999 9996217* pow(time,2) - 
0.0120999999998758*time + 0.00499999999986443;  
   } 
 
   if  (time > 3.5) 
   { 
 /* y = 0.00049999999999883500x3 - 0.005699999999988 49000x2 + 
0.01839999999996230000x - 0.01599999999995920000 */   
 h= 0.000499999999998835*pow(time,3) - 0.0056999999 9998849*pow(time,2) +  
0.0183999999999623*time - 0.0159999999999592;  
   } 
 
   if  (time > 4.0) 
   { 
 /*y = -0.00049999999999894600x3 + 0.006299999999986 21000x2 - 
0.02319999999994000000x + 0.02239999999991310000*/ 
  
 h=-0.000499999999998946* pow(time,3) + 0.006299999 99998621*pow(time,2)- 
0.02319999999994*time + 0.0223999999999131;  
   } 
 
  
   if  (time > 4.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0072000000000214 1000x2 + 
0.03130000000010220000x - 0.04060000000016320000 */  
    h= 0.000500000000001499*pow(time,3) - 0.0072000 0000002141*pow(time,2) + 
0.0313000000001022*time - 0.0406000000001632;  
 
   } 
  
  
   if  (time > 5.0) 
    { 
     /*y = -0.00049999999999894600x3 + 0.007799999999983 04000x2 - 0.03729999999990920000x 
+ 0.05239999999983820000 */ 
      h= -0.000499999999998946*pow(time,3)+ 0.00779 999999998304*pow(time,2) - 
0.0372999999999092*time + 0.0523999999998382; 
    }   
  
   if  (time > 5.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0087000000000259 1000x2 + 
0.04720000000014960000x - 0.07960000000028830000*/ 
    h= 0.000500000000001499*pow(time,3) - 0.0087000 0000002591*pow(time,2) + 





   } 
  
  if  (time > 6.0) 
   { 
 /*y = -0.00049999999999894600x3 + 0.009299999999979 88000x2 - 
0.05439999999987210000x + 0.09799999999972940000*/ 
    h= -0.000499999999998946*pow(time,3) + 0.009299 99999997988*pow(time,2) - 
0.0543999999998721*time + 0.0979999999997294; 
   } 
 if  (time > 6.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0102000000000304 0000x2 + 
0.06610000000020590000x - 0.13600000000046500000*/ 
    h= 0.000500000000001499*pow(time,3) - 0.0102000 000000304*pow(time,2) + 
0.0661000000002059*time - 0.136000000000465; 
   } 
 if  (time > 7.0) 
   { 
 /*y = -0.00049999999999894600x3 + 0.010799999999976 70000x2 - 
0.07449999999982870000x + 0.16219999999958000000*/ 
    h= -0.000499999999998946*pow(time,3) + 0.010799 9999999767*pow(time,2) - 
0.0744999999998287*time + 0.16219999999958; 
   } 
 if  (time > 7.5) 
   { 
 /*y = 0.00050000000000149900x3 - 0.0117000000000349 0000x2 + 
0.08800000000027120000x - 0.21280000000070300000*/ 
    h=  0.000500000000001499*pow(time,3)- 0.0117000 000000349*pow(time,2) + 
0.0880000000002712*time - 0.212800000000703; 
   } 
 if  (time > 8.0) 
   {   
 
 /*y = -0.00049999999999883500x3 + 0.012299999999971 30000x2 - 
0.09759999999976480000x + 0.24799999999935700000*/ 
    h= -0.000499999999998835*pow(time,3) + 0.012299 9999999713*pow(time,2) - 
0.0975999999997648*time + 0.247999999999357; 
   } 
 if  (time > 8.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0131999999999697 0000x2 + 
0.11289999999973700000x - 0.31299999999924200000*/ 
    h= 0.000499999999998835*pow(time,3) - 0.0131999 999999697*pow(time,2) + 
0.112899999999737*time - 0.312999999999242; 
   } 
  if  (time > 9.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.013799999999967 80000x2 - 
0.12369999999970400000x + 0.35839999999909200000*/ 
    h= -0.000499999999998835*pow(time,3) + 0.013799 9999999678*pow(time,2) - 
0.123699999999704*time + 0.358399999999092; 
   } 
 
   if  (time > 9.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0146999999999662 0000x2 + 
0.14079999999967300000x - 0.43959999999894800000*/ 
    h= 0.000499999999998835*pow(time,3) - 0.0146999 999999662*pow(time,2) + 
0.140799999999673*time - 0.439599999998948; 
   } 
 
   if  (time > 10.0) 
   { 
    /*y = -0.00049999999999883500x3 + 0.015299999999964 30000x2 - 0.15279999999963600000x 
+ 0.49639999999876200000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.015299999 9999643*pow(time,2) - 





   } 
 
   if  (time > 10.5) 
   { 
    /*y = 0.00049999999999883500x3 - 0.0161999999999627 0000x2 + 0.17169999999960200000x - 
0.59559999999858600000*/ 
    h= 0.000499999999998835*pow(time,3) - 0.0161999 999999627*pow(time,2) + 
0.171699999999602*time - 0.595599999998586; 
   } 
 
   if  (time > 11.0) 
   { 
    /*y = -0.00049999999999883500x3 + 0.016799999999960 80000x2 - 0.18489999999956100000x 
+ 0.66499999999836200000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.016799999 9999608*pow(time,2) - 
0.184899999999561*time + 0.664999999998362; 
   } 
 
   if  (time > 11.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0176999999999592 0000x2 + 
0.20559999999952400000x - 0.78399999999815000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0176999999 999592*pow(time,2) + 
0.205599999999524*time - 0.78399999999815; 
   } 
 
   if  (time > 12.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.018299999999957 40000x2 - 
0.21999999999948000000x + 0.86719999999788300000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.018299999 9999574*pow(time,2) - 
0.21999999999948*time + 0.867199999997883; 
   } 
 
   if  (time > 12.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0191999999999557 0000x2 + 
0.24249999999943900000x - 1.00779999999763000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0191999999 999557*pow(time,2) + 
0.242499999999439*time - 1.00779999999763; 
   } 
 
   if  (time > 13.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.019799999999953 90000x2 - 
0.25809999999939100000x + 1.10599999999732000000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.019799999 9999539*pow(time,2) - 
0.258099999999391*time + 1.10599999999732; 
   } 
 
   if  (time > 13.5) 
   { 
 /*y = 0.00049999999999883500x3 - 0.0206999999999522 0000x2 + 
0.28239999999934700000x - 1.26999999999703000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0206999999 999522*pow(time,2) + 
0.282399999999347*time - 1.26999999999703; 
   } 
 
   if  (time > 14.0) 
   { 
 /*y = -0.00049999999999883500x3 + 0.021299999999950 40000x2 - 
0.29919999999929500000x + 1.38439999999666000000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.021299999 9999504*pow(time,2) - 
0.299199999999295*time + 1.38439999999666; 
   } 
 





   { 
 /*y = 0.00049999999999883500x3 - 0.0221999999999487 0000x2 + 
0.32529999999924800000x - 1.57359999999632000000*/ 
   h= 0.000499999999998835*pow(time,3) - 0.02219999 99999487*pow(time,2) + 
0.325299999999248*time - 1.57359999999632; 
   } 
 
   if  (time > 15.0) 
   { 
    /*y = -0.00049999999999883500x3 + 0.022799999999946 90000x2 - 
0.34329999999919200000x + 1.70539999999591000000*/ 
 h= -0.000499999999998835*pow(time,3) + 0.022799999 9999469*pow(time,2) - 
0.343299999999192*time + 1.70539999999591; 
   } 
 
   if  (time > 15.5) 
   { 
  /*y = 0.00049999999999883500x3 - 0.0236999999999452 0000x2 + 
0.37119999999914200000x - 1.92159999999552000000*/ 
 h= 0.000499999999998835*pow(time,3) - 0.0236999999 999452*pow(time,2) + 
0.371199999999142*time - 1.92159999999552; 
   } 
 
   if  (time > 16.0) 
   { 
 /*y = -0.00050000000000083300x3 + 0.024300000000041 40000x2 - 
0.39040000000068500000x + 2.07200000000378000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.024300000 0000414*pow(time,2) - 
0.390400000000685*time + 2.072000000003780; 
   } 
 
   if  (time > 16.5) 
   { 
  /*y = 0.00050000000000061100x3 - 0.0252000000000305 0000x2 + 
0.42010000000050800000x - 2.31700000000281000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0252000000 000305*pow(time,2) + 
0.420100000000508*time - 2.31700000000281; 
   } 
 
   if  (time > 17.0) 
   { 
  /*y = -0.00050000000000083300x3 + 0.025800000000043 90000x2 - 
0.44050000000077100000x + 2.4872000000045100000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.025800000 0000439*pow(time,2) - 
0.440500000000771*time + 2.48720000000451; 
   } 
 
   if  (time > 17.5) 
   { 
    /*y = 0.00050000000000061100x3 - 0.0267000000000324 0000x2 + 
0.47200000000057000000x - 2.76280000000335000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0267000000 000324*pow(time,2) + 
0.47200000000057*time - 2.76280000000335; 
   } 
 
   if  (time > 18.0) 
   { 
  /*y = -0.00050000000000083300x3 + 0.027300000000046 40000x2 - 
0.49360000000086100000x + 2.95400000000532000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.027300000 0000464*pow(time,2) - 
0.493600000000861*time + 2.95400000000532; 
   } 
 
   if  (time > 18.5) 
   { 
    /*y = 0.00050000000000061100x3 - 0.0282000000000342 0000x2 + 





 h= 0.000500000000000611*pow(time,3) - 0.0282000000 000342*pow(time,2) + 
0.526900000000637*time - 3.26200000000395; 
   } 
 
   if  (time > 19.0) 
   { 
  /*y = -0.00050000000000083300x3 + 0.028800000000048 90000x2 - 
0.54970000000095600000x + 3.47540000000623000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.028800000 0000489*pow(time,2) - 
0.549700000000956*time + 3.47540000000623; 
   } 
 
   if  (time > 19.5) 
   { 
 /*y = 0.00050000000000061100x3 - 0.0297000000000360 0000x2 + 
0.58480000000070700000x - 3.81760000000462000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0297000000 00036*pow(time,2) + 
0.584800000000707*time - 3.81760000000462; 
   } 
 
   if  (time > 20.0) 
   { 
    /*y = -0.00050000000000083300x3 + 0.030300000000051 40000x2 - 
0.60880000000105700000x + 4.05440000000724000000*/ 
 h= -0.000500000000000833*pow(time,3) + 0.030300000 0000514*pow(time,2) - 
0.608800000001057*time + 4.05440000000724; 
   } 
 
   if  (time > 20.5) 
   { 
    /*y = 0.00050000000000061100x3 - 0.0312000000000379 0000x2 + 
0.64570000000078100000x - 4.43260000000536000000*/ 
 h= 0.000500000000000611*pow(time,3) - 0.0312000000 000379*pow(time,2) + 
0.645700000000781*time - 4.43260000000536; 
   } 
     if  (time > 21.0) 
   { 
    /*y = -0.00050000000000083300x3 + 0.031800000000053 90000x2 - 
0.67090000000116200000x + 4.69400000000835000000*/ 
     h=-0.000500000000000833*pow(time,3) + 0.031800 0000000539*pow(time,2) - 
0.670900000001162*time + 4.69400000000835; 
  
   } 
 
if  (time >21.5) 
   { 
 /*y = 0.00050000000000061100x3 - 0.0327000000000397 0000x2 + 
0.70960000000085900000x - 5.11000000000618000000*/ 
 h=0.000500000000000611*pow(time,3) - 0.03270000000 00397*pow(time,2) + 
0.709600000000859*time - 5.11000000000618; 
 
   } 
if  (time >22.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.033300000000056 40000x2 - 0.73600000000127200000x + 
5.39720000000956000000*/ 
  h= -0.00050000000000833*pow(time,3) + 0.033300000 0000564*pow(time,2) - 
0.736000000001272*time + 5.39720000000956; 
 
   }     
 
if  (time >22.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0342000000000415 0000x2 + 0.77650000000094000000x - 
5.85280000000708000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0342000000 000415*pow(time,2) + 





   } 
if  (time >23.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.034800000000058 90000x2 - 0.80410000000138700000x + 
6.16700000001089000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0348000000 000589*pow(time,2) - 
0.804100000001387*time + 6.16700000001089; 
 
   } 
if  (time >23.5) 
   { 
 /*y = 0.00050000000000061100x3 - 0.0357000000000434 0000x2 + 0.84640000000102500000x - 
6.66400000000806000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0357000000 000434*pow(time,2) + 
0.846400000001025*time - 6.66400000000806; 
 
   } 
if  (time >24.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.036300000000061 40000x2 - 0.87520000000150800000x + 
7.00640000001234000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0363000000 000614*pow(time,2) - 
0.875200000001508*time + 7.00640000001234; 
 
   } 
if  (time >24.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0372000000000452 0000x2 + 0.91930000000111300000x - 
7.54660000000913000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0372000000 000452*pow(time,2) + 
0.919300000001113*time - 7.54660000000913; 
 
   } 
if  (time >25.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.037800000000063 90000x2 - 0.94930000000163300000x + 
7.91840000001391000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0378000000 000639*pow(time,2) - 
0.949300000001633*time + 7.91840000001391; 
 
   } 
if  (time >25.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0387000000000470 0000x2 + 0.99520000000120600000x - 
8.50360000001029000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0387000000 00047*pow(time,2) + 
0.995200000001206*time - 8.50360000001029; 
 
   } 
if  (time >26.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.039300000000066 40000x2 - 1.02640000000176000000x + 
8.90600000001561000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0393000000 000664*pow(time,2) - 
1.02640000000176*time + 8.90600000001561; 
 
   } 
if  (time >26.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0402000000000489 0000x2 + 1.07410000000130000000x - 
9.53800000001154000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0402000000 000489*pow(time,2) + 
1.0741000000013*time - 9.53800000001154; 
 
   } 
if  (time >27.0) 





/*y = -0.00050000000000083300x3 + 0.040800000000068 90000x2 - 1.10650000000190000000x + 
9.97220000001744000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0408000000 000689*pow(time,2) - 
1.1065000000019*time + 9.97220000001744; 
 
   } 
if  (time >27.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0417000000000507 0000x2 + 1.15600000000140000000x - 
10.65280000001290000000*/ 
     
h = 0.000500000000000611*pow(time,3) - 0.0417000000 000507*pow(time,2) + 
1.1560000000014*time - 10.6528000000129; 
 
   } 
if  (time >28.0) 
   { 
/*y = -0.00050000000000083300x3 + 0.042300000000071 40000x2 - 1.18960000000204000000x + 
11.120000000019400000002*/ 
h= -0.000500000000000833*pow(time,3) + 0.0423000000 000714*pow(time,2) - 
1.18960000000204*time + 11.120000000019400000002; 
 
   } 
if  (time >28.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0432000000000525 0000x2 + 1.24090000000150000000x - 
11.85100000001440000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0432000000 000525*pow(time,2) + 
1.2409000000015*time - 11.8510000000144; 
 
   } 
if  (time >29.0) 
   { 
/*y = -0.0005000000000008330x3 + 0.0438000000000739 000x2 - 1.2757000000021800000x + 
12.3524000000215000000*/ 
 
h= -0.0005000000000008330*pow(time,3) + 0.043800000 0000739*pow(time,2) - 
1.27570000000218*time + 12.3524000000215; 
   } 
if  (time >29.5) 
   { 
/*y = 0.00050000000000061100x3 - 0.0447000000000544 0000x2 + 1.32880000000161000000x - 
13.13560000001590000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0447000000 000544*pow(time,2) + 
1.32880000000161*time - 13.1356000000159; 
 
   } 
if  (time >30.0) 
   { 
/*y = y = -0.00050000000000083300x3 + 0.04530000000 007640000x2 - 1.36480000000233000000x 
+ 13.67240000002380000000*/ 
h= -0.000500000000000833*pow(time,3) + 0.0453000000 000764*pow(time,2) - 
1.36480000000233*time + 13.6724000000238; 
 
   } 
if  (time >30.5) 
   { 
/*y = y = 0.00050000000000061100x3 - 0.046200000000 05620000x2 + 1.41970000000172000000x - 
14.50960000001760000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0462000000 000562*pow(time,2) + 
1.41970000000172*time - 14.5096000000176; 
 
   } 
if  (time >31.0) 
   { 






h= -0.000500000000000833*pow(time,3) + 0.0468000000 000789*pow(time,2) - 
1.45690000000249*time + 15.0830000000262; 
 
   } 
if  (time >31.5) 
   { 
 
/*y = 0.00050000000000061100x3 - 0.0477000000000580 0000x2 + 1.51360000000184000000x - 
15.97600000001940000000*/ 
h = 0.000500000000000611*pow(time,3) - 0.0477000000 00058*pow(time,2) + 
1.51360000000184*time - 15.9760000000194; 
   } 
if  (time >32.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.048300000000005 60000x2 - 1.55200000000018000000x + 
16.58720000000200000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0483000000 000056*pow(time,2) - 
1.55200000000018*time + 16.587200000002; 
   }     
 
if  (time >32.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0491999999999733 0000x2 + 1.61049999999914000000x - 
17.53779999999080000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0491999999 999733*pow(time,2) + 
1.61049999999914*time - 17.5377999999908; 
 
   } 
if  (time >33.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.049800000000005 70000x2 - 1.65010000000020000000x + 
18.18800000000220000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0498000000 000057*pow(time,2) - 
1.6501000000002*time + 18.1880000000022; 
 
   } 
if  (time >33.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0506999999999724 0000x2 + 1.71039999999909000000x - 
19.19799999998990000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0506999999 999724*pow(time,2) + 
1.71039999999909*time - 19.1979999999899; 
 
   } 
if  (time >34.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.051300000000005 90000x2 - 1.75120000000021000000x + 
19.88840000000240000000*/ 
 h= -0.000500000000000056*pow(time,3) + 0.051300000 0000059*pow(time,2) - 
1.75120000000021*time + 19.8884000000024;   
   } 
if  (time >34.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0521999999999716 0000x2 + 1.81329999999903000000x - 
20.95959999998900000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0521999999 999716*pow(time,2) + 
1.81329999999903*time - 20.959599999989; 
   } 
if  (time >35.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.052800000000006 10000x2 - 1.85530000000022000000x + 
21.69140000000260000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0528000000 000061*pow(time,2) - 
1.85530000000022*time + 21.6914000000026;  
 
   } 





   { 
/*y = 0.00049999999999972300x3 - 0.0536999999999708 0000x2 + 1.91919999999897000000x - 
22.82559999998800000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0536999999 999708*pow(time,2) + 
1.91919999999897*time - 22.825599999988; 
 
   } 
if  (time >36.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.054300000000006 20000x2 - 1.96240000000023000000x + 
23.60000000000290000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0543000000 000062*pow(time,2) - 
1.96240000000023*time + 23.6000000000029;  
   } 
if  (time >36.5) 
   { 
/*yy = 0.00049999999999972300x3 - 0.055199999999969 90000x2 + 2.02809999999891000000x - 
24.79899999998690000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0551999999 999699*pow(time,2) + 
2.02809999999891*time - 24.7989999999869; 
   } 
if  (time >37.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.055800000000006 40000x2 - 2.07250000000024000000x + 
25.61720000000310000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0558000000 000064*pow(time,2) - 
2.07250000000024*time + 25.6172000000031;  
   } 
if  (time >37.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0566999999999691 0000x2 + 2.13999999999885000000x - 
26.88279999998580000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0566999999 999691*pow(time,2) + 
2.13999999999885*time - 26.8827999999858; 
   } 
if  (time >38.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.057300000000006 60000x2 - 2.18560000000026000000x + 
27.74600000000330000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0573000000 000066*pow(time,2) - 
2.18560000000026*time + 27.7460000000033;  
 
   } 
if  (time >38.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0581999999999683 0000x2 + 2.25489999999879000000x - 
29.07999999998460000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0581999999 999683*pow(time,2) + 
2.25489999999879*time - 29.07999999998460; 
 
   } 
if  (time >39.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.058800000000006 70000x2 - 2.30170000000027000000x + 
29.98940000000360000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0588000000 000067*pow(time,2) - 
2.30170000000027*time + 29.9894000000036;  
 
   } 
if  (time >39.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0596999999999674 0000x2 + 2.37279999999873000000x - 
31.39359999998340000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0596999999 999674*pow(time,2) + 
2.372799999998730*time - 31.39359999998340; 
 





if  (time >40.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.060300000000006 90000x2 - 2.42080000000028000000x + 
32.35040000000390000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0603000000 000069*pow(time,2) - 
2.42080000000028*time + 32.3504000000039;  
 
   } 
if  (time >40.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0611999999999666 0000x2 + 2.49369999999866000000x - 
33.82659999998210000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0611999999 999666*pow(time,2) + 
2.49369999999866*time - 33.8265999999821; 
 
   } 
if  (time >41.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.061800000000007 10000x2 - 2.54290000000030000000x + 
34.83200000000420000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0618000000 000071*pow(time,2) - 
2.5429000000003*time + 34.8320000000042;  
   } 
if  (time >41.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0626999999999658 0000x2 + 2.61759999999859000000x - 
36.38199999998070000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0626999999 999658*pow(time,2) + 
2.61759999999859*time - 36.3819999999807; 
   } 
if  (time >42.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.063300000000007 20000x2 - 2.66800000000031000000x + 
37.43720000000450000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0633000000 000072*pow(time,2) - 
2.66800000000031*time + 37.4372000000045;  
   }     
 
if  (time >42.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0641999999999650 0000x2 + 2.74449999999852000000x - 
39.06279999997920000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0641999999 99965*pow(time,2) + 
2.74449999999852*time - 39.0627999999792; 
 
   } 
if  (time >43.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.064800000000007 40000x2 - 2.79610000000033000000x + 
40.16900000000480000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0648000000 000074*pow(time,2) - 
2.79610000000033*time + 40.1690000000048;  
 
   } 
if  (time >43.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0656999999999641 0000x2 + 2.87439999999845000000x - 
41.87199999997770000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0656999999 999641*pow(time,2) + 
2.87439999999845*time - 41.8719999999777; 
 
   } 
if  (time >44.0) 






/*y = -0.00050000000000005600x3 + 0.066300000000007 60000x2 - 2.92720000000034000000x + 
43.03040000000510000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0663000000 000076*pow(time,2) - 
2.92720000000034*time + 43.0304000000051;  
   } 
if  (time >44.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0671999999999633 0000x2 + 3.00729999999838000000x - 
44.81259999997620000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0671999999 999633*pow(time,2) + 
3.00729999999838*time - 44.8125999999762; 
 
   } 
if  (time >45.0) 
   { 
 
/*y = -0.00050000000000005600x3 + 0.067800000000007 70000x2 - 3.06130000000036000000x + 
46.02440000000550000000*/ 
h = -0.000500000000000056*pow(time,3) + 0.067800000 0000077*pow(time,2) - 
3.06130000000036*time + 46.0244000000055;  
   } 
if  (time >45.5) 
   { 
     
/*y = 0.00049999999999972300x3 - 0.0686999999999625 0000x2 + 3.14319999999831000000x - 
47.88759999997450000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0686999999 999625*pow(time,2) + 
3.14319999999831*time - 47.8875999999745; 
 
   } 
if  (time >46.0) 
   { 
 
/*y = -0.00050000000000005600x3 + 0.069300000000007 90000x2 - 3.19840000000037000000x + 
49.15400000000580000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0693000000 000079*pow(time,2) - 
3.19840000000037*time + 49.1540000000058; 
 
   } 
if  (time >46.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0701999999999616 0000x2 + 3.28209999999823000000x - 
51.09999999997280000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0701999999 999616*pow(time,2) + 
3.28209999999823*time - 51.0999999999728; 
   } 
if  (time >47.0) 
   { 
 
/*y =y = -0.00050000000000005600x3 + 0.070800000000 00810000x2 - 3.33850000000039000000x + 
52.42220000000620000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0708000000 000081*pow(time,2) - 
3.33850000000039*time + 52.4222000000062; 
   } 
if  (time >47.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0716999999999608 0000x2 + 3.42399999999815000000x - 
54.45279999997090000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0716999999 999608*pow(time,2) + 
3.42399999999815*time - 54.4527999999709; 
   } 
if  (time >48.0) 
   { 






h= -0.000500000000000056*pow(time,3) + 0.0723000000 000082*pow(time,2) - 
3.4816000000004*time + 55.8320000000066; 
   } 
if  (time >48.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0731999999999600 0000x2 + 3.56889999999807000000x - 
57.94899999996910000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0731999999 9996*pow(time,2) + 
3.56889999999807*time - 57.9489999999691; 
   } 
if  (time >49.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.073800000000008 40000x2 - 3.62770000000042000000x + 
59.38640000000700000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0738000000 000084*pow(time,2) - 
3.62770000000042*time + 59.386400000007; 
   } 
if  (time >49.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0746999999999591 0000x2 + 3.71679999999799000000x - 
61.59159999996710000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0746999999 999591*pow(time,2) + 
3.71679999999799*time - 61.5915999999671; 
   } 
if  (time >50.0) 
   { 
 
/*y = -0.00050000000000005600x3 + 0.075300000000008 60000x2 - 3.77680000000044000000x + 
63.08840000000750000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0753000000 000086*pow(time,2) - 
3.77680000000044000000*time + 63.0884000000075; 
   } 
if  (time >50.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0761999999999583 0000x2 + 3.86769999999791000000x - 
65.38359999996500000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0761999999 999583*pow(time,2) + 
3.86769999999791*time - 65.383599999965; 
 
   } 
if  (time >51.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.076800000000008 80000x2 - 3.92890000000046000000x + 
66.94100000000790000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0768000000 000088*pow(time,2) - 
3.92890000000046*time + 66.9410000000079; 
 
 
   } 
if  (time >51.5) 
   { 
 /*y = 0.00049999999999972300x3 - 0.0776999999999575 0000x2 + 4.02159999999783000000x - 
69.32799999996290000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0776999999 999575*pow(time,2) + 
4.0215999999978300*time - 69.32799999996290; 
 
   } 
if  (time >52.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.078300000000008 90000x2 - 4.08400000000047000000x + 
70.94720000000840000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0783000000 000089*pow(time,2) - 
4.08400000000047*time + 70.9472000000084; 
 
   }     
 





   { 
/*y = 0.00049999999999972300x3 - 0.0791999999999566 0000x2 + 4.17849999999774000000x - 
73.42779999996070000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0791999999 999566000*pow(time,2) + 
4.17849999999774*time - 73.4277999999607; 
 
   } 
if  (time >53.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.079800000000009 10000x2 - 4.24210000000049000000x + 
75.11000000000890000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0798000000 000091*pow(time,2) - 
4.24210000000049*time + 75.1100000000089; 
 
   } 
if  (time >53.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0806999999999558 0000x2 + 4.33839999999765000000x - 
77.68599999995840000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0806999999 9995580000*pow(time,2) + 
4.33839999999765*time - 77.6859999999584; 
   } 
if  (time >54.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.081300000000009 30000x2 - 4.40320000000051000000x + 
79.43240000000940000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0813000000 000093*pow(time,2) - 
4.40320000000051*time + 79.4324000000094; 
 
 
   } 
if  (time >54.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0821999999999550 0000x2 + 4.50129999999756000000x - 
82.10559999995600000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0821999999 99955*pow(time,2) + 
4.50129999999756*time - 82.105599999956; 
 
   } 
if  (time >55.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.082800000000009 40000x2 - 4.56730000000053000000x + 
83.91740000000990000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0828000000 000094*pow(time,2) - 
4.56730000000053*time + 83.9174000000099; 
 
   } 
if  (time >55.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0836999999999541 0000x2 + 4.66719999999747000000x - 
86.68959999995350000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0836999999 999541*pow(time,2) + 
4.66719999999747*time - 86.68959999995350; 
 
   } 
if  (time >56.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.084300000000009 60000x2 - 4.73440000000055000000x + 
88.56800000001040000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0843000000 000096*pow(time,2) - 
4.73440000000055*time + 88.5680000000104; 
 
   } 
if  (time >56.5) 
   { 






h = 0.000499999999999723*pow(time,3) - 0.0851999999 999533*pow(time,2) + 
4.83609999999738*time - 91.4409999999509; 
   } 
if  (time >57.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.085800000000009 80000x2 - 4.90450000000057000000x + 
93.38720000001100000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0858000000 000098*pow(time,2) - 
4.90450000000057*time + 93.387200000011; 
   } 
if  (time >57.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0866999999999525 0000x2 + 5.00799999999728000000x - 
96.36279999994830000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0866999999 999525*pow(time,2) + 
5.00799999999728*time - 96.3627999999483; 
 
   } 
if  (time >58.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.087300000000009 90000x2 - 5.07760000000059000000x + 
98.37800000001150000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0873000000 000099*pow(time,2) - 
5.07760000000059*time + 98.3780000000115; 
 
   } 
if  (time >58.5) 
   { 
 
/*y = 0.00049999999999972300x3 - 0.0881999999999517 0000x2 + 5.18289999999719000000x - 
101.45799999994500000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0881999999 999517*pow(time,2) + 
5.18289999999719*time - 101.457999999945; 
   } 
if  (time >59.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.088800000000010 10000x2 - 5.25370000000061000000x + 
103.54340000001200000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0888000000 000101*pow(time,2) - 
5.25370000000061*time + 103.543400000012; 
 
   } 
if  (time >59.5) 
   { 
/*y = 0.00049999999999972300x3 - 0.0896999999999508 0000x2 + 5.36079999999709000000x - 
106.72959999994300000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0896999999 999508*pow(time,2) + 
5.36079999999709*time - 106.729599999943; 
 
   } 
if  (time >60.0) 
   { 
/*y = -0.00050000000000005600x3 + 0.090300000000010 30000x2 - 5.43280000000063000000x + 
108.88640000001300000000*/ 
h= -0.000500000000000056*pow(time,3) + 0.0903000000 000103*pow(time,2) - 
5.43280000000063*time + 108.886400000013; 
 
   } 
if  (time > 60.5) 
{ 
/*y = 0.00049999999999972300x3 - 0.0911999999999500 0000x2 + 5.54169999999699000000x - 
112.18059999994000000000*/ 
h = 0.000499999999999723*pow(time,3) - 0.0911999999 9995*pow(time,2) + 
5.54169999999699*time - 112.18059999994; 
} 






     
/*Need new a, using reference coordinates of edge o f parabola which stays constant (x,y)= 
(0.01125,0)*/ 
/*double check x coordinate on reference*/ 
    
   /*a= (x-k)^2/(4(y-h)) */ 
     
   a= (0.011125-k2)*(0.011125-k2)/(4*(0-h)); 
 
   
/* Loop over the deforming boundary zone's faces;                    */ 
/* inner loop loops over all nodes of a given face;                   */ 
/* Thus, since one node can belong to several faces , one must guard  */ 
/* against operating on a given node more than once :                 */ 
 
  begin_f_loop (f, tf) 
    { 
      f_node_loop (f, tf, n) 
        { 
          node_p = F_NODE (f, tf, n); 
 
          /* Update the current node only if it has not been         */ 
    /* previously visited:                                     */ 
          if  (NODE_POS_NEED_UPDATE (node_p)) 
            { 
              /* Set flag to indicate that the current node's        */ 
     /* position has been updated, so that it will not b e   */ 
              /* updated during a future pass through the loop:      */ 
              NODE_POS_UPDATED (node_p); 
 
     x     = NODE_X (node_p); 
    
     
    /* equation of parabola*/ 
     
              y= (1/(4*a))*(x-k2)*(x-k2)+ h; 
 
       
    NODE_Y (node_p) = y; 
    
            } 
        
   }  
    } 
  end_f_loop (f, tf);  
     
} 
/************************************************** *******************/ 
/* End of the UDF.                                              */ 

















Appendix D-  
Dextran Media Alteration 
Introduction 
To increase the viscosity of the media, Dextran has previously been used for cell tests 
with endothelial cells up to 20% Dextran [174].  First, the effect of varying percentages 
of Dextran on smooth muscle cell response was investigated.  Once 1% Dextran solution 
was chosen, a smaller study was performed to verify that it would not negatively affect 
the smooth muscle cells. With the added component to the cell media, it is important to 
first evaluate if the changes in the media affect the cell response and eliminate it as a 
possible additional variable during experimental testing.  
 
Materials and Methods  
Dextran Effect on Media Viscosity 
Dextran (Sigma, D8476, MW 100,000-200,000) was added to Dulbecco’s Modification 
of Eagle’s Media (Mediatech, 45000-304) to create solutions of 0%, 5%, 10%, 20%.  
Viscosities of the media were tested using a rheometer (Anton Paar, MCR-300) with a 
CP-75  measuring system with a sweep of 10-750 s-1 averaged for the viscosity readings.   
 
Cell response of cells to varying viscosity and FBS levels 
RASMC (P4) obtained from MUSC were seeded in 96-well polystyrene plates at 
a concentration of 2.5 x 104 cells/ml and allowed to reach confluency in DMEM 
supplemented with 10% FBS (Sigma-Aldrich, F4135) and 1% antibiotic/antimycotic 





deionized water and autoclaving the solution for 45 min at 121 C according to the 
manufacturer’s protocol for sterilization in an aqueo s solution.  DMEM was 
supplemented with this solution to create solutions f 0%, 5%, 10%, and 20% Dextran.   
After 24 hours, the media was removed from the cells and exchanged with DMEM 
supplemented with 0%, 5%, 10%, or 20% Dextran and 0%, 0.5%, or 1.0% FBS.   All 12 
media groups received supplementation of 1% Antibiotic-Antimycotic.  Cells were 
evaluated at 24 hours following exposure to DMEM with Dextran. Live/Dead 
Viability/Cytoxicity Assay (Invitrogen, L-3224) and CellTiter 96 Aqueous One Solution 
Proliferation Assay (Promega, TB245) were performed with n=4 for each sample group.  
Cell Titer 96 Proliferation Assay 
Cell Titer 96 AQueous ONE Solution Cell Proliferation Assay (MTS) (Promega 
Corporation, G-3580, Madison, WI) was used to examine the proliferation activity of the 
cells.  In this assay, 100 ul was added to each well and incubated for 3 hours.  The optical 
density was determined at 490 nm (Beckman Instruments, Inc., Model# DU 640B, 
Fullerton, CA).  
 
Live/Dead Assay 
In the Live/Dead assay, Calcein produces a strong green fluorescence in live cells at an 
excitation about 495 nm and emission at 515 nm.  Ethidium homodimer-1 (EthD-1) 
penetrates cells with damaged membranes and binds to nucleic acids.  This produces a 
red fluorescence in dead cells with excitation at 528 nm and emission around 615 nm.      





Probes, L-3224) was followed according to the manufct rer’s protocol in this 
preliminary study.  A working solution consisting of approximately 2µM calcein AM and 
4 µM EthD-1 was prepared.  A black 96-well plate was used for cell culture and readings 
to limit fluorescent cross-talk between wells.  Cells were washed twice with DPBS 
solutions prior to exposure of 100µL of the working solution.  The cell plate was then 
incubated for 45 min at room temperature.  The fluorescence was then read using the 
Gemini Plate reader (specs here) at 530 nm and 615 nm for Calcein and EthD-1, 
respectively.  Wells without cells but with working solution were used as blanks in 
analysis.  These were subtracted from the fluorescence readings and the relative 
fluorescence of each sample group was used for comparison.       
 
Altered 1% Dextran Cell Media on Cell Response 
Following the testing of the effect of Dextran on the smooth muscle cells, solution 
percentages of Dextran and FBS were chosen based upon the results and usage in 
literature [174].  Since 1% Dextran was not specifically tested, an additional experiment 
was added.  In this study, the experimental media is compared to the normal cell culture 
media containing 10% FBS as well.  The control media consisted of 10% FBS and 1% 
Antibiotic-Antimycotic.  The two other groups tested consisted of 1% FBS, 1% 
Antibiotic-Antimycotic, and 1% FBS, 1% Antibiotic-Antimycotic, 1% Dextran.  In 
addition, cell analysis techniques of CyQuant Cell Proliferation Assay for cell 
proliferation and TUNEL assay for cell apoptosis were implemented in place of MTS and 





Rat Aortic Smooth Muscle Cells (P6) were seeded on C llagen (50 µg/ml, 
PureCol Collagen) coated 12-well plates at a density of 7.5x 104 cells/ml.  The cells were 
maintained in DMEM with 10% FBS, 1% Antibiotic-Antimycotic for the first 24 hours.  
The media switched to experimental groups for 48 hours, with the media being changed 
after the first 24 hours.  This media regimen is identical and simulates the regimen that 
the cells in the 24hour dynamic study are subject to.   A One-Way ANOVA statistical 




Addition of Dextran increased the viscosity of the m dia with the trend shown in Figure 
2.  Using the developed equation, the viscosity of 1% media was estimated to be 0.0014 
Pa*s.  Experimental measurement of the 1% media was measured to be 0.0016 Pa*s, 
within 10% of the theoretical estimate.      
  
Figure D.1  Effect of Dextran on media viscosity 



























Variation of Dextran effect on cells- MTS 
MTS readings for each media group are provided in Table 1.  These readings represent 
the absorbance at 490 nm with the absorbance of media without cell exposure subtracted.  
Three samples per media group were measured. 
 
Table D.1. MTS Readings for media groups at 490 nm 
 Media Combination Mean Std. Dev. 
1 0% FBS 0% Dextran 0.146 0.046137 
2 0% FBS 5% Dextran 0.128 0.023415 
3 0% FBS 10% Dextran 0.194 0.011442 
4 0% FBS 20%Dextran 0.260 0.006994 
5 0.5% FBS 0%Dextran 0.161 0.034919 
6 0.5% FBS 5%Dextran 0.239 0.010344 
7 0.5% FBS 10%Dextran 0.290 0.034664 
8 0.5% FBS 20%Dextran 0.264 0.071365 
9 1% FBS 0%Dextran 0.161 0.027085 
10 1% FBS 5%Dextran 0.236 0.037633 
11 1% FBS 10%Dextran 0.340 0.043323 
12 1% FBS 20%Dextran 0.258 0.042884 
 
Graphical and statistical comparison of this data cn be seen in Figures 3-4.  Figure 3 
compares the variation of percentages of Dextran (0%-2 %) for each value of %FBS.  
Figure 3 a) indicated a statistical difference of 20% Dextran compared to both 0% and 
5% Dextran for 0% FBS media.  For the case of 0.5%FBS, both 10% and 20% 
demonstrated significantly increased absorbance compared to the 0% Dextran media.  In 
the case of 1% FBS, significant differences were det ct d between 5% and 10% Dextran, 
and between 0%, 10%, and 20%.  The general trend of the data in Figure 3 suggests that 
10% and 20% significantly increase the proliferation of the smooth muscle cells.  Values 



























Figure D.2  Comparison of MTS Proliferation Assay for varying percentages of Dextran 
with absorbance readings at 490 nm.  Statistical comparison performed with One-way 
ANOVA with SNK analysis, * represents a significant difference between samples a) 0% 
FBS: p=0.008 b) 0.5% FBS: p= 0.007 c)  1% FBS: p<0.001 
 
Figure 4 compares the effect of the three FBS percentag s added to the media.  
Figures a) and d) did not show a significant difference in MTS absorbance in the cases of 
0% and 20% dextran, respectively.  Figures b) and c) representing 5% Dextran and 10% 
Dextran demonstrated significant differences for the case of 0% FBS compared to 0.5% 
and 1% FBS.  This data suggest that FBS values of 0.5% and 1% did not show significant 
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Figure D.3  Comparison of MTS Proliferation Assay for %FBS for each %Dextran with 
absorbance readings at 490 nm.  Statistical comparison performed with One-way 
ANOVA with SNK analysis, * represents a significant difference between samples a) 0% 
Dextran: p= 0.797  b) 5 % Dextran: p= 0.015 c)  10% Dextran: p< 0.001 d) 20%Dextran 
(p=0.540) 
 
Dextran effect on cells- Live/Dead Assay 
 Calcein corresponding to live cell readings at 515nm exhibited the following 









Effect of FBS with 0% Dextran 
Effect of FBS with 10% Dextran 
Effect of FBS with 5% Dextran 
Effect of FBS with 20% Dextran 
0%               0.5%            1.0% 0%               0.5%            1.0% 







Table D.2 Calcein Readings for live cells at 515 nm 
 Media Combination Mean Std. Dev. 
1 0% FBS 0% Dextran 43.04 12.70 
2 0% FBS 5% Dextran 28.83 18.75 
3 0% FBS 10% Dextran 49.44 25.66 
4 0% FBS 20%Dextran 36.78 16.23 
5 0.5% FBS 0%Dextran 30.78 7.43 
6 0.5% FBS 5%Dextran 49.32 6.03 
7 0.5% FBS 10%Dextran 52.92 15.94 
8 0.5% FBS 20%Dextran 20.02 10.33 
9 1% FBS 0%Dextran 43.60 11.42 
10 1% FBS 5%Dextran 60.69 15.17 
11 1% FBS 10%Dextran 36.22 5.56 
12 1% FBS 20%Dextran 32.19 7.12 
 
Graphical and statistical comparisons for the calcein fluorescence for varying percentages 
of Dextran are shown in Figures 5-6.  For 0% FBS, no significant differences were seen 
between the variations in %Dextran as shown in Figure 5 a).  For the case of 0.5% shown 
in Figure 5 b), significantly less cells were detected for the case of 20% cells compared to 
both 5% and 10% Dextran.  For 1%FBS shown in Figure 5 c), significantly lower number 




















Figure D.4 Comparison of calcein for live cells as p rt of the Live/Dead microplate assay 
for varying percentages of Dextran with fluorescence readings at 515nm.  Statistical 
comparison performed with One-way ANOVA with SNK analysis, * represents a 
significant difference between samples a) 0% FBS: p=0.486 b) 0.5% FBS: p=0.003        
c) 1% FBS: p= 0.011 
 
0%           5%           10%          20% 
a) b) c) 
0%           5%           10%          20% 0%           5%           10%          20% 
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Comparing the different solutions with variations i live cell expression only when 
































Figure D.5   Comparison of live cells as part of the Live/Dead microplate assay for 
comparison of effect of %FBS at varying percentages of Dextran with fluorescence 
readings at 515nm.  Statistical comparison performed with One-way ANOVA with SNK 
analysis, * represents a significant difference betwe n samples a) 0% Dextran: p= 0.217 
b) 5% Dextran: p=0.034 c)  10% Dextran: p=0.410  d) 20% Dextran: p=0.174 
 
The EthD-1 readings of fluorescence represent the readings of dead cells.  A summary of 







Effect of FBS with 0% Dextran 
Effect of FBS with 10% Dextran Effect of FBS with 20% Dextran 
Effect of FBS with 5% Dextran 
a) b) 
c) d) 
0%               0.5%            1.0% 0%               0.5%            1.0% 






Table D.3 EthD-1 Readings for dead cells at 617 nm 
 Media Combination Mean Std. Dev. 
1 0% FBS 0% Dextran 0.44 0.18 
2 0% FBS 5% Dextran 1.02 0.30 
3 0% FBS 10% Dextran 1.72 0.17 
4 0% FBS 20%Dextran 1.85 0.05 
5 0.5% FBS 0%Dextran 0.76 0.16 
6 0.5% FBS 5%Dextran 1.29 0.22 
7 0.5% FBS 10%Dextran 1.74 0.32 
8 0.5% FBS 20%Dextran 1.97 0.30 
9 1% FBS 0%Dextran 1.08 0.19 
10 1% FBS 5%Dextran 1.30 0.39 
11 1% FBS 10%Dextran 1.47 0.30 
12 1% FBS 20%Dextran 2.33 0.18 
 
Figures 7-8 represent the number fluorescence readings for the varying percentages at 
each level of %FBS.  Figure 7 a) for 0% Dextran demonstrated significant difference 
between all groups except 10% and 20% Dextran, with bo  higher %Dextran expressing 
higher fluorescence than the other values.  For 0.5%FBS, 0% and 5%Dextran were not 
significantly different and represents lower expression of dead cells.  For the case of 1% 
FBS in Figure 7 c), 20% Dextran was the only signifcantly higher expression of dead 

































Figure D.6  Comparison of dead cells as part of the Liv /Dead microplate assay for 
varying percentages of Dextran with fluorescence readings at 617 nm.  Statistical 
comparison performed with One-way ANOVA with SNK analysis, * represents a 
significant difference between samples a) 0% FBS: p<0.001 b) 0.5% FBS: p<0.001 c)  
1% FBS: p< 0.001 
  
When comparing the %FBS at the four percentages of Dextran, 1%FBS was significantly 
higher than 0%FBS for 0%Dextran and 20%Dextran as shown in Figure 8 a) and d).  For 
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Figure D.7  Comparison of dead cells as part of the Liv /Dead microplate assay for 
comparison of effect of %FBS at varying percentages of Dextran with fluorescence 
readings at 617 nm.  Statistical comparison performed with One-way ANOVA with SNK 
analysis, * represents a significant difference betwe n samples a) 0% Dextran: p=0.002 
b) 5% Dextran: p=0.396 c) 10% Dextran: p=0.345 d) 20% Dextran: p=0.023 
 
 
Media Verification study with 1% FBS, 1% Dextran 
CyQuant assay 
The control media consisting of 10% FBS, 1% Antibiotic-Antimycotic resulted in 1.89 
x105 ± 3.06 x104 SD cells.  The experimental medias of 1% FBS, 1% Antibiotic-
Antimycotic and 1% FBS, 1% Dextran, 1% Antibiotic-Antimycotic resulted in cell 
counts of  1.09 x105 ±1.51 x104 SD cells and 1.31 x105 ± 1.30 x104 SD cells.  ANOVA 
and SNK analysis indicated a significant difference in the 10% FBS media (p=0.002).  
Effect of FBS with 0% Dextran 
Effect of FBS with 10% Dextran Effect of FBS with 20% Dextran 
Effect of FBS with 5% Dextran 
a) b) 
c) d) 
0%               0.5%            1.0% 0%               0.5%            1.0% 







These results can be seen in Figure 8 a).  No differenc  was seen between the two 1% 







                               (a)                                                               (b) 
Figure D.8  Control and experimental media  a) CyQuant assay results (p=0.002) b) 
TUNEL assay results (p=0.863) 
 
TUNEL Apoptosis assay 
Results from the TUNEL apoptosis assay indicated no significant difference 
between the three medias as shown in Figure 8 b).  ANOVA indicated a p value of 0.863.  
Results represent n=9 points of imaging.  As a control for apoptosis, samples were 
exposed to UV for 30 minutes which has been shown t cause cell apoptosis [187].  This 
control allowed ease in imaging to separate background staining from the localized green 
fluorescence in the nuclei of apoptotic cells.  Reduced serum and added Dextran did not 
result in increased apoptotic response. 
 
Discussion of Altered Media  
The measurements of the viscosity of the media disagreed slightly with the value 
determined in Aim 2.  Fairly large percentages of Dextran are required to significantly 
affect the viscosity of the media.  The measured value of media without Dextran 
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supplementation was slightly lower in the measurement in this case 0.001 Pa*s versus 
0.0015 Pa*s measured in Aim 2.  Supplementation with 1% Dextran increased the 
viscosity to 0.0016 Pa*s.  Compared to the 0% measur d in this aim, it resulted in an 
approximate 50% increase in viscosity, but only about a 7% increase in viscosity 
compared to the previously determined viscosity.  These differences could be due to 
changes in the measuring system of the rheometer or othe  possible differences in testing.            
Results from the MTS for 0, 5, 10, and 20% Dextran in 0%, 0.5%, and 1% FBS 
media solutions suggested that the addition of Dextran can have an effect on cell activity.  
MTS results suggested that up to 5% Dextran would not affect the metabolic proliferative 
activity of cells compared to media without Dextran.   Higher percentages of 10% and 
20% Dextran suggested higher metabolic activity of cells.  Differences due to alterations 
in FBS were not as apparent.  For the live/dead assay, there were general trends of 
increased expression of EthD-1 representing dead cells with increased percentages of 
Dextran.  The fluorescent expression of Calcein did not present general trends in 
statistical behavior and had increased variability of testing.  The Calcein expression did 
show that addition of Dextran resulted in similar expression of fluorescence representing 
live cells, particularly when comparing lower addition of Dextran expression. 
 The first cell study acted as a platform to choose a media combination used for 
testing.  Since lower amounts of Dextran did not seem to significantly change the cell 
response, a 1% Dextran 1% FBS solution was implemented.  To verify this assumption, 
this media was compared to control cell culture media and media without Dextran 





of the Live/Dead and MTS assay for reliability and consistency with analysis techniques 
implemented in the 24 hour dynamic study.  The increased proliferation using the 10% 
compared to the 1% FBS medias was expected since low percentages FBS media are 
documented and implemented as lower proliferation media and used to reduce cell 
responses due to FBS. 
 
Conclusion of Altered Media 
Dynamic in vitro testing is important when trying to model the mechanical forces 
present in the arterial system.  In order to investigate the effects of alterations in 
parameters such as shear stresses on cells, alterations of the viscosity of the media are 
needed.  The use of Dextran to increase viscosity for shear testing has been tested on 
endothelial cells1, but not to smooth muscle cells.  This study demonstrates that high 
percentages of Dextran can affect smooth muscle cell response but low percentages may 
be a viable option.  Although the low addition of 1% may not dramatically increase the 
viscosity of the media and therefore the applied wall shear stresses as originally intended, 
the viscosity agrees more with previously determined values and does slightly increase 
the wall shear stresses on the cells.  This presentd work represents the first phase of 
determining in static in vitro conditions which levels of Dextran can be implemented in 
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